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Abstract: 
 
Competency to practise has become an essential part of a health professional’s lifelong journey. It is 
defined in many ways to encompass the intellectual and experiential elements of training along with a 
person’s efforts to keep up-to-date. Many would describe competency as ‘fit for purpose’ to do the job, 
ensuring that the public are protected and given the professional service that meets their expectation. 
One of the conundrums of the regulators of pharmacy practice is how the competency of pharmacists 
can be measured and monitored to fulfil their statutory obligations to the public. Many agree that the 
best way of determining competency would be to observe people in their day-to-day practice. However, 
this would be a prohibitively costly exercise. 
This thesis originated from the question of how competency could be assessed in a form that would 
give regulators confidence and that was cost effective. Most assessment methods used are de facto 
methods of measurement. However, regulators need to have confidence that the assessments are able to 
accurately measure the standard of a person’s professional practice.   
Competency assessment was explored in this work with pharmacists in Tasmania. Initially research was 
undertaken for the Pharmacy Board of Tasmania. The Board set up a project to explore what approach 
could be undertaken in developing an assessment cycle designed to ensure that pharmacists registered in 
Tasmania were competent to practise. Pharmacists were first asked by questionnaire what they did to 
keep their practice up-to-date and their support was canvassed for different methods of assessing and 
maintaining competency. Of the pharmacists surveyed (n = 92) in 2000, 85% indicated that their 
practice was in community pharmacy and they had a median age of 42 years of age.  The most popular 
way of maintaining competency was reading journals, attending continuing education events and doing 
multiple-choice questions. There was also support for long-term competency assessment. 
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Initial work on two competency assessment tools for pharmacists was undertaken in collaboration with 
the Pharmacy Board of Tasmania. The first competency assessment using a written questionnaire 
format was developed with practice-based scenarios to build a picture of what may be encountered in 
everyday pharmacy practice with typical patients. This involved fifteen common community-based 
scenarios. Questions were designed to test how a pharmacist would handle the situations in their 
practice along with multiple-choice questions relating to clinical information that would underpin their 
practice knowledge. However, members of the Pharmacy Board were concerned that the material was 
too ‘clinical’ and would create a negative attitude towards competency. A simpler version of the 
competency tool was refined to six of the fifteen cases of the first competency assessment tool; this 
asked pharmacists both therapeutic and professional questions. When evaluated, the internal reliability 
of this tool was found to be high (Cronbach’s Alpha = 0.9, N = 54).  
The third and final competency assessment tool was designed with a different approach. This was 
developed as a self-assessment tool for pharmacists. It used a web-based format to facilitate pharmacist 
access to information along with feedback and reference material that could then be accessed for further 
reading if needed.  
Professional competence relies on a reflective process as part of lifelong learning. Consequently this tool 
was designed to be a self-assessment tool to enable pharmacists to be able to assess their own learning in 
a framework where learning is self-determined and lifelong. Three modules were developed; two used 
chronic disease areas identified as diseases of national priority – diabetes and asthma, and the third used 
pain management. The design of the self-assessment tools was case-based, asking clinical questions 
relevant to each scenario. When responses were submitted, the participant received feedback and web-
based reference material to access for further reading. Participants attempted the modules twice if 
desired. This self-assessment tool was promoted to pharmacists using a flier posted to all Tasmanian 
registered pharmacists, by e-mail to subscribers of AustPharmList, members of the Pharmaceutical 
Society of Australia (Tasmanian Branch) and nationally to members of the Society of Hospital 
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Pharmacists of Australia. Overall, two hundred and forty-one pharmacists requested access to these 
modules. 
The self-assessments were received favourably by participating pharmacists. As a new concept, 
pharmacists reported having some difficulty with the design and layout of the Fourpoint Learning 
website. There was good internal reliability for the Asthma self-assessment (Cronbach’s Alpha = 0.7, 
N=21) and the Diabetes self-assessment (Cronbach’s Alpha = 0.8, N = 24), but not for the Pain self-
assessment tool (Cronbach’s Alpha = 0.3, N = 21). Analysis of variance between the scores of each of 
the modules and participants’ opinions in the completed surveys did not provide any clear conclusions 
about relationships between their performance and their attitudes.  
Analysis of competency illustrates that it is a complex process that is difficult to interpret. Self-
assessment tools need to be considered as part of a suite of tools and not be relied upon as an 
independent entity.  
Based on the experience gained in the course of this research I would make the following 
recommendations: 
1. A cycle of competency should be nominated for each pharmacist over a five-year period that 
covers every aspect of their practice in both therapeutic and practice topics using a competency 
matrix to guide their Continuing Professional Development (CPD). 
2. The delivery of education to pharmacists needs to be deconstructed. Clearly the literature 
indicates that using one mode of educational CPD will not be sufficient for competency-based 
learning to be successful. There should be clear guidance for pharmacists that all formats of 
CPD delivery should be undertaken. Methods of assessment like Objective Structured Clinical 
Examinations (OSCEs) and the delivery of CPD in the format of Patient Oriented Evidence 
that Matters (POEMS) should be blended into CPD delivery where possible.  
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3. A greater emphasis on learning using personal practice should be promoted with more emphasis 
on the analysis of outcomes of personal practice. This could be explored using electronic 
recording systems such as the one developed in the Pharmacy Recording of Medication and 
Incidents and Services (PROMISe)1 research.  
4. The validation instruments developed by Azzopardi2 should be explored and developed for the 
Australian setting to support the process of competency.   
5. The re-registration process for pharmacists should consider two categories of pharmacists’ 
registration – clinical and non-clinical registration. This may allay concerns amongst pharmacists 
who fear that their business and livelihood will be taken from them if their competency is under 
question. 
                                                 
1 Peterson G Tenni P Hasan O Liauw C Reeve J  Turner P  Vial J. Pharmacy Recording of Medication Incidence and Services electronic 
documentation system (PROMISe).  2004  [accessed February 2007]; Available from: www.guild.org.au 
2 Azzopardi LM. Validation Instruments for Community Pharmacy: Pharmaceutical Care for the Third Millennium: Pharmaceutical 
Products Press; 2000 
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C h a p t e r  1  
 
1. Introduction 
One of the conundrums of the regulators of pharmacy practice is how the competency of pharmacists 
can be measured and monitored to fulfil their statutory obligations to the public. Many agree that the 
best way of determining competency would be to observe people in their day-to-day practice. However, 
this would be a prohibitively costly exercise. This thesis originated from the question of how 
competency could be assessed in a form that would give regulators confidence and that was cost 
effective.  
1.1 Competency 
Competency in professional practice is defined in a number of ways. Holland and Nimmo proposed 
that competency has a number of elements (1). They describe competency as the psychomotor skills and 
intellectual problem solving in combination with a person’s attitudes, values and judgment. Holland and 
Nimmo describe the evolution of pharmacy practice from compounding and distribution to 
pharmaceutical care (2). This took place as changes like large-scale manufacturing took over the primary 
task of pharmacists and made way for the pharmacy role promoting the safe and effective use of 
medicines to become predominant. Depending on the working location of the pharmacist, the role took 
on a guidance and advice role for consumers in the community or patient specific clinical information 
on optimal drug utilization in the acute hospital setting (1). The evolution of pharmacy practice (3, 4) 
needed the profession to define what were the prerequisites for pharmacy practice, as well as articulating 
the standards of professional competency in pharmacy practice. The evolution of the change from 
continuing education (CE) to continual professional development (CPD) articulates the transition that 
we are seeing to competency-based practice (5). 
Kane’s definition (1) of professional competency is as follows: 
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‘the degree to which the individual can use knowledge, skills, and judgment associated with the 
profession to perform effectively in the domain of possible encounters defining the scope of 
professional practice’ 
Schön’s definition (1) is as follows -   
‘Judgment and wise action in complex, unique, and uncertain situations with conflicting values and 
ethical stances. In addition to theoretical and technical knowledge, professional competency requires 
reflective and practical knowledge and competencies for dealing with areas that do not yield technical or 
familiar solutions.’ 
Competency of medical practitioners was reviewed by Epstein (6), expanding its definition not only to 
knowledge, skills, attitudes and beliefs, but to the context of competence to the task at hand. This will 
also depend on the training stage at which competency is measured. The competency of a student will 
mainly rely on the knowledge and problem solving they have experienced, whereas a qualified physician 
could draw on a higher level of experience. 
Holland and Nimmo (1) examined competency in the context of the way that a pharmacist works – with 
their hands and their minds.  They described it as a pharmacist’s skill set. This forms a combined 
professional socialization with judgment that is then applied, along with the knowledge and skills needed 
in the practice-model a pharmacist works in. To the average pharmacist, this definition may appear to be 
too abstract to be applied to their work. Epstein’s description (6) of competency is context-dependent 
and may be more applicable: 
‘Competence is a statement of relationship between an ability (in the person), a task (in the world), and 
the ecology of health systems and clinical contexts in which those tasks occur’ 
The simplest way to describe competency would be practitioners who are ‘fit for purpose’ (7).   
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1.2 Australian competency development 
The majority of pharmacists accept that it is their responsibility to maintain competency at an 
appropriate level in order to continue to practise, recognizing that pharmacy as a profession is 
constantly evolving and they have an obligation of duty of care to the public. The issue of competency 
was discussed in Australian pharmacy circles for many years (8) with the original National Pharmacy 
Competency Standards published in 1992 (9, 10). However, they were primarily used as a guide for the 
registration of pharmacists. A complete revision was undertaken in 2002 and the Competency Standards 
for Australian Pharmacists was published in 2003 (11). These standards described competency as the 
‘skills, attitudes and other attributes (including values and beliefs) attained by an individual based on 
knowledge (gained through study at bachelor’s degree level at least) and experience (gained through 
subsequent practice) which together are considered sufficient to enable the individual to practise as a 
pharmacist’. The Standards provide a comprehensive guide to pharmacists of each competency needed 
to practise, broken down into functional areas. This allows practitioners in any area of practice to 
determine and understand the criteria that fit into their practice. By doing this, the Standards can be 
applied in all circumstances where a pharmacist’s competency needs to be defined e.g. in employment, at 
registration or in self-assessment. 
Currently pharmacists in Australia provide evidence of their participation in different forms of 
education, giving an indirect indication of their competency. Concern about the value of these has 
heralded a re-birth of the awareness of competency nationally and the implementation of the 
Continuing Professional Development program by the Pharmaceutical Society of Australia (PSA) in 
2005 (12). 
The Pharmacy Board of Tasmania, as the registering authority, recognized that it had a responsibility to 
ensure the competency of registered pharmacists. This is because of expectations by the public that 
pharmacists are competent to provide their professional services. The Board undertook a competency 
consultation process with the profession in 1996 and gained the support of all key pharmacy 
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organizations in Tasmania. In 1999, a working party was set up to consider the pathway to competency-
based re-registration in Tasmania. This group resolved to research a competency-based assessment for 
pharmacist registration as the first step in the pathway to requiring competency assessment for annual 
re-registration.  
The genesis of competency-based practice for registered pharmacists was formally introduced in 
Australia by a Report of the National Competition Policy Review of Pharmacy (Wilkinson Report) in 
2000 (13). Its recommendations stated: 
Recommendation 16(g) 
‘States and Territories should move towards replacing qualifications-based criteria with solely 
competency-based registration requirements if and as appropriate workable assessable mechanisms can 
be adopted and applied.’   
Recommendation 18 
‘The review recommends that, within three to five years, States and Territories should implement 
competency-based mechanisms as part of the re-registration processes for all pharmacists.’  
These recommendations were in recognition locally, as well as internationally of the need to protect the 
public and ensure that the practice of all registered pharmacists was kept up-to-date. This would also 
support the self-regulation model and reduce the need for government intervention in professional 
standards, a concern for many professions (14).  
1.3 Continuing professional development 
Until recently, Australian pharmacists were provided with ongoing education in the form of continuing 
professional education (CPE) alone. The delivery of education in a CPE framework generally involves a 
didactic form of education delivery.  Increasingly there is a move to providing CPD (15), defined by the 
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International Pharmaceutical Federation (16) (Fédération Internationale Pharmaceutique - FIP) as ‘the 
responsibility of individual pharmacists for systematic maintenance, development and broadening of 
knowledge, skills and attitudes, to ensure continuing competency as a professional, throughout their 
careers’. There is evidence that the learning style involved in CPD intervention can influence 
professional practice compared to conference and didactic lecture presentations. Davis et al (17) looked 
at how didactic and interactive continuing medical education (CME) influenced medical practitioners’ 
performance and health care outcomes.  The didactic interventions did not significantly change or 
improve performance. However, interactive education such as case discussion, role-play, or hands-on 
practice sessions was more effective.  
The recognition of CPD as a component of re-registration for pharmacists currently occurs only in 
South Australia and Tasmania. The Pharmacy Board of Victoria is introducing a similar program to the 
South Australian model in 2007. 
 The South Australian Pharmacy Board introduced the ENRICH (18) program as a framework for their 
professional development program to promote lifelong learning. The Board issues an annual practicing 
certificate and requires applying pharmacists to have attained 20 ENRICH Credits (ECs), gained 
through CPD activity.  
The Pharmacy Board of Tasmania introduced competency-based re-registration for all registered 
pharmacists in 2004. Each pharmacist must assess their own competency and sign a statutory 
declaration that defines their area of practice along with a completed competency self-audit. As part of 
ongoing self-development, pharmacists are expected to keep a professional portfolio - a plan and record 
of continuing professional development. Pharmacists keep a portfolio of all their CPD activities in the 
previous three years; this is presented to the Board when they are selected for audit. This does not 
require accumulating CPD points, but has a self-directed learning approach, where pharmacists access 
CPD activities based on their own CPD needs. The Pharmacy Board audits 10% of registered 
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pharmacists each year. Pharmacists who are chosen for audit are required to provide the Board with a 
copy of their portfolio as evidence of their competency.  
The PSA introduced the Continuing Professional and Practice Improvement (CPD&PI) program in 
2005. The aim of this program was to promote CPD for Australian pharmacists, introducing the 
concept of a professional portfolio and promoting the concept of greater value for education that had a 
more active learning style. The program encourages pharmacists to actively examine their own personal 
educational needs to improve their practice and to be more self-motivated in maintaining their own 
competency. The PSA CPD&PI program provides credit points to pharmacists based on an educational 
activity’s ability to be interactive, have multiple interventions linked to a pharmacist’s personal practice 
and be based on their own identified educational needs. The PSA credit system has categorized 
educational activities into:  
Group 1 – Activities focusing on delivering information; 
Group 2 – Activities focusing on improving knowledge and skills; and 
Groups 3 – Activities focusing on facilitating change. 
Activities over longer periods are also promoted – research, higher degree courses, participation in the 
pharmacy workplace Quality Care Pharmacy Program (QCPP) (19), medication review accreditation, 
self-audits, self-assessment and safety training.  
1.4 Overseas 
A number of overseas countries also promote and recommend competency based assessment (20, 21). 
This will ensure that changing professional practices will be adopted by all pharmacists, protecting the 
public. These recommendations traditionally followed what was happening at entry level to the 
pharmacy profession where students’ pre-registration performance is increasingly being assessed using 
the competency standards. Out of a total of thirty seven countries surveyed, the Pharmacy Workforce 
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Survey (22) results indicated that CPD and/or CE is mandatory in nine countries and non mandatory in 
about twenty eight countries. 
1.4.1 New Zealand  
The Pharmaceutical Society of New Zealand introduced competency standards in 1995, defining the 
skills, knowledge and attitudes of a New Zealand registered pharmacist. The competency standards 
launched the New Zealand Continuing Competence program – ENHANCE in 2002. This outlined four 
steps in a CPD cycle: 
• Reflect – Determine the competence standards that are relevant to practice, which will be 
documented on a pharmacist’s annual practicing certificate;  
• Plan – Develop identified CPD needs into learning plans; 
• Action – Implement the planned learning; and 
• Evaluate – Evaluate the outcomes of learning and continue the cycle. 
Re-registration(23) in New Zealand now requires a declaration of competency to practise within the 
competency standards that apply to current practice within the pharmacist’s scope of practice. The 
pharmacist is required to make an annual declaration on the basis that they: 
• have undertaken CPD in any activities, relevant to their practice; 
• are a practising pharmacist and declare that they have assessed their competency in the standards 
which form their current practice; 
• have identified the competence standards that form part of their current practice; 
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• have addressed any lack of evidence for elements and activities within the competence standards 
that currently form part of their practice and undertaken CPD in these; 
• have assessed their practice if a change in practice area occurs and will assess themselves against 
any additional standards required relevant to the new role that they may not have evidence for; 
and 
• are enrolled and participating in an accredited recertification programme and achieving the 
recertification requirements set by the Pharmacy Council of NZ. 
In addition to the annual declaration, the re-registration process also requires  – 
1. Completing an assessment of their practice against the Pharmacy Council of NZ 
competence standards at least once every five years and when they change practice area; 
2. Documenting CPD fully using record sheets of the Pharmacy Council of NZ; 
3. Undertaking CPD activities in areas (identified from an assessment of their practice) that 
the Pharmacist does not have ‘evidence’ for; and 
4. Undertaking CPD to accumulate a minimum of twelve (12) Outcome Credits in a three 
(3) year period and achieve a minimum of four (4) Outcome Credits in the first year 
enrolled in an accredited re-registration programme. 
1.4.2 Canada 
In Canada, provinces are responsible for the level of regulation of pharmacists. Ontario was one of the 
first provinces to develop a system of competency assessment for re-registration of pharmacists. 
Learning portfolios were introduced in Ontario in 1997 and a selected sample of pharmacists had to 
provide a copy of their portfolio to the registering and regulating body for pharmacy, the Ontario 
College of Pharmacists. A self-assessment survey of learning and practice needs was required by the 
 9
College of Ontario for 20% of registered pharmacists. In addition to this, randomly selected pharmacists 
were asked to complete a written clinical knowledge assessment that consists of cases and multiple-
choice questions, as well as participating in a clinical skills assessment using an Objective Structured 
Clinical Examination (OSCE) with standardized patients and pharmacy staff. An OSCE consists of a 
series of role-plays where a scenario is presented that will assess a particular competency.  A review by 
Croteau and Marini in 2002 (24) reported that since 1997, one thousand and thirty six had undertaken 
the practice review with the majority of pharmacists (86%) meeting or exceeding the standards.  
The Canadian National Association of Registering Authorities (NAPRA) published a Model Continuing 
Competence Program Framework for Canadian Pharmacists in May 2003 (25). The plan outlined how 
continuing competency for practicing pharmacists would be achieved across all the Canadian 
provinces. The model suggested using four assessment tools: 
• Assessment of clinical knowledge. This would consist of a knowledge assessment that 
would be administered nationally, with questions designed to address each of the 
major competencies required to practise as a pharmacist; 
• Peer and patient assessment. Peer assessment would examine the decisions and actions 
of a pharmacist by their peers. Patient assessments would address communication 
skills, ethical considerations and general professional demeanor; 
• Simulated scenarios administered through an OSCE; and 
• Prescription database analysis. This would examine the standards of pharmaceutical 
care using indicators of substandard quality that could be used to screen potential 
problems in pharmacy practice in a particular pharmacy. 
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1.4.3 United Kingdom 
Pharmacy practice in the United Kingdom (UK) has evolved from a supply-led service to a more patient 
focused practice. While many of the advances in pharmacy practice in the UK have occurred in hospital, 
increasingly community pharmacists are also providing new services and are subject to a process of 
accreditation e.g. pharmacist supplementary prescribing. The Royal Society of Great Britain is the 
regulatory and professional body for pharmacists. As a result of the UK government’s policy paper A 
first class service: Quality in the new NHS (20), the re-registration process for pharmacists in the UK has 
evolved from a system requiring continuing education participation of at least 30 hours per year to one 
of CPD for all registered pharmacists (26). After consultation with pharmacists between 1998 and 2002, 
the Royal Society of Great Britain received feedback from its implementation proposals in 2003 (27). As 
a result of this, pharmacists supported splitting the pharmacist register into two groups - practicing and 
non-practicing. Practicing pharmacists are required to comply with the Society’s CPD requirements. 
Non-practicing pharmacists have to declare that they would not engage in pharmacy practice or give 
professional advice. Each practicing pharmacist is expected to keep a CPD record reviewing their 
activities in a plan, do, study, and act format. CPD records are confidential and can be recorded online. 
Each pharmacist is expected to keep his or her record up-to-date and produce it to the Society when 
requested. There is no specific mix of activities and no minimum time requirement. The emphasis of the 
CPD program is that it is a personal and continual process with the emphasis on quality. At this stage 
the CPD process is being tested and re-tested, prior to a formal CPD process commencing. 
1.5 Other health professions in Australia 
The Royal Australian College of General Practitioners (RACGP) is responsible for ensuring that 
General Practitioners (GPs) access ongoing education. The RACGP Quality Assurance and Continuing 
Professional Development (QA&CPD) Program is designed to ensure that GPs provide the highest 
standards of care (28). Participation in QA&CPD recognized educational activities is linked to meeting 
continuing education commitments required for listing on the RACGP vocational register. By meeting 
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the minimum requirements of the QA&CPD Program, patients of recognised GPs are eligible to receive 
higher rebates from Medicare. The focus of GP education is based on adult learning principles, designed 
to reflect evidence that works and involves peer and self-review processes. The current RACGP 
triennium (28) requires GPs to choose their education from two categories of educational delivery: 
Group 1 activities (5 points per hour) – includes active learning modules, clinical audit modules, small 
group learning modules, supervised clinical attachment modules, learning plan and portfolio modules. 
Group 2 activities (2 points per hour) – includes workshops, seminars, presentations, conference 
attendance, as well as teaching.  
The requirements for GPs are 130 points over the triennium, with a minimum of two Category 1 
activities. 
 The Australian Nursing Council and Midwifery Council (29) developed competency standards for 
registration of nurses in 1997 and they are updated regularly. Registering bodies in each state control the 
standards for nurse registration. In Tasmania, nurses renew their registration or enrolment each year and 
are issued with an annual practising certificate. Most states require registered nurses to undergo a 
process of self-assessment to determine professional competence. In Tasmania nurses are required to 
provide a statutory declaration of their competency on re-registration. On a national level, the National 
Nursing Organisations (30), a national lobby group for the nursing profession, issued a consensus 
statement supporting lifelong learning for nurses. It stated that nurses had a professional responsibility 
to maintain their competency using both formal and informal opportunities for education. 
1.6 Learning styles 
Learning styles can guide the strategies and approach to delivering pharmacy education in a way that will 
support lifelong learning. Austin developed and validated a Pharmacists Inventory of Learning Styles 
(PILS) (31) which he used to examine the learning styles and career choices of pharmacists (32). While 
 12
the sample in the study was small, it provides an insight into the trends of personality types of 
pharmacists in different careers and the format of teaching they preferred. 
Wyatt stated that one of the many challenges in changing to a competency-based method of assessment 
was the need to re-examine the way in which learning takes place, especially in the workplace. He 
suggested that rather than passive listening in lectures, doing work activities with questions relating to 
clinical practice, combined with an open mind to errors, with evidence based information to assist with 
decision making, will begin to change the way in which learning in the workplace is done in the future 
(33). Shah proposed providing work-based clinical skills to students has been shown to be an excellent 
way of learning clinical skills needed in practice (34). Incorporating CPD into the workplace is an ideal 
way of learning. Wyatt (33) explored suggestions on how this could be approached in medical practice 
expanding on how cultural changes could be implemented; this included self-directed learning.  
In pharmacy practice, the recognition that learning is lifelong provided support by using personal 
development plans (20). Developing strategies to support this approach has reinvigorated educators that 
are responsible for delivering education to reformulate how CPD is accounted for and delivered to 
pharmacists (11, 35, 36).  
There is an increased emphasis on the reflection of practice in areas such as counseling patients about 
their medication to ensure that pharmacists are more aware of their competency. Being trained to reflect 
on practice is one of the key elements of attaining competency and is a necessary component of learning 
from experience (37). It enables an individual to identify learning needs and further develop skills and 
knowledge needed to be competent. A Finnish study (38) looked at how pharmacists achieved a high 
level of competency in the context of being able to be reflective about their learning and deliver 
medication counseling rather than medication information. The study found that most pharmacists were 
not at a high level of competency to counsel patients in a detailed guiding way and recommended that 
educators of pharmacists needed to provide further training and support in this area when educating 
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pharmacists. Training pharmacy students to reflect on their practice with a mentor was also used 
successfully to promote lifelong learning (37).  
1.7 Assessing pharmacy competency 
The way in which competency-based practice is assessed will be one of the many challenges faced by 
professionals. The traditional way of keeping up-to-date, by didactic educational sessions, is not 
regarded as an effective approach to adult learning (17) and competency. The cost effectiveness of 
continuing professional development to ensure competency is not known (39); this will need to be 
examined before deciding which approach is best. Future training will involve changing from the current 
structure and process-based curriculum to a competency-based curriculum and evaluation of outcomes. 
(40) Where pharmacy students demonstrate intrinsic motivation to learning, they are more likely to be 
lifelong learners (41).  
Predicting competency is an area of considerable interest to pharmacy registering bodies. Competency 
assessment was measured by Fielding et al (42) and compared to a knowledge test score. Pharmacists in 
British Columbia were asked to undertake both a knowledge based assessment and a competency based 
assessment (an OSCE) and the results of each were correlated. An OSCE is a timed multi-station 
examination using standardised patients to simulate clinical scenarios where communication, clinical 
skills and counselling are assessed. Fielding’s study suggested that pharmacists who obtained higher 
scores on a knowledge test also obtained higher scores on the assessment of competency. However, 
they concluded that predicting competency was a complex task, but did note that participants viewing 
themselves as life long learners with a positive attitude towards the profession were more likely to pass 
knowledge assessments. For medical practitioners, Tamblyn et al. (43) showed a link between final exam 
licensure results and indices of preventative care and acute and chronic disease management in primary 
care practice. In the area of drug knowledge, Tamblyn and colleagues suggest that increasing the pass 
criteria and failing physicians not meeting a higher level would reduce the expected risk of 
contraindicated prescriptions for elderly patients seen by physicians by approximately 40%. While this 
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may prompt a review of the academic standard of individuals entering a profession, the question of 
assessing competency of those already within a profession like pharmacy would require an expensive 
and complex process.  
The level of competency is described as developmental by Epstein (6) because whereas students use the 
same cognitive skills to solving all problems, experienced practitioners draw on other strategies based on 
the professional experiences encountered. In his review, mixed results are quoted on the method of 
assessment. The design of an assessment tool and the type of practice it is designed to assess will also 
have an impact on results. In a study by Fielding (42), pharmacists had their knowledge and their 
competency tested by using a series of questions and an OSCE assessment respectively. The study noted 
that pharmacists who considered themselves specialists were likely to be found to have high ‘false 
negatives’ i.e. individuals who failed the knowledge assessments but passed the competency test in their 
study. The study suggested that the competency assessment used was designed for general pharmacists 
rather than a specialist who is likely to have a narrower range of practice. This suggests that competency 
assessment needs to be redesigned for specialist groups, rather than adding on competencies to a generic 
competency set. However, there is an acceptance that the profession needs to recognise specialty 
practice and there is a need to tailor a competency framework and assessments to fit (7, 44), allowing 
better validation of different areas of practice. 
1.8 Assessment tools 
Research on the assessment of competency for pharmacists is scarce in the literature. The effort in many 
professions to date has been in defining what competency is and what could be measured to assess 
competency. Few tools to measure competency have been reported in the literature (40). Other 
professional groups such as medical practitioners have examined competency in detail. However, their 
skill set is in diagnosis rather than medication management skills. Many of the professional skills of self-
assessment, judgement, communication, managing relationships and the context in which professional 
services are provided would be applicable in many professions. However, frameworks need to be 
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designed to assess competency at the right level of practice (7, 42) and need to ensure that assessment 
does not focus too heavily on knowledge based competencies (45). 
Prior learning is used in a number of circumstances where the cost of in-depth assessment is not 
possible. Austin looked at a systematic method of developing the prior learning assessment in Canada 
for foreign trained pharmacists (46).  The results of this work highlighted the need to consider cultural 
and communication competencies that are difficult to do with normal paper based competency 
assessments. 
Many professions use Objective Structured Clinical Examination (OSCE) assessment. They regard this 
as the most effective method for assessing a professional’s competency. However, to use OSCEs on an 
ongoing basis to measure competency would be prohibitively expensive to the health system.  
Multiple-choice examinations are popular methods of assessment. However, these can only examine 
factual information and hypothetical problem solving. Many professional groups use multiple-choice 
exams in combination with evidence of participation in different learning strategies. However, this 
approach has also been reported to be used to apply clinical knowledge. Language proficiency is 
regarded as a factor in a pharmacist’s ability to respond to questions where the application of knowledge 
is assessed.  
Professional portfolios are used in many professions to provide evidence for maintaining competency. 
This is a collection of evidence that individual pharmacists collate to demonstrate their individual 
educational activities that reflect their own identified needs to maintain their professional competence. 
These are generally designed to allow an opportunity to observe and reflect on growth, development 
and learning. The Ontario College of Pharmacists introduced portfolios as part of its quality assurance 
peer review process. The use of these portfolios was measured by Austin et al (21) who suggested that a  
portfolio provides structure. However, pharmacists also need guidance and discussion on how to 
achieve their self directed learning. This may include a self-assessment in various areas of competency 
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and can be promoted as part of the reflection process of personal learning (47). This can also provide 
balance to the use of peer review (48).  
The Ontario College of Pharmacists started reviewing the competency of its pharmacists in the mid 
nineties (21). Each year, twenty per cent of registered pharmacists are randomly chosen to submit their 
self-assessment and about 240 of these are selected to participate in a Quality Assurance Review. This 
process was reviewed by Austin et al. (49) for the period from 1996 to 2001 and included a multiple 
choice test to assess clinical knowledge and an OSCE to assess the application of clinical knowledge, 
ability to gather information, ability to manage patients’ drug related needs and communication skills. In 
this five-year period, eighty six per cent of pharmacists met the standards – the remainder needed peer 
assistance. Pharmacists who had difficulty with this review tended to be those who were educated 
outside Canada, or in community practice or who had been in practice for 25 years or more. Mills et al 
(50) also noted that male, older pharmacists, who own their own pharmacy also need support to 
increase their competency skills.  
One small study (51) examined self-assessment in competency of clinicians in the area of evidence based 
medicine (EBM). GPs were asked to rate their understanding of some EBM terms before participating 
in a structured interview where they were asked to explain each of the EBM terms to a student. The 
self-rating of EBM understanding did not match the objective criterion based assessment. This poses 
the question of how valid self-reporting and self-assessment are as an assurance that professionals are 
competent in critical areas of their practice.  
A validation instrument for community pharmacists was published in 2000 by Azzopardi (52) for 
pharmaceutical care. The model used internal validation tools ― community pharmacy setting, 
dispensing a prescription, responding to symptoms, communicating with the patients, equipment and 
professional services available in a community setting, as well as external validation tools such as a 
consumer services tool and health professionals tool. The reliability and the internal consistency for each 
validation tool was high (Cronbach’s Alpha>0.8 for internal tools and >0.95 for external tools). This is a 
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very objective approach that focuses on the outcomes delivery by the pharmacy rather than assessing 
pharmacists in a CPD cycle process or against competency standards. 
1.9 E-learning assessment tools 
E-learning is increasingly being used as a vehicle to deliver education to many health professionals 
including pharmacists. This includes journals, online video presentations and online discussion groups as 
well as multiple-choice assessments. E-learning options are gaining in acceptance because they provide 
access to education at a time and place that is convenient to the user (53, 54). When designed properly, 
they can be comparable to live educational activities (55). 
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C h a p t e r  2  
2 Method 
The aim of this research was to explore how competency could be assessed to manage a pharmacist’s 
registration based on their competency. When this research started, the concept of competency was new 
and practical elements of how to implement an assessment of competency were being debated. 
2.1 Initial methodology 
In the initial stages, work for the Pharmacy Board of Tasmania was undertaken. The aim of this work 
was to develop, trial and assess a mechanism for competency based annual re-registration within 
Tasmania. Its main objective was to examine what approach could be taken by the Board to undertake a 
cycle of assessment ensuring that pharmacists registered in Tasmania are competent to practice.  When 
this work was started in 2000, the Competency Standards in Australia (2003) for Pharmacists were not 
available. The Competency Standards for Entry Level Pharmacists (9) were used to underpin the initial 
work for a competency model with consideration of the PSA’s Professional Practice Standards (56), the 
Standards for the Provision of Pharmacist Only and Pharmacy Medicines in Community Pharmacy (57), 
other guidelines of the Society and guidelines produced by the Society of Hospital Pharmacists of 
Australia (58) and the Pharmacy Guild’s Quality Care Pharmacy Program (19).  
The original objectives are outlined as follows: 
• Inform all pharmacists about what competency standards are and how they apply to individual 
practice; 
• Find out what the barriers are likely to be from practicing pharmacists; 
• Find out what are the successful elements of competency measurement that can be adopted 
from other states, countries and other professions; 
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• Investigate the most important pharmacy practice outcomes that need to be measured; 
• Explore what choices will allow pharmacists to select their own methods of demonstrating their 
competency; and 
• Develop, test and pilot an assessment tool that will be user-friendly. 
The scope of this work involved consultation with pharmacists in Tasmania, by way of a survey sent to 
all Tasmanian registered pharmacists. It involved individual phone interviews and a formal consultation 
process with organisations representing pharmacists in Tasmania – the PSA and the SHPA. Prior to 
receiving any information, pharmacists were initially informed of the project by a letter sent to all 
Tasmanian registered pharmacists from the Pharmacy Board of Tasmania, explaining the project and 
inviting any interested pharmacists to contact Mary Collins as the project researcher.  
2.2 Phase 1 – Pharmacists’ survey 2000 
In 2000, pharmacists in Tasmania were invited to respond to a survey (Appendix 1) examining the issue 
of pharmacy competency. The main aim of the survey was to ascertain what Tasmanian pharmacists did 
at the time to maintain their competence and to gauge their attitude and opinions on which educational 
activities they would support as part of the process of maintaining professional competence. 
The survey was posted to all registered pharmacists on the Pharmacy Board of Tasmania mailing list, 
including those who were living in other Australian states. A random sample of pharmacists was 
interviewed by phone, using the same survey questions as the basis of collecting demographic details 
about respondents. Interviewees were also asked the following questions: 
1. What are the most important elements of pharmacy practice that a pharmacist must be competent 
in? 
2. What skills are of most value to practise pharmacy? 
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3. If you were asked to test a pharmacist’s competency, what scenario would you use? 
The results of these phone interviews were collated separately to the postal survey.  
2.3 Phase 1 - Competency assessment tool No 1  
The first competency assessment tool (Appendix 2) was developed by researcher Mary Collins at the 
request of the Pharmacy Board of Tasmania as part of a body of work they funded. This consisted of 
fifteen scenarios designed to allow pharmacists to reflect on a scenario and how they would approach 
this scenario problem from their own practice and knowledge point of view.  
The 2001 Competency Standards(11) work undertaken by the PSA had not been undertaken when this 
assessment was undertaken. Accordingly, the 1993 Competency Standards for the initial registration as a 
pharmacist (entry-level) after pre-registration had been undertaken were used in the development of this 
assessment tool. 
This assessment tool contained fifteen scenarios and each one was designed to portray a typical scenario 
in a community pharmacy. Each scenario had questions on knowledge and pharmacy practice approach, 
designed to allow reflection of a pharmacist’s action and how they would apply their knowledge. The 
knowledge-based questions were in multiple-choice format. The practice approach questions asked the 
pharmacist to indicate what they would do in the normal practice circumstance in their pharmacy – 
‘Always’, ‘Sometimes’, ‘Never’ in response to a proposed action in the scenarios. The scenarios were 
designed to cover all pharmacist competencies. 
The assessment tool covered the following scenarios: 
Scenario 1: 
A new patient presents to your pharmacy with a prescription for Imdur (isosorbide mononitrate) tablets 
60 mg. He tells you he had a recent angina attack but has since seen a specialist and was given this 
prescription by his GP today. While you are dispensing his Imdur tablets, he hands a box of Solprin 
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(aspirin) to your assistant. When you are finished dispensing his Imdur, he also asks you for some 
Anginine (glyceryl trinitrate); a nurse at the hospital said he could buy them without a prescription. 
Scenario 2: 
A 17-year-old girl M.L. presents a prescription for doxycycline 100 mg daily. She appears anxious, 
indicating that she would like to have a talk with the pharmacist and says that she will call back for her 
medicine the following day. Some hours later M.L’s mother calls into the pharmacy and asks your 
assistant if her daughter has had a prescription dispensed. 
Scenario 3: 
A 15-year-old asthmatic Miss Gaze presents at your pharmacy and asks if she could get two Ventolin 
(salbutamol) inhalers because she is going on holidays for two weeks. She said she wanted a spare 
inhaler in case she loses one. In conversation she tells you that she has been very wheezy in the last few 
days. 
Scenario 4: 
Mrs H is a nursing home patient in her early seventies with a history of diabetes, hypertension, 
depression and anxiety. An endocrinologist recently reviewed her during a hospital admission. Her 
current medications are buspirone, glibenclamide, enalapril and paroxetine. The RN telephones you 
requesting a prescription for erythromycin that had just been prescribed for a URTI. Mrs H administers 
her own medication and uses a dose administration aid.  The RN would like you to prepare an updated 
one as a matter of urgency. 
Scenario 5: 
Mr W has been having methadone 70 mg as a daily dose for three months. He appears in your 
pharmacy for his usual dose, appears to stagger but talks to you in a coherent way. 
Scenario 6: 
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Mrs Long has been a regular customer in your pharmacy for various minor ailments in the past. She has 
mentioned that she dislikes taking medication and once confided in you that she regularly visits a 
herbalist. Mrs Long was dispensed sertraline a few days ago in your pharmacy by a locum and said she 
was fine for the first few days but now has returned saying that she has the shivers, sweats a bit and feels 
agitated. She thinks that she has caught flu and asks you what you would recommend. 
Scenario 7: 
Mrs Long is a 50-year-old with a history of chronic back pain and has been prescribed Panadeine Forte 
(paracetamol/codeine phosphate 500/30 mgs) by her doctor. She has been requesting preparations for 
constipation from you for some time. She has seen an article in a woman’s magazine on bowel cancer 
and is very concerned that she is at risk and has asked your assistant if there is a herbal remedy that can 
be used to prevent any problems developing. 
Scenario 8: 
A 34-year-old mother of two regularly has prescriptions filled for Ventolin (salbutamol) and Becotide 
(beclomethasone). She is occasionally prescribed prednisolone for exacerbations of her asthma. She has 
not had any prescriptions filled for prednisolone in the past six months. She requests a small box of 
aspirin and asks for a fungal cream for the itchiness between her toes. 
Scenario 9: 
Nursing home patient Mrs Jolly is an 88-year-old with a history of heart failure. She is being prescribed 
enalapril and indapamide by her GP and has taken Voltaren (diclofenac) occasionally for a sore 
shoulder. You are aware that her symptoms include breathlessness and swollen ankles. When you last 
did a medication review a week ago, her latest electrolytes were Na 130 mmol/L, K 5.3mmol/L and 
Creatinine 120 mmol/L. The RN on duty has contacted your pharmacy requesting spironolactone 25mg 
daily for Mrs Jolly. 
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Scenario 10: 
Mrs Scott has had her prescriptions dispensed at your pharmacy for the last five years. She has had a fall 
recently but has generally been in good health as far as you are aware. She had her prescriptions filled 
yesterday. At the time she appeared to be very energetic. She has been stable on irbesartan and 
hydrochlorothiazide for 6 months. 
Her daughter Ms Scott arrives in your pharmacy two weeks later and presents her prescription for the 
pill. She says that she is concerned about her mother and tells you that her mother is now very dizzy and 
seems a bit off. She said that her mother pulled a muscle in her shoulder a week ago, but that the pain 
was under control after she gave her some of her own pain killers for it. 
Scenario 11: 
A consumer presents at your pharmacy in a distressed state. He shows you a very inflamed area on his 
lower arms and hands. He has a burning sensation on these areas since he started using a cream 
prescribed by his dermatologist that was prepared in your pharmacy. He says it has been very itchy and 
inflamed and he has a burning sensation on his skin. The initials on the cream label indicate that your 
registration student prepared this cream a week ago. 
Scenario 12: 
Mr Smith, a 65-year-old, has fallen in your pharmacy on his way out after having his prescription filled 
for Imdur (isosorbide mononitrate) and Dyazide (hydrochlorothiazide and triamterene). Mr Smith was 
able to get up unaided but received a few cuts and grazes on his right hand and lower arm. Your 
dispensing assistant was the only person who witnessed the accident. 
Scenario 13: 
A carer looking after Mr English, a 70-year-old pensioner, contacts your pharmacy by phone one 
morning to check up on medication dispensed at your pharmacy a week ago. He said he had assumed 
that they were a new brand of his medication but wanted to be certain. He is prescribed Avapro 
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(irbesartan), frusemide (Lasix) and warfarin. On investigation it was found that Aropax (paroxetine) was 
dispensed as a single item by a locum instead of Avapro.   
Scenario 14: 
Mrs Jones, who is thirty weeks pregnant comes into your pharmacy with her 4-year-old son James. She 
asks you for advice on what preparation she should use to treat James’ rash. The rash is behind his ears 
and she has been treating it with hydrocortisone 1% that you gave her some time ago for a previous 
rash. After taking a history, you determine that her son is most likely to have a head lice infestation. 
Scenario 15: 
Mr McGraw is a 79-year-old male who has been on gemfibrozil for the past three years and on 
nefazodone for depression. His GP has recently started him on simvastatin. Mr McGraw’s GP contacts 
you requiring some information regarding the medications Mr McGraw is taking because the latter has 
presented to him with severe muscle cramps. 
2.4 Competency assessment tool No 2 
A second competency assessment tool (Appendix 3) was developed when the first assessment tool did 
not meet the approval of the Pharmacy Board of Tasmania. This was developed, using the scenarios of 
the first assessment tool, in accordance with the needs and concerns of the Pharmacy Board of 
Tasmania and incorporating their feedback into its design.   
This assessment tool presented a simpler version of six of the fifteen case scenarios developed by the 
first self-assessment tool. The questions were written in simpler form, asking questions about both 
therapeutic and professional decisions in multiple-choice format. For each scenario, a brief feedback 
summary was provided. 
This was evaluated by community pharmacists, hospital pharmacists, 4th year and pre-registration 
students, using 1st year pharmacy students as a control (See Appendix 4). It was assumed that 1st year 
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students would have little knowledge and ability to respond to pharmacy practice scenarios commonly 
experienced in the day-to-day practice of pharmacy.  
2.5 Phase 2 - Self-assessment modules 
Using the experience of this work, a different approach was taken with the last self-assessment tool 
developed. In line with the philosophy that competency is driven by an individual’s needs for education 
and training, this tool was developed as a pharmacist’s self-assessment in the form of web-based 
modules. These would link with personal continuing professional development rather than being an 
assessment provided to a third party. The topics covered were diabetes, asthma and pain management.  
2.5.1 Module design: 
The case-based modules were designed to explore the level of knowledge that participants had and their 
ability to apply their knowledge to a case-based based scenario. Modules were based on the national 
priority areas of chronic diseases – Asthma (Appendix 5) and Diabetes (Appendix 6), and Pain 
management (Appendix 7).  Feedback on the correct responses to each question was provided when 
each question was attempted. The case study for each module was based on typical patients who had 
complex disease presentations that pharmacists would have to deal with on a regular basis in community 
practice. Participants were given unlimited time; question attempts were voluntary and could be 
deferred. Each of the modules could be attempted twice, giving participants a second chance at 
choosing answers with the ability to look up references that would provide them with background 
material to the question.  
Pharmacists were recruited to participate in this study in 2006 using a flier sent to all Tasmanian 
registered pharmacists, members of AusPharmList (an online discussion group) (59), members of the 
PSA (Tasmanian Branch) and SHPA members nationally (See Appendix 9).  
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Completed modules were posted on FourPoint Learning (60), a web based platform for education (See 
screenshot below). Fourpoint is an online Learning Delivery System designed to facilitate interactive, 
self-paced, just-in-time learning run by a company called Etech. The platform provides an ability to put 
educational content into modules consisting of questionnaire and survey formats that can be accessed 
by learners to complete work assigned for student work, professional development or formal 
assessment. 
 
The Asthma, Diabetes and Pain modules were loaded on to Fourpoint Learning platform’s QT 
assessment area using a ‘cut and paste’ technique from Microsoft Word. The platform did not allow any 
formatting of text within the modules so fine-tuning some aspects of the web presentation was not 
possible. The system required that the self-assessment questions and survey feedback questions were 
separate. When pharmacists registered their interest in doing these modules they were given a logon and 
password, they were also given instructions explaining what to do (See Appendix 10). Each self-
assessment required participants to compete a survey that provided feedback and their opinions about 
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their performance on that topic. When all the self-assessment modules were completed, pharmacists 
were asked to complete a general CPD survey to gain CPD points (See Appendix 8). This CPD survey 
canvassed each pharmacist’s personal views of pharmacy practice. A prize was offered as an incentive 
for pharmacists to complete all three surveys.  
The self-assessments were designed to allow some modification according to need e.g. amount of time a 
participant to compete a task and the number of attempts. 
The following screen prints illustrate the ability of the Fourpoint Learning platform to develop online 
learning material. They show how the assessments can be modified for the user, to specify the number 
of attempts, whether questions could be submitted at once or postponed until later.  However, at the 
time the system was accessed for these illustrations, the screens did not present properly, this was an 
ongoing issue when using the system because support from Etech was not timely. The screenshot below 
shows the design options available, however the text is not seen. Although requested, Etech did not 
provide a screenshot without errors before this research was submitted. The reports extracted from 
Fourpoint were also of inferior quality and requested adjustments were not made available to assist with 
data extraction. 
 28
Figure 2.1: Screenshots of the Fourpoint QT assessment illustrating its properties 
 
The correct display is illustrated below –  
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Figure 2.2: Screenshot of the Fourpoint QT assessment showing a preview of QT  
assessment options 
 
2.5.2 Asthma Module: 
Module Education Objectives: 
• Review the pharmacist’s professional knowledge of rational therapy for asthma management; 
• Improve knowledge to support the pharmacist’s role in asthma drug therapy management;  
• Assist with a pharmacist’s understanding of the differences between asthma and chronic 
obstructive pulmonary disease (COPD); 
• Review professional knowledge of drug interactions in asthma therapy; and 
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• Using a case study, review asthma therapy and medication changes required for optimal patient 
benefit.  
Asthma Module Case study: 
A regular pensioner patient of yours, 72-year-old Mrs Brown asks you about an asthma drug she has just 
heard about – Singulair and whether it would have any benefit for her asthma. She tells you that she 
finds her current medications are not working any more and she has trouble using her inhalers. Her 
hands are arthritic and she finds that they are not strong enough to actuate her inhalers. 
She has been a smoker for twenty years and has a history of hypertension and arthritis that mainly 
affects her hands. You know that she has had several admissions to hospital in the past year mainly due 
to asthma. Recently her doctor told her that she has emphysema. She is one hundred and sixty eight 
centimeters tall, weighs sixty-two kilograms (BMI = 22), and at present finds it almost impossible to take 
daily exercise. When you question her further, she tells you that she wakes up wheezing each morning 
and she gets short of breath when walking up the footpath to her house. 
Her current medications are: ramipril 5 mg once daily, paracetamol 500mg – one or two four times daily, 
prednisolone 5 mg daily, fluticasone/salmeterol (Seretide) inhaler 250/50mg - two puffs twice daily, 
ranitidine 300 mg daily, ipratropium bromide 42 micrograms/dose (Atrovent Forte) two puffs three 
times daily when required. 
2.5.3 Diabetes Module: 
Module Education Objectives: 
• Review the pharmacist’s professional knowledge of rational drug therapy in managing type 2 
diabetes;  
• Improve knowledge to support for the pharmacist’s role in the management of type 2 diabetes;  
• Review the role of cardiovascular disease management in type 2 diabetes;  
• Review the selection of drugs for glycaemic control in type 2 diabetes; and 
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• Using a case study, review type 2 diabetes therapy and medication changes for optimal patient 
benefit.  
Diabetes Module Case study: 
A retired 70-year-old teacher Mr Smith is a regular patient of your pharmacy. His current medications 
are: aspirin 150 mg once daily, ramipril 5 mg once daily, amlodipine 10 mg once daily, simvastatin 20 mg 
once daily and celecoxib 200 mg once daily. He smokes, has a history of hypertension and has elevated 
lipid levels. He is five feet three inches tall, his weight is poorly controlled, (at present his weight is one 
hundred and two kilograms) and he finds it almost impossible to take daily exercise because of arthritic 
knees. He is on metformin 500 mg four times daily, and has also been on gliclazide MR 30 mg daily for 
the past two months. 
He suffers regularly from flu and is just recovering from a recent bout of illness. He has told you that he 
had been visiting his daughter in Brisbane with his wife for the last four weeks. During that time he was 
admitted to the local hospital to investigate his complaints of dizzy spells. This dizziness was thought to 
have precipitated a recent severe fall that fractured his arm.  
2.5.4 Pain Module: 
Module Education Objectives: 
• Review the pharmacist’s professional knowledge of rational therapy in managing chronic pain; 
• Improve knowledge to support the pharmacist’s role in chronic pain management; 
• Review the role of oxycodone therapy in chronic pain management; 
• Review drug interactions involved in pain management therapy; 
• Assess the risks of abuse and dependence in chronic pain; and 
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• Using a case study, review pain management therapy and medication changes needed for 
optimal benefit.  
Pain Module Case study: 
A 60-year-old patient, Mr Parker, until recently had a small business but was forced to retire because of 
severe osteoarthritis. He has restricted dexterity in his hands, has difficulty walking any distance because 
his knee joints have become very painful and he is unable to do any physical work after he was involved 
in a motor vehicle accident about five years ago. He also has a past history of asthma since childhood. 
However, his current pain regimen does not exacerbate this. He now presents a prescription for 
Oxycontin (oxycodone) 10 mg twice daily. His GP has prescribed increasing numbers of medicines to 
manage his pain. He started coming to your pharmacy two years ago, shortly after he had reconstruction 
surgery of his right knee. He was taking paracetamol and indomethacin and seemed to cope well with 
his pain.  
About six months ago, Mr Parker’s GP prescribed Codalgin Forte. When he had a laminectomy about 
three months ago, he was discharged from hospital and prescribed celecoxib and ketorolac. However, 
these did not control his pain post surgery and tramadol was initiated six weeks ago.  At the time, you 
spoke to his GP about his pain control. He told you that Mr Parker’s pain was complex, and that the 
specialist indicated that some of his pain was neuropathic in origin, as a result of his surgery. He also 
drinks about six cans of beer daily to cope with his pain. 
Your records tell you that he is currently taking the following prescribed medications: Celebrex 
(celecoxib) 200 mg daily, Codalgin Forte (codeine and paracetamol 30/500 mg) two four times daily, 
diazepam 5g four times daily when required, Endep (amitriptyline) 50 mg three at night, Indocid 
(indomethacin) suppositories 100 mg twice daily when required, Lipitor (atorvastatin) 20 mg at night, 
Panamax (paracetamol) 500 mg one to two four times daily when required, Rani-2 (ranitidine) 150 mg 
two twice daily, Seretide Accuhaler (fluticasone and salmeterol 100/50 mcg) one inhalation twice daily, 
Temaze (temazepam) 10 mg one to two at night, Toradol (ketorolac) 30mg amps for injection by GP 
and tramadol 150 mg SR twice daily. 
OTC medicines you know that he buys from your pharmacy regularly - Voltaren Emulgel (diclofenac), 
apply to knee as required and glucosamine 1000 mg daily. 
Mr Parker confirms that he is taking all his listed medication. However, he feels that he is taking too 
many medicines and wants to know if he should be taking all his medicines at the same time. Instead of 
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taking his new Oxycontin (oxycodone), he wants to know if he could increase the doses of other pain 
medicines instead.   
 
2.6 Evaluation  
All the modules were evaluated using questions that centred on aspects of competency – knowledge, 
skills, attitude and beliefs as well as opinions about each participant’s performance. The evaluation for 
each topic module was in survey format using Likert (61) scales to gauge pharmacist opinion.  
Figure 2.3 and Figure 2.4 illustrate how the module surveys were presented to pharmacist participants. 
Table 2.1 provides a list of general questions asked in each module and Table 2.2, Table 2.3 and Table 
2.4 list the questions asked in the Asthma, Diabetes and Pain surveys respectively. 
Figure 2.3: Screenshot of Asthma survey 
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Figure 2.4: Screenshot of Section 5 of Asthma Survey using Likert scales  
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Table 2.1: General questions asked in each module evaluation 
Section 1. Personal details          
Questions  
1. Gender 
2. Age (Range) 
3. Year of graduation 
4. Pre-registration training area of practice 
5. Accredited to conduct medication reviews 
6. Since you graduated have you gained any formal clinical qualifications? 
7. What is your current area of practice? 
8. What activities listed below do you do to maintain your competency? 
Questions Other feedback 
Section 4. Preferred approach to competency        
Questions Rating Scale:  Likert Scale 
1. A self-assessment tool is my preferred approach to revise my competency in this area 
2. Self-assessments provide an additional support to my competency development 
3. Self-assessment tools are useful to support other forms of learning 
4. I feel uncomfortable having my competency assessed in this way 
5. Competency assessment should only be undertaken at the workplace 
6. Competency assessment is a personal professional responsibility and should not be assessed by others 
1. Please write any comments or suggestions that you would like to make about this self-assessment 
2. In hours, how much time did this self-assessment take you? Your answer should be a number e.g.2, 2.5, 2.45  
 36
Section 5. Success with this self-assessment        
Questions Rating Scale:  Likert Scale 
1. I completed all the questions successfully 
2. Although some of my responses were not correct, I am happy with my progress in this area 
3. I need further continuing education in this area 
4. The standard of this assessment is too high for community pharmacists 
5. The standard of this assessment is too clinical 
6. This assessment is only useful for medication review accredited pharmacists 
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Table 2.2: Asthma tool evaluation questions 
Section 2. Asthma tool rating           
Questions Rating Scale:  Likert Scale 
1. Prior to doing this self-assessment I was not confident with my knowledge on asthma therapy 
2. This assessment tool helped me revise my current knowledge on asthma therapy 
3. This assessment has not provided additional information for me beyond my current knowledge on asthma 
therapy 
4. This assessment tool has not helped me 
5. This assessment tool helped me assess my knowledge of current asthma therapy 
Section 3. Skills in asthma therapy         
Questions Rating Scale:  Likert Scale 
1. I feel confident with my professional skills in this area 
2. I feel confident about assessing my patient's asthma therapy needs after completing this assessment 
3. I feel confident that I am able to counsel patients on how to use asthma devices after completing this 
assessment 
4. I am now confident in being able to demonstrate inhaler technique to my patients 
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Table 2.3: Diabetes tool evaluation questions 
Section 2. Diabetes tool rating        
Questions Rating Scale:  Likert Scale 
1. Prior to doing this self-assessment I was not confident with my knowledge on diabetes therapy 
2. This assessment tool helped me revise my current knowledge on diabetes therapy 
3. This assessment tool did not provide additional information for me beyond my current knowledge of diabetes 
therapy 
4. This assessment tool has not helped me 
5. This assessment provided me with new information on current diabetes therapy 
Section 3. Pharmacy skills in diabetes therapy        
Questions Rating Scale:  Likert Scale 
1. I feel confident with my professional skills in this area 
2. I feel confident about assessing my patient's needs for diabetes counselling after completing this assessment 
3. I feel confident about assessing my patient's drug management needs for diabetes after completing this 
assessment 
4. I feel confident that I am able to counsel patients on lifestyle issues after completing this assessment 
5. I am now confident in being able to counsel my patients on medication issues related to chronic diseases 
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Table 2.4: Pain tool evaluation questions 
Section 2. Pain tool rating         
Questions Rating Scale:  Likert Scale 
1. Prior to doing this self-assessment I was not confident with my knowledge on pain management therapy 
2. This assessment tool helped me revise my current knowledge on pain management therapy 
3. This assessment tool has not provided additional information for me beyond my current knowledge on pain 
management therapy 
4. This assessment tool has not helped me 
5. This assessment tool helped me assess my knowledge of current pain management therapy 
 
Section 3. Skills in pain management therapy        
Questions Rating Scale:  Likert Scale 
1. I feel confident with my professional skills in this area 
2. I feel confident about assessing my patient's pain management therapy after completing this assessment 
3. I feel confident that I am able to counsel patients on how to control their pain using their medication 
4. I am now confident in being able to assist patients with minimising risks associated with long-term pain 
medication management 
When participating pharmacists completed the self-assessments and surveys linked to asthma, diabetes 
and the pain topic, they were asked to complete a CPD survey. This survey asked pharmacists about 
their attitudes to statements about pharmacy practice and what they thought of the website and modules 
(Appendix 8).  
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2.7 Continuing professional development (CPD)  
CPD points were applied for to provide recognition for completing modules as an educational activity 
from the PSA and the SHPA. The self-assessment tools were categorised by PSA as Category 2 activities 
with 2 CPD points per hour and SHPA approved their members to claim the number of hours taken to 
complete the activity. The competencies(11) for each of the modules were: 
Asthma: 
Functional Area 1: Practice Pharmacy in a professional manner - 1.2.3, 1.3.1 and 1.3.2. 
Functional Area 2: Manage work issues and interpersonal relationships in pharmacy practice - 2.1.3. 
Functional Area 3: Promote and contribute to optimal use of medicines -3.1.1, 3.1.2, 3.1.3, 3.1.4, 3.1.5, 
3.2.1, 3.2.2, 3.2.3, 3.3.1 and 3.3.2. 
Functional Area 4: Dispense Medicines - 4.2.2 and 4.2.3. 
Functional Area 6: Provide primary health care - 6.1.1, 6.1.2, 6.2.2, 6.2.4, 6.2.5 and 6.3.2. 
Functional Area 7: Provide medicines and health information and education - 7.1.5, 7.2.2, 7.2.3, and 
7.3.2. 
Diabetes:  
Functional Area 1: Practice Pharmacy in a professional manner - 1.2.3, 1.3.1 and 1.3.2. 
Functional Area 2: Manage work issues and interpersonal relationships in pharmacy practice - 2.1.3. 
Functional Area 3: Promote and contribute to optimal use of medicines - 3.1.1, 3.1.2, 3.1.3, 3.1.4 and 
3.3.2. 
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Functional Area 4: Dispense Medicines - 4.2.3 and 4.3.3. 
Functional Area 6: Provide primary health care - 6.1.1, 6.1.2, 6.2.2, 6.2.4 and 6.3.2. 
Functional Area 7: Provide medicines and health information and education - 7.1.5, 7.2.2, 7.2.3 and 
7.3.2. 
Pain:  
Functional Area 1: Practice Pharmacy in a professional manner - 1.2.3, 1.3.1 and 1.3.2. 
Functional Area 2: Manage work issues and interpersonal relationships in pharmacy practice - 2.1.3. 
Functional Area 3: Promote and contribute to optimal use of medicines - 3.1.1, 3.1.2, 3.1.3, 3.1.4 and 
3.3.2. 
Functional Area 4: Dispense Medicines - 4.2.1, 4.2.2, 4.2.3 and 4.3.3. 
Functional Area 6: Provide primary health care - 6.1.1, 6.1.2, 6.2.2, 6.2.4 and 6.3.2. 
Functional Area 7: Provide medicines and health information and education - 7.1.5, 7.2.2 and 7.2.3. 
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2.8 Analysis 
The Pharmacist Survey 2000 was summarised in Microsoft Excel according to the year of pharmacist 
registration, their area of practice, how they maintained their competency, their attitude to the mode of 
education delivery (e.g. lectures, multiple choice questions) and how often they felt it should be 
undertaken. 
The Competency assessment tool No 2 was collated and analysed in SPSS. The question responses were 
summarised as correct or incorrect answers and a Cronbach’s Alpha analysis was used to test the inter-
reliability of the questions.  The responses of the evaluation of this assessment were collated in Excel 
and graphs were prepared of response summaries.  
The results of the self-assessment modules and their surveys were downloaded from Etech’s Fourpoint 
learning web platform in an Excel spreadsheet format. An analysis of data from all surveys and statistical 
analysis was undertaken in SPSS 14.0 for Windows. The self-assessment results provided information on 
a pharmacist’s answer, whether they were completed, their points, the maximum score and time spent. 
Unfortunately, the Etech platform did not provide accurate and consistent reports on the time each of 
the participants spent on their self-assessments. Consequently, this information was not used in the 
analysis. The data provided in both the self-assessments and surveys had to be re-designed and all linked 
to each participant to allow analysis in SPSS.  
 The self-assessment responses for each module were collated as either correct or incorrect for each of 
response and Cronbach’s Alpha used to determine the internal reliability of the self-assessments. The 
relationship of the score as a variable was explored statistically as follows:  
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• with groups of pharmacists (accredited and not accredited3) using unpaired samples t-test;  
• their opinions about their performance in the self-assessments and their area of practice  using One-
way between groups ANOVA;   
• if there was a relationship between scores and the pharmacist’s time since graduation using Pearson 
product-moment correlation coefficient (r); and 
• the relationship between their scores and the amount of CPD activities they undertook using 
Spearman’s Rank Order Correlation (rho). 
                                                 
3 Pharmacists accredited to undertake Medication Management Reviews 62. Department of Health and Ageing. Medication Management 
Reviews   [accessed December 2007]; Available from: 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/Medication+Management+Reviews  
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C h a p t e r  3  
3 Results 
This research was conducted in two phases over a six-year period, during which time the environment 
of pharmacists’ practice has evolved significantly. In 2001, the PSA published Competency Standards 
for Pharmacists in Australia (10). This was revised in 2003 (11) to cover a wider range of practices and 
was designed to be used as a primary reference for the profession as well as a reference for registering 
and credentialing bodies, employers, universities and providers of pharmacy education. In this landscape 
the relevance and application of competency to the day-to-day practice of pharmacists had evolved to 
such an extent that the learnings in Phase 1 were factored into planning educational activities for Phase 
2.  
3.1 Phase 1 
A survey developed in consultation with the Pharmacy Board of Tasmania was sent to all Tasmanian 
registered pharmacists in 2000. Phone interviews with individual pharmacists and a formal consultation 
process with organisations representing pharmacists in Tasmania (PSA and SHPA) were undertaken.  
3.1.1 Pharmacist’s Survey 2000 
This survey was designed to find out what pharmacists did for their continuing education and their 
opinions of different forms of continuing education activities (See Appendix 1). Ninety-two pharmacists 
responded to the survey, giving a response rate of nineteen per cent.  
Data collated from the 2000 survey are illustrated in Figure 3.1 and 3.2. Figure 3.1 show that a higher 
representation from pharmacists who were recent graduates participated in this survey. Figure 3.2 shows 
where participant pharmacists practiced according to the choices given by the survey. Community 
pharmacists were the biggest group in this survey with thirty three per cent being community pharmacist 
owners, thirty per cent community pharmacists and twenty one per cent community pharmacist locums. 
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Survey Participants
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Because this survey was only circulated to Tasmanian pharmacists, it is not surprising that the number 
of hospital pharmacists would be low compared to community pharmacists. However, the percentage of 
hospital pharmacists in this group (13%) compares to the national figure of 15% (63).  
Figure 3.1: Pharmacists’ Survey 2000: summary of registration years of 
 participating pharmacists 
Figure 3.2: Pharmacists’ Survey 2000: Area of practice of participating pharmacists 
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Figure 3.3 summarises the activities that participating pharmacists used to maintain their competency. 
The most common activities nominated were continuing education (CE) attendance (17%) and journal 
reading (19%). The reason why a high proportion of pharmacists nominated multiple choice questions 
(16%) as one of the top three CE methods is likely to be because at the time of the survey the Pharmacy 
Board of Tasmania sent out a multiple choice questionnaire to all Tasmanian registered pharmacists, 
similar to the PSA’s Gold questionnaire, on an annual basis. 
 
Methods of maintaining competency 2000
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Figure 3.3: Pharmacists’ Survey 2000: Methods of maintaining competency of  
participating pharmacists  
When pharmacists were asked about their attitude on which form of education would provide the 
greatest benefit to maintain their competency, there was a mixed response.  
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 Figure 3.4: Summary of Pharmacists’ attitudes on the benefit of formats of educational  
delivery in Phase 1 (N = 92). 
 
The responses (Figure 3.4) indicated that most types of CE were generally regarded as of benefit, 
with reading journals and CE attendance having the most perceived benefit for pharmacists who 
responded to the survey. Pharmacists were asked how often each of the educational activities should 
be undertaken in intervals of one per year, 1-5 per year, 6-12 per year, every two years or never. 
Pharmacists chose only CE presentations, Multiple Choice questions, Reading journals and Peer 
Review as activities that they would like to do to maintain their competency. None of the 
pharmacists selected regular journal club, self-directed learning, pharmacy setting review, self-
assessment tools or using a portfolio. 
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Figure 3.5: Pharmacists’ Survey 2000: Nominated frequency of CPD activities 
From Figure 3.5 above, the most frequent activity that pharmacists supported was multiple choice 
questions between one to five times per year, reading journals on a monthly basis and attending CE 
about one to five times per year. Pharmacists were asked to rate the CE activities that were listed in 
the survey, rating on a scale of 1 to 5, with 1 as most important. From Table 3.1 below, pharmacists 
overwhelmingly supported CE presentations, multiple-choice questions and reading journals as the 
most important way of maintaining their competency.  
 
 
 
  
 49
 
Table 3.1: Pharmacists’ rating of the importance of education activities in 
 maintaining competency (N = 92) 
 
Activity Rating of activities (Percent.)  
 1 2 3 4 5 
CE presentations 24.2 16.2 21.2 9.1 13.1 
Multiple Choice questions 24.2 23.2 20.2 8.1 10.1 
Reading Journals  38.4 28.3 13.1 4 7.1 
Peer Review 10.1 18.2 15.2 17.2 18.2 
Regular Journal club 21.2 3.0 10.1 23.2 9.1 
Self-directed learning 19.2 25.3 26.3 9.1 8.1 
Pharmacy setting review 11.1 16.2 21.2 10.1 19.2 
Self-assessment tool 18.2 26.3 18.2 12.1 8.1 
Portfolio  13.1 18.2 5.1 9.1 21.2 
In addition to pharmacists’ surveys, discussions with the local branch council of the PSA and a 
presentation to the SHPA’s 2001 annual Tasmanian conference were undertaken. There were mixed 
views from both bodies. The overall impression was that there was little awareness of what 
competency involved. However, there was overwhelming support for the concept. Many expressed 
the view that dispensing was a compulsory component of competent pharmacy practice. When 
asked how they would test a pharmacist’s competency, there was support from registering bodies 
for spending time with a pharmacist, using case studies that also involved OTC products and 
observing how a pharmacist was able to counsel patients. Fourteen pharmacists were interviewed by 
phone because it became too difficult to engage pharmacists on a face-to-face basis. 
Overwhelmingly, pharmacists responded that drug information and good communication skills were 
essential elements of a competent pharmacist.  
3.1.1.1 Competency assessment tool No 1 
This assessment tool was reviewed by the Pharmacy Board, with most Board members completing the 
assessment tool. The Board rejected this tool as a competency assessment tool for pharmacists, 
requesting that it needed to be made simpler for the majority of community pharmacists. (See Method 
2.3) 
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3.1.2 Competency assessment tool No 2 
This competency assessment tool was undertaken by 1st and 4th year pharmacy students, pre-registration 
students known as Graduate Accreditation Program (GAP) trainees, as well as community and hospital 
pharmacists in 2002. The competency assessment tool was completed without references under exam 
conditions. Participants were not restricted to a specific time period; most took about an hour to 
complete it.  
Table 3.2: Representation of pharmacist groups who participated in  
Competency assessment tool No 2. 
 
Assessment participants Number (N) 
1st year pharmacy students 28 
4th year pharmacy students 28 
Graduate Accreditation Program students 
(GAP) - Pre-registration trainees 
9 
Hospital pharmacists 13 
Community pharmacists 9 
 
Correct responses were documented from all respondents and were marked against the possible total of 
possible correct responses (see Appendix 3). All questions were assessed as having one correct answer 
and if there were more than one answer marked, the questions were marked as incorrect/not answered.  
Figure 3.6 illustrates a summary of the answers. This shows that in both an assessment of theory and 
practice questions, all participants except some 1st year pharmacy students achieved over 50% of the 
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maximum score. It would have been expected that 1st Year pharmacy students would not have been able 
to achieve a high score on a test like this if questions were targeted at information and practice that 
could distinguish pharmacists from students with a reasonable amount of health knowledge.  
Results of competency assessment test
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Figure 3.6: Competency assessment results summary for all participating 
 groups (mean scores) 
Statistical analysis using Cronbach’s Alpha coefficient, measuring how well the competency questions fit, 
showed that there was good inter-reliability between the questions. (Cronbach’s Alpha coefficient 0.9, N 
= 54). However, the high score rate result of all the test groups indicates that that it was not a suitable 
instrument to test competency of pharmacists involved in a re-registering process. 
Community pharmacists, hospital pharmacists and GAP trainees undertook an evaluation of the 
assessment tool after completing it (See Appendix 4). The scores in Figure 3.7 were from 1 to 10 and 
the ratings were as follows: 
• Applicability: Not at all applicable – Very applicable 
• Easy of use: Not at all easy to use – Very easy to use 
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• Professional feedback: Not at all – Provides good feedback.  
• For competency regarding knowledge, judgment and attitudes: Not at all – Very well 
As shown in Figure 3.7, the results indicated that all participants regarded the tool in a positive light.  
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Figure 3.7: Summary of Competency Survey in 2002: Opinions about the survey: median  
of response  from each group represented.  
When asked if the competency tool was a reasonable method to explore competency assessment in 
pharmacy, none of the groups gave a ‘Yes’ response. In response to the question ‘In your opinion would 
this assessment tool cover competency in hospital pharmacy practice’, the hospital pharmacists and 
GAP trainees responded ‘No’ overall and the community pharmacists were unsure. 
3.2 Phase 2 - Self-assessment modules 
Requests to undertake the CPD modules in asthma, diabetes and pain were received from two hundred 
and seventy four pharmacists following the circulation of a flier to all registered pharmacists in 
Tasmania, SHPA members nationally and a posting on AusPharmList. (See Appendix 9)  
 53
The modules were loaded on to the Fourpoint Learning platform hosted by Etech. The system required 
that the self-assessment questions and survey feedback questions were separate. When pharmacists were 
given a logon and password, they were also given instructions detailing what to do (See Appendix 10). 
Each self-assessment required participants to compete a survey that provided feedback and their 
opinions about their performance on that topic. When all the self-assessment modules were completed, 
pharmacists were asked to complete a general survey to gain CPD points. The CPD survey was a 
general questionnaire that canvassed each pharmacist’s personal views of pharmacy practice. 
The Fourpoint Learning online system based its scoring on the number of correct responses answered 
by participants. Correct single question responses were scored as 1, and multiple question responses 
were marked according to the number of correct choices in the question. If a multiple responses 
question had two correct choices out of four, and the participant selected the right two, the score would 
be four because all the choices were correct. When modules were analysed, the results were adjusted to 
one mark per question.  
An example from the Asthma module is shown below:  
Question / Instructions 
You have decided to research COPD to further your understanding of Mrs Brown’s condition. On completion 
of your reading, you now feel able to recommend a review of Mrs Brown’s medication to her GP. For a 
review of her asthma medicines and COPD. Which of the following statements are correct?  
 
A Inhaled bronchodilators provide relief and may increase exercise capacity  
B 
Long acting bronchodilators provide sustained relief of symptoms in moderate to severe 
COPD 
 
C Long term systemic corticosteroids are recommended in COPD  
D 
Inhaled corticosteroid should be considered in patients with a documented response or 
those who have severe COPD with frequent exacerbations. 
 
  
Where questions had more than one answer, the response for giving the correct answers were shown as: 
Response 
4 out of 4 selections are correct 
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An example of a question that had only one answer is: 
How many puffs would you normally recommend be used at one time in a spacer?  
 
A One   
B Two  
C Six  
D As many as required   
The response for this correct answer was given as: 
Response 
Your answer is correct 
 
3.2.1 Pharmacist profile 
One hundred and twenty pharmacists participated in this research out of the two hundred and seventy 
four pharmacists who volunteered to participate. They were predominantly female (64%) and were in 
the age range of 40 or less, and had graduated in 1990 or later, had trained in community pharmacy or a 
combination of community or hospital (66.4%). Fifty per cent now worked in community pharmacy 
practice and thirty one per cent were accredited to do medication reviews (64, 65). The demographics of 
the participants who completed at least one or more self-assessment tools were as shown in Table 3.3.   
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Table 3.3: Demographics of pharmacists who completed one or more  
self-assessments (N = 120) 
 
Demographics Variables Percent. 
Male 35.6 Gender 
Female 64.4 
Community Pharmacy 53.8 
Hospital  33.6 
Area of practice for pre-
registration 
Combination of both 
Community and Hospital 
12.6 
Community 50.5 
Hospital 39 
Primary of area of 
pharmacy practice 
Other 10.5 
Accredited to do 
medication reviews 
Yes 31.1 
20-25 14.5 
26-30 22.2 
31-40 17.9 
41-50 24.8 
51-60 15.4 
Age range 
Over 60 5.1 
 
When year of graduation was grouped into bands as illustrated in the histogram in Figure 3.8, the year of 
graduation bands show a normal distribution. This shows a lower representation of pharmacists who 
were registered twelve to sixteen years ago in this study. This was not the case in the 2000 survey (Figure 
3.1) that involved only Tasmanian registered pharmacists. Perhaps this was because the 2000 survey was 
sent directly to each Tasmanian registered pharmacist and the 2006 self-assessment tool used post for 
Tasmanian registered pharmacists and electronic distribution for other pharmacy groups.  
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Figure 3.8: Year of graduation (as a range) for all participants who completed one  
or more self-assessments 
Participant pharmacists had eleven choices of pharmacy practice to identify as their area of practice. The 
results showed that in many cases, pharmacists practice in both community and hospital practice. The 
proportion of pharmacists who identified community practice and hospital practice for first choice was 
roughly equal (See Figure 3.9). In community practice 8.6% were owners, 2.9% were managers, 22.9% 
pharmacists, and 16.2% were locums. In hospital practice 34.3% were pharmacists and 4.8% were 
managers, with other categories accounting for the remainder of the group. 
                                                                                                
                                                                                                                           Scale 
                                                                                                                           1= 2005-2006 
                                                                                                                           2= 2004-2000 
                                                                                                                           3= 1999-1995 
                                                                                                                           4= 1994-1990 
                                                                                                                           5= 1989-1980 
                                                                                                                           6=1979-1970 
                                                                                                                           7=1969-1960 
                                                                                                                          8=>1959                    
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Figure 3.9: Primary area of practice identified by all participants who completed one or  
more self-assessments:  
Pharmacists were asked to identify what form of CPD activities they undertook to maintain their 
competency, from a prepared list (Figure 3.10). The number of CPD activities that pharmacists 
identified ranged from 1 up to 10. To use this information in a meaningful way, a CPD rating was 
formulated from these numbers to gauge if pharmacists who engaged in a greater variety of activities 
were more successful in achieving higher scores on the self-assessments. The choices are listed as 
follows:  
• CE attendance 
• Reading journals 
• Using a mentor 
• Self directed learning 
12.0010.008.006.004.00 2.000.00 
Area of Practice Full Group 
(N = 105) 
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0
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2 = Community (manager) 
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(pharmacist) 
4 = Community (locum) 
5 = University 
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8 = Hospital (pharmacist) 
9 = Liaison pharmacist 
10 = Educational visitor 
11 = Other 
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• CE presentation 
• Self-assessment tool 
• Peer review 
• Audit 
• Student supervision 
• Multiple choice questions 
• Review in the pharmacy setting 
• Regular journal club 
• Other. 
  
Figure 3.10: CPD rating of participating pharmacists 
 
The number of different types of CPD activities pharmacists selected was counted for each individual 
(Figure 3.10, Table 2.1). The total number of activities was divided by the maximum number of possible 
results of the self-assessments; these were averaged out over the number of self-assessments undertaken 
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by that individual and multiplied by 10 to get a rating range of 1-10. The median number of activity 
types that pharmacists undertook was 3.9, representing an undertaking of nearly four types of CPD 
activities, out of a scale of 10. (Mean = 4, SD = 1.5) 
 
The formula used to calculate the CPD rating was as follows:  
( X1 + X2 +X3 )  
_______________           X 10 
           Y 
X1, X2, X3  = The number of activities undertaken by pharmacists expressed as a fraction of 1, in the 
Asthma, Diabetes and Pain modules.  
Y = the number of modules undertaken 
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3.2.2 Asthma Self-assessment  
The Asthma self-assessment consisted of twenty-two multiple-choice questions, eight had more than 
one response and the remainder had single choice response answers. The pass mark set for all the 
Fourpoint Learning module assessments was sixty per cent. The Asthma self-assessment was 
undertaken by one hundred and seven (39%) of the two hundred and seventy four pharmacists who 
registered to do the CPD modules (See Figure 3.11). The Fourpoint Learning scoring system recorded a 
pass for 74.8% of participants. When the Asthma module scores were adjusted to weight each question 
equally, only 44.9% of participants passed i.e. obtained a score of more than sixty per cent (Mean (score 
out of 22) = 12.1, Median = 13, SD = 4.7). 
Using SPSS, the internal reliability of the Asthma self-assessment tool was undertaken using the adjusted 
question responses attributed as correct or incorrect. Using SPSS, Cronbach’s Alpha was 0.7 (N = 21), 
showing consistent inter-reliability between the self-assessment responses.  
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Figure 3.11: Results of Asthma self-assessment: questions answered correctly 
Examination of these results revealed that only 34 pharmacists completed a second attempt of the 
module (Table 3.4). This group had a higher number of correct responses (Mean = 15.8, SD = 2.5) 
compared to the full group (N = 107). It would appear that many of the participants ‘cherry-picked’ the 
questions they wanted to answer. As a result, it was not possible to compare the two series of answers to 
detect changes or improvements in answer responses.  
Table 3.4: Comparison of first and second Asthma self-assessments attempts 
 
Assessment Mean Std. Deviation N 
1st Asthma self-
assessment 
15.8 2.5 34 
2nd Asthma self-
assessment 
10.9 2.1 34 
25.0020.0015.0010.00 5.00 0.00 
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3.2.3 Asthma Survey 
The Asthma Survey was completed by one hundred and two participants (Table 2.1, 2.2, and 3.5). The 
Asthma survey collected information on personal details, how long it took and asked participants to rate 
the self-assessment in the competency areas of knowledge, skills, attitude and beliefs. 
The pharmacists who undertook the Asthma self-assessment were predominantly female, had primarily 
trained and were now working in community pharmacy.  Thirty three per cent were accredited to 
undertake medication reviews. Most were less than or equal to forty years of age. The mean number of 
years since graduation was 16.8. Participants reported taking an average of an hour and a half to 
compete the self-assessment (Table 3.6).  
Table 3.5: Demographics of pharmacists who completed the Asthma survey (N = 102) 
 
Demographics Variables Percent. 
Male 33.3 Gender 
Female 66.7 
Community Pharmacy 53.9 
Hospital  33.3 
Combination of both 
Community and Hospital 
10.8 
Area of practice for pre-
registration 
Other 2.0 
Community 51 
Hospital 39 
Primary area of 
pharmacy practice 
Other 10 
Accredited to do 
medication reviews 
Yes 33 
20-25 16.7 
26-30 21.6 
31-40 17.6 
41-50 25.5 
51-60 12.7 
Age range (Years) 
Over 60 5.9 
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Table 3.6: Details of time since graduation and length of time taken to do  
Asthma self-assessment. 
 
 Mean Median SD Range 
Number of years 
since graduation 
16.8 12 13.6 1-64 
Time taken to do self-
assessment (Hours)  
1.4 1 0.75 1-3.7 
 
Pharmacists also provided information (Table 2.1 & 2.2) on the self-assessment regarding how they 
rated the self-assessment tools. The questions were formulated to ask questions that examined the 
competency elements of knowledge, skills, attitude and beliefs using Likert Scales.  
Analysis of the survey questions (Table 3.7) shows that participants strongly supported one response 
over all others in a number of the questions. The statement “This assessment has not helped me” (Table 
3.7: 2.4) was disagreed or strongly disagreed with by eighty three per cent of participants. Seventy per 
cent agreed that the self-assessment helped assess their knowledge of asthma, sixty six per cent agreed 
with the statement “I feel confident about assessing my patient’s asthma therapy needs after completing 
this assessment” (Table 3.7: 3.2) and sixty five per cent agreed with the statement “I am confident in 
being able to demonstrate inhaler technique to my patients” (Table 3.7: 3.4). This supports the use of a 
self-assessment in reviewing drug therapy in a disease area chosen for revision by a pharmacist. The 
attitude of pharmacists to self-assessments was supportive, with seventy two per cent indicating that 
they were useful to support other forms of learning. More than half (58.3%), were not concerned about 
having their competency assessed by others. The statement ‘I completed all the questions successfully’ 
(Table 3.7: 5.1) was disagreed with by 61% and 69% indicated that they were happy with their progress 
with asthma. This would point to asthma being an area in which pharmacists appreciate CPD support.  
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This is supported by the Asthma self-assessment being the most popular choice of self-assessment tool 
amongst pharmacists who registered to do these modules.  
Table 3.7:  Asthma Survey: Number of Pharmacist responses (84) 
Survey questions 
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Asthma tool rating        
2.1 Prior to doing this assessment I was 
not confident with my knowledge on 
asthma therapy 
2 
(2.4%)
3   
(3.6) 
19 
(22.6) 
26  
(31) 
32 
38.1) 
2        
(2.4) 
84 
2.2 This assessment tool helped me revise 
my current knowledge on asthma therapy  
2    
(2.6) 
0 40 
(51.3) 
6   
(7.7) 
2   
(2.6) 
28    
(35.9) 
78 
2.3 This assessment tool has not provided 
me with additional information beyond 
my current knowledge on asthma therapy 
3    
(3.8) 
0 11 
(14.1) 
4   
(5.1) 
49 
(62.8) 
11    
(14.1) 
78 
2.4 This assessment has not helped me 2       
(3) 
0 3      
(4) 
8 
(10.4) 
53 
(68.8) 
11    
(14.3) 
77 
2.5 This assessment tool helped me assess 
my knowledge on current asthma therapy 
1    
(1.3) 
0 54 
(70.1) 
3   
(3.9) 
3   
(3.9) 
16    
(20.8) 
77 
Skills in asthma therapy        
3.1 I feel confident with my professional 
skills in this area 
0 0 51   
(68) 
12  
(16) 
8 
(10.7) 
4        
(5.3) 
75 
3.2 I feel confident about assessing my 
patient’s asthma therapy needs after 
completing this assessment 
0 0 49 
(66.2) 
11 
(14.9) 
5   
(6.8) 
9      
(12.2) 
74 
3.3 I feel confident that I am able to 
counsel patients on how to use asthma 
devices after completing this assessment 
0 0 42 
(56.8) 
8 
(10.8) 
4   
(5.4) 
20       
(27) 
74 
3.4 I am confident in being able to 
demonstrate inhaler technique to my 
patients 
0 0 49 
(65.3) 
5   
(6.7) 
1   
(1.3) 
20    
(26.7) 
75 
Preferred approach to competency         
4.1 A self-assessment tool is my preferred 
approach to revise my competency in this 
area 
0 0 42 
(57.5) 
15 
(20.5) 
6   
(8.2) 
9      
(12.3) 
73 
4.2 Self-assessments provide an additional 
support to my competency development  
0 0 58 
(79.5) 
2   
(2.7) 
 13    
(17.8) 
72 
4.3 Self-assessment tools are useful to 
support other forms of learning  
0 0 52 
(72.2) 
1   
(1.4) 
 19    
(26.4) 
72 
4.4 I feel uncomfortable having my 
competency assessed in this way 
1    
(1.4) 
0 11 
(15.1) 
9 
(12.3) 
40 
(54.8) 
12    
(16.4) 
73 
        
                                                 
4 Participants did not respond to all survey questions 
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Survey questions 
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4.5 Competency assessment should only 
be undertaken at the workplace 
0 0 3   
(4.1) 
12 
(16.4) 
46   
(63) 
12    
(16.4) 
73 
4.6 Competency assessment is a personal 
professional responsibility and should not 
be assessed by others 
1    
(1.4) 
0 6   
(8.3) 
23 
(31.9) 
37 
(51.4) 
5        
(6.9) 
72 
        
Success with this self-assessment        
5.1 I completed all the questions 
successfully 
1    
(1.4) 
0 12 
(16.4) 
12 
(16.4) 
45 
(61.6) 
3        
(4.1) 
73 
5.2 Although some of my responses were 
not correct, I am happy with my progress 
in this area 
  50 
(69.4) 
7   
(9.7) 
12 
(16.7) 
3        
(4.2) 
72 
5.3 The standard of this assessment is too 
high for community pharmacists 
4    
(5.5) 
0 2   
(2.7) 
5   
(6.8) 
51 
(69.9) 
11    
(15.1) 
73 
5.4 The assessment is only useful for 
medication review accredited pharmacists 
0 0 1   
(1.4) 
3   
(4.1) 
52 
(71.2) 
17    
(23.3) 
73 
5.5 The standard of this assessment is too 
clinical 
0 0 2   
(2.7) 
6   
(8.2) 
51 
(69.9) 
14    
(19.2) 
73 
 
3.2.4 Asthma Module analysis 
The survey questions explored knowledge, skills, attitudes and beliefs about the participants’ 
competency. SPSS analysis of variance was used to ascertain whether their opinions were linked to the 
correct answers obtained (Table 3.8). Respondents were asked whether they were unsure, strongly 
agreed, agreed, were neutral, disagreed or strongly disagreed with the statements (Table 3.7). Question 
5.2 in Table 3.7 was the only question where there was a significant difference in response. (One-way 
ANOVA: F(3,52) = 2.7, p = 0.05). The highest ranking (i.e. highest test scores) for this question was 
from those who agreed with the statement, indicating that their competency in this area was not under 
question for them. No other survey question identified a link between performance on the self-
assessment and opinions. The numbers of participants undertaking this survey was small (N = 102) and 
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that range of responses was limited. Hence, it was difficult to explore statistical links with the responses 
of this survey.  
 
 
 
Table 3.8: Analysis of variance between Asthma module scores and Asthma survey. 
 
Survey questions: One-way ANOVA F (df) p 
Prior to doing this assessment I was not confident with 
my knowledge on asthma therapy 
0.3 (5,61) 0.93 
This assessment tool helped me revise my current 
knowledge on asthma therapy  
2.0 (4,56) 0.11 
This assessment tool has not provided me with 
additional information beyond my current knowledge on 
asthma therapy 
1.0 (4.57) 0.44 
This assessment has not helped me 1 (4,56) 0.46 
This assessment tool helped me assess my knowledge on 
current asthma therapy 
0.2 (4,56) 0.93 
I feel confident with my professional skills in this area 0.8 (3,54) 0.46 
I feel confident about assessing my patient’s asthma 
therapy needs after completing this assessment 
1.3 (3,54) 0.28 
I feel confident that I am able to counsel patients on 
how to use asthma devices after completing this 
assessment 
0.19 (3,54) 0.9 
I am confident in being able to demonstrate inhaler 
technique to my patients 
1.1 (3,55) 0.35 
A self-assessment tool is my preferred approach to 
revise my competency in this area 
1.5 (4,52) 0.21 
Self-assessments provide an additional support to my 
competency development  
0.05 (2,54) 0.95 
Self-assessment tools are useful to support other forms 
of learning  
0.99 (2,54) 0.38 
I feel uncomfortable having my competency assessed in 
this way 
0.43 (4,52) 0.79 
Competency assessment should only be undertaken at 
the workplace 
0.95 (3,53) 0.96 
Competency assessment is a personal professional 
responsibility and should not be assessed by others 
0.72 (4,51) 0.58 
I completed all the questions successfully 1.88 (4,52) 0.13 
Although some of my responses were not correct, I am 
happy with my progress in this area 
2.72 (3,52) 0.05 
The standard of this assessment is too high for 
community pharmacists 
0.87 (4,52) 0.49 
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Survey questions: One-way ANOVA F (df) p 
The assessment is only useful for medication review 
accredited pharmacists 
0.54 (3,53) 0.66 
The standard of this assessment is too clinical 0.37 (3,53) 0.77 
 
The number of different types of CPD undertaken by participants was converted into a rating for the 
entire group ranging from 0-10 (Figure 3.10). The number of CPD activities that pharmacists were 
involved in was not related to their asthma score (Table 3.9). A correlation between the number of CPD 
activities and the Asthma self-assessment score was not significant (r = 0.14, p = 0.17, N = 91). 
There was a considerable range in the time since participants graduated, with a median of 12 years 
(Mean = 16.8, SD = 13.6, Range = 1 – 64 years). Using SPSS, a Pearson correlation between the asthma 
score and the number of years since graduation was undertaken (Table 3.9). However, there was no 
significant correlation between these variables (r = 0.15, p = 0.19, N = 79) 
The relationship between the Asthma self-assessment scores and whether the pharmacists were 
accredited (33%) was investigated (Table 3.9). Using an independent samples t-test, there was no 
significant difference between the accredited (Mean =13.67, SD = 3.4) and non-accredited pharmacists 
(Mean = 12.5, SD = 4.4; t (82) =1.1, p = 0.3).  
The areas of practice categorized as Community, Hospital and Other were explored to see whether the 
area of practice showed differences in the Asthma self-assessment responses, but there was no 
significant difference between the groups. (One-way ANOVA – F (2, 82) = 0.93, p = 0.4) 
Table 3.9: Relationship of Asthma Self-assessment scores with variables 
 
Variable Correlation 
Coefficient 
p N 
CPD rating (0 – 10)* r = 0.14 p = 0.17 91 
Number of years since 
graduation+ 
r = 0.15 p = 0.19 79 
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Accredited to do 
medication reviews# 
t(82) = 1.1 
Yes = Mean 13.67 
SD=3.4 
No = Mean 12.6, SD = 
4.4 
 
p = 0.29 (Yes) = 28 
(No) = 56 
+Pearson correlation coefficient, * Spearman’s rho, #T-Test  
3.2.5 Diabetes self-assessment 
The Diabetes self-assessment was undertaken by seventy-seven of the participants who registered to do 
the CPD modules. The Diabetes self-assessment module consisted of 27 multiple-choice questions, 16 
of which had more than one response and 11 were single choice response questions. On the Fourpoint 
learning score, 89.6% of participants passed with a pass mark set at sixty per cent. When this was 
adjusted to weight each question equally, 72.7% passed the assessment (Mean (score out of 27): 18.4, 
Median 18, SD 4.9). Using SPSS, the internal reliability of the Diabetes self-assessment responses was 
found to be reliable (Cronbach’s Alpha = 0.8, N = 24). In SPSS, three questions were removed 
automatically because they had zero variance.  
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Figure 3.12: Results of Diabetes self-assessment: questions answered correctly 
Only twenty-two participants made a second attempt at doing the self-assessment (Table 3.10). 
Pharmacists (N = 22) who had a second attempt had a higher correct response rate (Mean = 23.6, SD = 
2.6) compared to the full group (N = 77). Like the Asthma self-assessment (Table 3.6), the results show 
that these participants did not attempt all the questions they had undertaken in the first self-assessment 
(Mean = 14.6, Median = 15, SD = 2.55).  
Table 3.10: Comparison of first and second Diabetes Self-assessments attempts 
 
Assessment Mean Std. Deviation N 
1st Diabetes self-
assessment 
23.6 2.6 22 
2nd Diabetes self-
assessment 
14.6 2.7 22 
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3.2.6 Diabetes Survey 
The Diabetes survey was completed by seventy-two participants (Table 2.1, 2.3, 3.11). However, not all 
survey questions were completed. Participants were 73.6% female and 34.7% were accredited to do 
medication reviews. In the area of practice, 44.4% nominated community pharmacy practice and 43.1% 
nominated hospital pharmacy practice as their first choice of current practice. The Median age range was 
31-40 years (Table 3.11) and the mean number of years since graduation (Table 3.12) was 17.7 (SD = 
13.6, Range = 1 – 64). Overall, pharmacists only took a Mean of 1.3 hours to do this assessment.  
Table 3.11: Demographics of pharmacists who completed the Diabetes Survey (N = 72) 
 
Demographics Variables Percent. 
Male 26.4 Gender 
Female 76.6 
Community Pharmacy 59.7 
Hospital  31.9 
Area of practice for 
pre-registration 
Combination of both 
Community and Hospital 
8.3 
Community 44.4 
Hospital 43.1 
Primary area of 
pharmacy practice 
Other 12.5 
Accredited to do 
medication reviews 
Yes 34.7 
20-25 15.3 
26-30 19.4 
31-40 20.8 
41-50 23.6 
51-60 16.7 
Age range 
Over 60 4.2 
The mean of the number of hours taken to complete this self-assessment reported in hours or a fraction 
of an hour, was 1.3. (Table 3.12: Median = 1, SD = 0.7, Range = 0.2 – 4).  
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Table 3.12: Details of time since graduation and length of time taken to do  
Diabetes Self-assessment. 
 
 Mean Median SD Range 
Number of years 
since graduation 
17.6 14 13.6 1-64 
Time taken to do 
self-assessment 
(Hours)  
1.3 1.0 0.70 0.2 – 4.0 
 
Participants were asked to rate questions about their practice and the competency elements of 
knowledge, skills and beliefs using a Likert Scale (Table 3.13 and Appendix 10). The number of 
respondents (N = 72) and the range of responses was too small to undertake extensive statistical 
analysis. However, some clear trends were evident in the ratings. There was overwhelming agreement 
that this self-assessment helped revise participants’ knowledge in diabetes therapy (93% agreed or 
strongly agreed).  Generally, participants were confident with their skills, assessing needs and ability to 
counsel patients in diabetes therapy. Participants were supportive of having their competency assessed. 
Overall 69.3% disagreed or strongly disagreed with the statement ‘I feel uncomfortable having my 
competency assessed in this way’ (Table 3.13: 4.5) and sixty five per cent disagreed or strongly disagreed 
with the statement ‘Competency assessment is a personal responsibility and should not be assessed by 
others’ (Table 3.13: 4.7). The statement ‘Competency should only be assessed in the workplace’ (Table 
3.13: 4.6)  was disagreed or strongly disagreed with by eighty two per cent of pharmacists, supporting 
the assessment of pharmacists by external groups in other forums of pharmacy practice. The self-
assessment was supported as not being too clinical (87.3%) or too high a standard for community 
pharmacists and 85.8% disagreed with the statement ‘The standard of this assessment is too high for 
community pharmacists’ (Table 3.13: 5.4). 
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Table 3.13: Diabetes survey - pharmacist responses 
  
Survey questions 
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2.0 Diabetes tool rating        
2.1 Prior to doing this assessment I was not 
confident with my knowledge on diabetes 
therapy 
0 6 
(9.7) 
17 
(27.4) 
13 
(21) 
24 
(38.7) 
2      
(3.2)  
62 
2.2 This assessment tool helped me revise my 
current knowledge on diabetes therapy  
0 16 
(25) 
44 
(68.8) 
2 
(3.1) 
1 
(1.6) 
1      
(1.6) 
64 
2.3 This assessment tool has not provided me 
with additional information beyond my current 
knowledge on diabetes therapy 
0 0 6 
(9.5) 
10 
(15.9) 
42 
(42) 
5      
(7.9) 
63 
2.4 This assessment has not helped me 0 0 3 
(4.7) 
4 
(6.3) 
46 
(71.9) 
11  
(17.2) 
64 
2.5 This assessment tool provided me with 
new information on current asthma therapy 
0 8 
(12.5) 
37 
(57.8) 
17 
(26.6) 
2 
(3.1) 
0 64 
3.0 Pharmacist skills in diabetes therapy        
3.1 I feel confident with my professional skills 
in this area 
0 6 
(9.4) 
51 
(79.7) 
6 
(9.4) 
1 
(1.6) 
0 64 
3.2 I feel confident about assessing my 
patient’s needs for diabetes counseling after 
completing this assessment 
1 
(1.6) 
8 
(12.5) 
48 
(75) 
5 
(7.8) 
2 
(3.1) 
0 64 
3.3 I feel confident about assessing my 
patient’s drug management needs for diabetes 
after completing this assessment 
1 
(1.6) 
6 
(9.4) 
49 
(76.6) 
5 
(7.8) 
3 
(4.7) 
0 64 
3.4 I am confident in being able counsel 
patients on lifestyle issues after competing this 
assessment  
0 20 
(31.3) 
40 
(62.5) 
4 
(6.3) 
0 0 64 
3.5 I am confident in being able to counsel my 
patients on medication issues related to chronic 
disease 
2 
(3.2) 
10 
(15.9) 
42 
(66.7) 
9 
(14.3) 
0 0 63 
4.0 Preferred approached to competency        
4.1 This is my preferred approach to revise my 
competency in this area 
3 
(4.8) 
7 
(11.1) 
34 
(54) 
13 
(20.6) 
6 
(9.5) 
0 63 
4.2 Self-assessments are tedious 1 
(1.6) 
3 
(4.8) 
 8 
(12.7) 
48 
(76.2) 
3      
(4.8) 
63 
4.3 Self-assessments provide an additional 
support to my competency development  
0 14 
(23) 
46 
(75.4) 
1 
(1.6) 
0 0 61 
4.4 Self-assessment tools are useful to support 
other forms of learning  
0 16 
(25.4) 
46 
(73) 
1 
(1.6) 
0  63 
4.5 I feel uncomfortable having my 
competency assessed in this way 
1 
(1.6) 
5 
(8.1) 
10 
(16.1) 
3 
(4.8) 
40 
(64.5) 
3      
(4.8) 
62 
4.6 Competency assessment should only be 
undertaken at the workplace 
0 0 4 
(6.5) 
7 
(11.3) 
40 
(64.5) 
11  
(17.7) 
62 
4.7 Competency assessment is a personal 
professional responsibility and should not be 
assessed by others 
0 0 7 
(11.1) 
15 
(23.8) 
37 
(58.7) 
4      
(6.3) 
63 
        
5.0 Success with self-assessment        
5.1 I completed all the questions successfully 2 
(3.2) 
1 
(1.6) 
23 
(37.1) 
4 
(6.5) 
30 
(48.4) 
2      
(3.2) 
62 
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5.2 Although some of my responses were not 
correct, I am happy with my progress in this 
area 
0 12 
(19) 
44 
(69.8) 
5 
(7.9) 
2 
(3.2) 
0 63 
5.3 I feel some of my responses were not 
correct, I need further continuing education in 
this area 
0 5 
(7.9) 
31 
(49.2) 
11 
(17.5) 
15 
(23.8) 
1      
(1.6) 
63 
5.4 The standard of this assessment is too high 
for community pharmacists 
3 
(4.8) 
0 1 
(1.6) 
5 
(7.9) 
43 
(68.3) 
11  
(17.5) 
63 
5.5 The standard of this assessment is too 
clinical 
1 
(1.6) 
1 
(1.6) 
0 6 
(9.5) 
44 
(69.8) 
11  
(17.5) 
63 
5.6 The assessment is only useful for 
medication review accredited pharmacists 
0 1 
(1.6) 
0 2 
(3.2) 
49 
(77.8) 
11  
(17.5) 
63 
 
3.2.7 Diabetes Module analysis 
An analysis of the number of correct answers in the Diabetes self-assessment was compared with the 
Diabetes Survey questions using SPSS (ANOVA) to explore links between the scores and respondents’ 
opinions on areas of practice (Table 3.14).  
This analysis showed a level of significance for the Diabetes score and the statement ‘This assessment 
has not helped me’ (F (3,57) = 3.5, p = 0.02) with 89% of participants disagreeing (Table 3.13:2.4).  
Post-hoc comparisons using the Tukey HSD test indicated that there was no significant difference 
between the mean score of the groups Agree (Mean = 17, SD = 0, N = 2), Neutral (Mean = 19, SD = 
4, N = 4), Disagree (Mean = 18.4, SD = 4.7,N = 44) and Strongly Disagree (Mean = 23, SD = 4.1, N = 
11). This indicates that the participants who scored the highest found the greatest benefit from this self-
assessment. This links with the statement ‘This assessment helped me revise my current knowledge on 
diabetes therapy’ (Table 3.13:2.2) with a high proportion of participants who passed in both groups 
(72% and 94%) agreeing with this statement.  
The statement ‘Self-assessments are tedious’ (Table 3.13: 4.2) showed a level of significance, (F(4,56) = 
3, p = 0.03). Post-hoc comparisons between the mean score of the groups Unsure (Mean = 20, N = 1), 
Agree (Mean = 12.3, SD = 6.4, N = 3), Neutral (Mean = 19, SD = 3,N = 8), Disagree (Mean = 20, SD 
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= 3.8, N = 46) Strongly Disagree (Mean = 22.3, SD = 4.2, N = 3) could not be undertaken because of 
the small numbers in the Unsure (1), Agree (3) and Strongly disagree (3) groups. However, the group 
with the highest score disagreed strongly with ‘Self-assessments are tedious’, indicating that those who 
performed well liked this approach to learning.  
The statement ‘The Standard of this assessment is too high for community pharmacists’ (Table 3.13:5.4)  
showed a level of significance (F(4,56) = 3.2, p = 0.02). However, the numbers in some of the 
categories were too small for post-hoc analysis; Unsure (Mean = 12.3, SD = 6.4, N = 3), Agree (Mean = 
22, N = 1), Neutral (Mean = 22.5, SD = 3.9, N = 4), Disagree (Mean = 19.7, SD = 4, N = 43), Strongly 
disagree (Mean = 19.5, SD = 2.9, N =10). 
The statement ‘The standard of this assessment is too clinical’ (Table 3.13: 5.5) had a high level of 
significance  (F(4,56) = 3.9, p = 0.007) . The number of responses indicated a strong disagreement with 
this statement but ad-hoc analysis was not possible because of small numbers within some groups - 
Unsure (Mean = 5, N = 1), Strongly agree (Mean = 22, N = 1), Neutral (Mean = 18, SD = 5, N = 5), 
Disagree (Mean = 19.8, SD = 3.8, N = 43), Strongly disagree (Mean = 20, SD = 3.5, N = 11). The 
group who disagreed with this statement most were those who had the highest score. From the 
numbers of responses in each of the categories, it would appear that on the whole, pharmacists did not 
think this self-assessment was too clinical.  
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Table 3.14: Analysis of variance between Diabetes Module scores and Diabetes Survey 
 
Survey questions: ANOVA F(df) p 
Prior to doing this assessment I was not confident with my 
knowledge on diabetes therapy 
0.76 (4,59) 0.55 
This assessment tool helped me revise my current 
knowledge on diabetes therapy  
2.2 (4,56) 0.08 
This assessment tool has not provided me with additional 
information beyond my current knowledge on diabetes 
therapy 
1.28 (3,56) 0.29 
This assessment has not helped me 3.5 (3,57) 0.02 
This assessment tool provided me with new information 
on current asthma therapy 
0.96 (3,57) 0.41 
I feel confident with my professional skills in this area 0.44 (3,58) 0.72 
I feel confident about assessing my patient’s needs for 
diabetes counseling after completing this assessment 
0.89(4,57) 0.48 
I feel confident about assessing my patient’s drug 
management needs for diabetes after completing this 
assessment 
0.95 (4,57) 0.43 
I am confident in being able counsel patients on lifestyle 
issues after competing this assessment  
0.82 (2,59) 0.44 
I am confident in being able to counsel my patients on 
medication issues related to chronic disease 
2.29(3,57) 0.09 
This is my preferred approach to revise my competency in 
this area 
1.3 (4,56) 0.28 
Self-assessments are tedious 3.0 (4,56) 0.03 
Self-assessments provide an additional support to my 
competency development  
0.8 (2,56) 0.46 
Self-assessment tools are useful to support other forms of 
learning  
0.37 (2,58) 0.7 
I feel uncomfortable having my competency assessed in 
this way 
0.86(5,54) 0.51 
Competency assessment should only be undertaken at the 
workplace 
1.48 (3,56) 0.23 
Competency assessment is a personal professional 
responsibility and should not be assessed by others 
1.18 (3,57) 0.32 
I completed all the questions successfully 0.68(5,54) 0.63 
Although some of my responses were not correct, I am 
happy with my progress in this area 
0.06(3,57) 0.98 
I feel some of my responses were not correct, I need 
further continuing education in this area 
0.66 (4,56) 0.62 
The standard of this assessment is too high for community 
pharmacists 
3.17 (4,56) 0.02 
The standard of this assessment is too clinical 3.8 (4,56) 0.00
7 
The assessment is only useful for medication review 
accredited pharmacists 
0.29 (3,57) 0.83 
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The pharmacists who did the Diabetes self-assessment reported on the number of different types of 
continuing education they undertook. This was converted into a rating for the entire group ranging from 
0 – 10. The relationship between whether this made a difference to their Diabetes self-assessment scores 
was investigated using a Spearman correlation coefficient (Table 3.15). This showed it was close to 
significance, indicating that the level of CPD undertaken may have had some impact on the self-
assessment score. (r = 0.22, p = 0.06, N = 74) 
In the Diabetes self-assessment group the Mean number of years since graduation was 17.7 years 
(Median 14, SD 13.6, Range 1-64). The relationship between the number of years since pharmacists had 
graduated and their Diabetes self-assessment scores was undertaken using a Pearson correlation 
coefficient (Table 3.15).  There was no correlation between these variables (r = -0.10, p = 0.45, N = 59); 
the amount of time since graduation did not show up as a significant factor in the score obtained for 
this self-assessment.   
The relationship between whether a pharmacist was accredited to undertake medication reviews was 
explored using a T-Test coefficient (Table 3.15). There was no significant difference between these two, 
t (63) = -0.07, p = 0.94. The Mean of the group who were not accredited was higher (Mean = 19.1, SD 
= 6.0), compared to those who were accredited (Mean = 18.9, SD = 2.8), a surprising result because 
there is greater emphasis on clinical knowledge and drug management associated with being an 
accredited pharmacist.  
 
 
 
 
 
 77
Table 3.15: Relationship of Diabetes Self-assessment scores with variables 
 
Variable Correlation 
coefficient 
P N 
CPD rating* r = 0.22 0.06 74 
Number of years since 
graduation+ 
r = -0.10 p = 0.45 59 
Accredited to do 
medication reviews#  
t(63) = -0.07 p = 0.94 Yes = 25 
No =40 
+ Pearson correlation coefficient, * Spearman’s rho, #T-Test. 
The relationship between the Diabetes self-assessment scores and the area of practice was explored by 
looking at the variability between pharmacists who practised in the community, the hospital setting and 
‘other’ category. A one-way ANOVA between-groups was conducted but was found not to be 
significant (F (2, 62) 0.75, p = 0.47).  
3.2.8 Pain Self-assessment 
The Pain self-assessment was completed by eighty pharmacists (Figure 3.13). The Pain self-assessment 
consisted of twenty-one multiple-choice questions; five had more than one answer and sixteen were 
single response questions. On the Fourpoint score, 88.8% of participants passed the self-assessment. 
When the Pain module scores were adjusted to weight each question equally, only 73.8% of participants 
passed i.e. obtained a score of more than sixty per cent (Mean (score out of 21) = 13.2, Median = 14, 
SD =  4.58). Using SPSS, the internal consistency of these Pain self-assessment answers was found to 
have relatively poor inter-reliability (Cronbach’s Alpha = 0.31, N = 21). 
Details of the Cronbach’s Alpha’s inter-reliability were analysed to see if any particular question 
influenced the result. The questions that were pain management based in their design were excluded 
from analysis to see if this had an impact on some question responses e.g. questions about the WHO 
analgesic ladder and different types of pain. Also, the NSAIDs questions were tested alone. However, 
exploration of questions did not improve the inter-reliability.  In the analysis of the Pain self-assessment, 
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all the individual question inter-reliability scores were very low. 
 
Figure 3.13: Results of Pain Self-assessment: questions answered 
Only seven participants completed the Pain self-assessment for the second time (Table 3.16). The results 
showed that participants did not complete the same number of questions from their first attempt 
(Median = 13, Mean = 13.1, SD = 3.1). Observations of the questions attempted for the second time 
suggest that participants used the second attempt to retest themselves on answers that were wrong in 
their first attempt.  
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Table 3.16: Comparison of first and second Pain Self-assessment attempts  
 
Assessment Mean Std. Deviation N 
1st Pain self-
assessment 
17.42 1.8 7 
2nd Pain self-
assessment 
13 3.1 7 
 
3.2.9 Pain Survey 
The Pain survey was completed by sixty-five participants (Table 2.1, 2.4, 3.17). However, not all survey 
questions were answered. Participants were 73.8% female, with a Median age range of 30 – 40 and 
Median of 14 years since graduation (Table 3.18). Approximately equal numbers of pharmacists from 
community and hospital practice did this self-assessment with thirty one per cent accredited to do 
medication reviews. Table 3.17 shows that the pharmacists who did the Pain self-assessment had a 
similar profile to pharmacists who completed the other self-assessment modules. 
Table 3.17: Demographics of pharmacists who completed the Pain Survey (N = 65) 
 
Demographics Variables Percent. 
Gender Male 26.2 
 Female 73.8 
Area of practice for pre-
registration 
Community Pharmacy 52.4 
 Hospital  38.1 
 Combination of both 
Community and Hospital 
9.5 
Primary area of 
pharmacy practice 
Community 47.5 
 Hospital 45.9 
 Other 6.5 
Accredited to do 
medication reviews 
Yes 30.6 
Age range 20-25 13.8 
 26-30 18.5 
 31-40 20.0 
 41-50 27.7 
 51-60 18.5 
 Over 60 1.5 
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Table 3.18: Details of time since graduation and length of time taken to do  
Pain Self-assessment. 
 
 Mean Median SD Range 
Number of years 
since graduation 
16.7 14 11.61 1-40 
Time taken to do 
self-assessment 
(hours)  
1.15 1 0.56 0.3 - 3 
 
The Pain Survey (Table 3.19), like the Diabetes and Asthma surveys, showed that participating 
pharmacists recorded responses that predominantly expressed a similar opinion, leaving little scope for 
further analysis because of low numbers. However, there was strong support for the self-assessment as a 
competency tool. The Survey showed that 90% of pharmacists agreed or strongly agreed that ‘This 
assessment tool helped me revise my current knowledge on pain management therapy’. Ninety-six per 
cent agreed or strongly agreed that with the statement ‘This assessment tool helped me assess my 
knowledge on current pain management therapy’. All participating pharmacists (100%) agreed that self-
assessment tools were useful to support other forms of learning. Pharmacists were happy to have their 
competency assessment performed by others – 71.4% disagreed or strongly disagreed with the 
statement ‘Competency assessment is a personal professional responsibility and should not be assessed 
by others’. 
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Table 3.19: Summary of Pain Survey responses 
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2.0 Pain tool rating        
2.1 Prior to doing this assessment I was not 
confident with my knowledge on pain management 
1 
(1.6) 
2    
(3.2) 
17   
(27) 
8  
(12.7) 
30 
(47.6) 
5    
(7.9) 
63 
2.2 This assessment tool helped me revise my 
current knowledge on pain management therapy  
 17 
(27.4) 
39   
(63)  
5      
(8) 
1    
(1.6) 
 62 
2.3 This assessment tool has not provided me with 
additional information beyond my current 
knowledge on pain management therapy 
 2    
(3.2) 
8    
(13) 
6    
(9.7) 
43 
(69.4) 
3      
(5) 
62 
2.4 This assessment has not helped me  1    
(1.6) 
4    
(6.5) 
4    
(6.5) 
45 
(72.6) 
8    
(13) 
62 
2.5 This assessment tool helped me assess my 
knowledge on current pain management therapy 
 16   
(26) 
43 
(70.5) 
1    
(1.6) 
 1    
(1.6) 
61 
3.0 Skills in pain management         
3.1 I feel confident with my professional skills in 
this area 
 6    
(9.5) 
53   
(84) 
2    
(3.2) 
2    
(3.2) 
 63 
3.2 I feel confident about assessing my patient’s 
pain management therapy after completing this 
assessment 
 9  
(14.5) 
45 
(72.6) 
5    
(8.1) 
3  
(4.82) 
 62 
3.3 I feel confident that I am able to counsel 
patients on how to control their pain using their 
medication 
 16 
(25.4) 
45 
(71.4) 
1    
(1.6) 
1    
(1.6) 
 63 
3.4 I am now confident in being able assist patients 
with minimizing risks associated with long term 
pain medication management  
 10   
(16) 
50 
(79.4) 
2    
(3.2) 
1    
(1.6) 
 63 
4.0 Preferred approach to competency         
4.1 A self-assessment tool is my preferred approach 
to revise my competency in this area 
1 
(1.6) 
10 
(15.9) 
31 
(49.2) 
13 
(20.6) 
8  
(12.7) 
 63 
4.2 Self-assessments provide an additional support 
to my competency development  
1 
(1.6) 
10 
(15.9) 
31 
(49.2) 
13 
(20.6) 
8  
(12.7) 
 63 
4.3 Self-assessment tools are useful to support 
other forms of learning  
 15 
(23.8) 
48 
(76.2) 
   63 
4.4 I feel uncomfortable having my competency 
assessed in this way 
  9  
(14.3) 
4    
(6.5) 
44 
(69.8) 
6    
(9.5) 
63 
4.5 Competency assessment should only be 
undertaken at the workplace 
 1    
(1.6) 
3    
(4.8) 
7  
(11.3) 
39 
(62.9) 
12  
(9.5) 
62 
4.6 Competency assessment is a personal 
professional responsibility and should not be 
assessed by others 
1 
(1.6) 
 7  
(11.3) 
10   
(16) 
39   
(59) 
6    
(9.5) 
63 
5.0 Success with this self-assessment        
5.1 I completed all the questions successfully 1 
(1.6) 
2    
(3.2) 
25   
(38) 
8  
(12.7) 
25   
(38) 
2    
(3.2) 
63 
5.2 Although some of my responses were not 
correct, I am happy with my progress in this area 
 9  
(14.3) 
49 
(77.8) 
5      
(8) 
  63 
5.3 I need further continuing education in this area 1 
(1.6) 
3    
(4.8) 
30 
(48.4) 
12 
(19.4) 
15 
(24.2) 
1    
(1.6) 
62 
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Survey questions 
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5.4 The standard of this assessment is too high for 
community pharmacists 
4 
(6.3) 
 2    
(3.2) 
2    
(3.2) 
37 
(58.7) 
18 
(28.6) 
63 
5.5 The standard of this assessment is too clinical   1    
(1.6) 
2    
(3.2) 
42 
(66.7) 
18 
(28.6) 
63 
5.6 The assessment is only useful for medication 
review accredited pharmacists 
   3    
(4.8) 
39 
(61.9) 
21 
(33.3) 
63 
 
3.2.10 Pain Module analysis 
An analysis of the number of correct answers on the self-assessment was compared with the Pain 
Survey questions using ANOVA to explore links between the scores and their opinions on areas of 
practice. One of the responses reached the level of significance – ‘I am confident in being able assist 
patients with minimizing risks associated with long term pain medication management’ (F (3,57) 4.5, p = 
0.006). Ninety-five per cent of participants agreed with this statement. However, ad-hoc analysis could 
not be undertaken because of low numbers in some of the groups: Strongly agree (Mean = 13.9, SD = 
3.8, N = 9), Agree (Mean = 14.9, SD = 2.2, N = 49), Neutral (Mean = 8, SD = 8, N = 2), or Disagree 
(Mean = 13, N=1). The participants who scored highest in the Pain self-assessment agreed with this 
statement. This would indicate that this self-assessment supported pharmacists with assisting their 
patients minimise the risks associated with long-term pain in seventy-two per cent of cases. 
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Table 3.20: Analysis of variance between Pain Module scores and Pain survey 
 
Survey questions: ANOVA F (df) p 
Prior to doing this assessment I was not confident with my 
knowledge on pain management 
0.64 (5,55) 0.67 
This assessment tool helped me revise my current knowledge 
on pain management therapy  
0.17 (3,56) 0.92 
This assessment tool has not provided me with additional 
information beyond my current knowledge on pain 
management therapy 
0.51 (4,55) 0.45 
This assessment has not helped me 1.4 (4,55) 0.24 
This assessment tool provided me with new information on 
current pain management therapy 
0.42 (3,55) 0.74 
I feel confident with my professional skills in this area 0.84 (3,57) 0.47 
I feel confident about assessing my patient’s pain 
management therapy after completing this assessment 
0.62 (3,56) 0.61 
I feel confident that I am able to counsel patients on how to 
control their pain using their medication 
0.46 (3,57) 0.71 
I am confident in being able assist patients with minimizing 
risks associated with long term pain medication management  
4.5 (3,57) 0.006 
A self-assessment tool is my preferred approach to revise my 
competency in this area 
0.48 (4,56) 0.74 
Self-assessments provide an additional support to my 
competency development  
0.48 (4,56) 0.74 
Self-assessment tools are useful to support other forms of 
learning  
0.3 (1,59) 0.58 
I feel uncomfortable having my competency assessed in this 
way 
0.41 (3,57) 0.75 
Competency assessment should only be undertaken at the 
workplace 
1.26 (4,55) 0.3 
Competency assessment is a personal professional 
responsibility and should not be assessed by others 
0.45 (4,56) 0.77 
I completed all the questions successfully 0.57 (5,55) 0.72 
Although some of my responses were not correct, I am happy 
with my progress in this area 
0.55 (2,58) 0.58 
I need further continuing education in this area 0.43(5,54) 0.83 
The standard of this assessment is too high for community 
pharmacists 
0.59(4,56) 0.67 
The standard of this assessment is too clinical 0.85 (3,57) 0.74 
The assessment is only useful for medication review 
accredited pharmacists 
1.62 (2,58) 0.21 
 
There was a considerable range in the time since participants graduated, with a median of 14 years 
(Mean = 16.8. SD = 11.6, Range = 1-40 years). Using SPSS a Pearson correlation between the Pain 
score and the number of years since graduation was undertaken. There was a strong negative correlation 
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between the score of participants and their year since graduation (r = -0.097, p = 0.48, N = 56), 
suggesting that more recent graduates tended to have higher scores. 
The comparison of the Pain self-assessment score was compared to whether the participants were 
accredited to perform medication reviews using the T-Test. However, being accredited was not 
significantly related to the assessment score. (t (58) = 0.15, p = 0.6, N = 60) 
The CPD rating that was summarized for all three modules responses ranged from 0-10.  When these 
were correlated with the scores from the Pain assessment, the correlation coefficient was almost at 
significance (r = 0.17, p = 0.14, N = 75). This is along similar lines to the other two modules, where the 
greater the number of CPD types of activities that were undertaken appeared to have some impact on 
the participant’s knowledge.  
The areas of practice categorized as Community, Hospital and Other were explored to see whether the 
area of practice showed differences in the Pain self-assessment responses. A one-way ANOVA was 
conducted; there was no significant difference between the groups (ANOVA F (5, 51) = 0.59, p = 0.76).  
Table 3.21: Relationship of Pain Self-assessment scores with variables 
 
Variable  p N 
Number of years since 
graduation+ 
r = -0.097 0.48 56 
Accredited to do 
medication reviews# 
t = (58) 0.15 0.6 Yes = 18 
No = 42 
CPD rating* r = 0.17 0.14 75 
+Pearson correlation coefficient, #T-Test, *Spearman’s correlation coefficient  
3.2.11 CPD Survey 
The CPD Survey (Appendix 8) was used to canvass pharmacists’ opinions about their professional 
attitudes, and the ease of use of the self-assessments. This was completed by 88 participants. The survey 
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shows that pharmacists had strong views about their professional duties. For example, sixty four per 
cent of pharmacists disagreed or strongly disagreed with the statement ‘I am comfortable selling a 
product that may be of questionable value as long as it is not harmful’. Interestingly, there is a strong 
belief in this group of pharmacists that dispensing is not their core role. The opinion on ‘I see traditional 
sources of pharmacy remuneration as the only source of funds for the future’ was disagreed with or 
strongly disagreed with by seventy five per cent and the statement ‘A pharmacist’s most important job is 
dispensing’ was disagreed or strongly disagreed with by sixty four per cent of participants.  
Table 3.22: CPD survey: summary of responses. 
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I am comfortable with the technology changes 
taking place in pharmacy 
1 33 4
6 
3 3 2 88 
I see traditional sources of pharmacy 
remuneration as the only source of funds for 
the future  
7 1 4 10 53 13 88 
For me pharmacy is just a job  8  6 50 22 86 
I believe that pharmacists currently have too 
much to do and there is no capacity for change 
1  1
2 
16 45 13 87 
I generally enjoy my work  27 5
2 
4 2 2 87 
A pharmacists most important job is 
dispensing 
 1 3 12 51 19 86 
I am comfortable selling a product that may be 
of questionable value as long as it is not 
harmful 
  8 14 41 23 86 
I am able to perform my expected duties 
without interruption  
2 2 1
0 
9 40 23 86 
 
Pharmacists who participated in these online self-assessments had no difficulty using the Fourpoint 
Learning web site (Table 3.23) and indicated that the modules were well presented. 
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Table 3.23: CPD survey: Use of website 
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Self-assessment modules you completed 
were well presented 1 9 43 7 4  64 
 
3.3 Pharmacists’ opinions 
The Asthma, Pain and Diabetes modules invited feedback from pharmacists about each module as well 
as the CPD Survey. (See Appendix 8). All three topic modules’ feedback had a similar thread about the 
content, concepts and design of the modules. 
Common to all module feedback were comments about the design of the Fourpoint Learning web site 
and the way the content was laid out. A number commented that ‘navigation around site took some 
initial guesswork, easy once you know where to start’. Many participants complained about the question 
design and had trouble with the multiple choice and single choice questions “It would be helpful to 
know in advance that more than one answer may be correct”. The automated response of the program 
(e.g. two out of four responses were correct) was confusing for some pharmacists. The program did not 
confirm which answer was correct.  One participant commented “The answers were a little confusing 
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How easy or difficult was it to navigate 5 14 30 18 3 70 
The material in these modules was well 
presented 
4 26 15 10 11 66 
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when it reported that 6 out of 6 selections were correct”. However, this method of correct answer 
feedback was a design feature of the Fourpoint program and could not be altered. 
There were mixed responses to the content of the modules. A number of the participants found the 
questions and answers not clear. Some of examples of comments were : 
“Some of the questions were poorly worded and answers suggested incorrect. For example the 
Glycaemic Index (GI) foods. In my opinion the answers suggested should have offered a range rather 
than a specific value as the GI value varies even for a particular food!” 
However, there were many positive responses about the self-assessment modules in terms of their 
ability to give pharmacists educational material to test their knowledge and competency.  
“As for before (sic) I find a tutorial will greatly increase my confidence in answering questions and my 
learning ability” 
“Some of the questions in self-assessment are an eye opener to me. It improves my knowledge about 
lifestyle myths” 
“I would like to continue to use this method of assessment of my competencies” 
“I was dreadful! and even the second time was still dreadful!  Really indicated areas where I needed 
improvement” 
The variation of comments about the module content highlighted how one correct response to a 
question can be contradicted by another. This was summarised very well by the following comments : 
“Care should be taken to ensure that the standards of practice and the up-to-date clinical information 
are clarified into separate questions as there are areas where relevant clinical progression is being made 
of which practice has not yet fully embraced.” 
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This highlights one of the main issues of the comments where pharmacists indicated that they did not 
agree with the correct responses that were provided. The modules were designed to incorporate 
elements of medication management knowledge with patient disease management. The approach of 
pharmacists to this concept would vary to some extent and would depend on their own practice and 
learning experiences.  
Feedback in the overall pharmacists’ opinion survey (CPD Survey) that canvassed the design and ease of 
use of the website, provided favourable comments overall. These support the use of self-assessment 
tools as a concept: 
“If these were to become professional modules and formatting would need to be better (sic). However, 
as for information presented they were good” 
“These were good even though I think I still prefer face to face CE. Well thought out liked how 
information about answers was presented after submitting q (sic)  allowed you to learn more. It beats 
driving 2 hours to Sydney to attend an evening lecture!” 
“These modules were challenging and got me out of my comfort zone. They were well referenced and 
informative. Would it be possible to get a hard copy of q @ (sic) a along with supporting data??” 
“I have used many online learning features and Fourpoint is without a doubt the best. This would make 
a great addition to the education 'calendar' of the profession” 
These remarks provide good feedback on how future self-assessment design should be crafted. The 
elements of competency may need to be de-constructed more in the presentation and design of 
questions. Combining information on evidence-based material, as in this case, seemed to present some 
differences of opinion. Hence a number of pharmacists did not agree with the answers provided.  
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C h a p t e r  4  
4 Discussion 
4.1 Review of current research 
The published literature on competency in professional practice is limited.  The focus of research varies 
considerably.  Studies can be broadly divided into those that examine how professionals approach their 
competence, how successful they feel in achieving it (37, 38, 48, 50, 51, 66-69) and research that looks 
objectively at its impact on actual practice. Only a few studies examine how competence is translated 
into an objective measure of practice outcomes (43, 70-72). Research of note that explores the 
assessment of competence is published by Fielding et al. (42), Austin et al. (49), Fitzgerald (66) and 
Tamblyn et al. (43). These studies provide tangible evidence of the complexity of measuring competence 
and its relationship to day-to-day practice.  
Tamblyn’s study examining physicians’ training and its impact on their practice has no comparable 
research undertaken in pharmacy practice (43). Such as approach would provide an excellent platform 
for a pharmacy competency assessment framework. Austin’s review of Ontario’s quality assurance 
program, collecting data on 992 pharmacists over a five-year period provides evidence of professional 
standards in the province (49). However, none of these studies examined the impact which aspects of 
competency had on the actual quality of service delivered to the general community.  
Self-assessment studies were small and generally cast doubt on the validity of using them as a sole 
indicator of competency validation (48, 50, 51, 67-69). Perhaps this illustrates how measuring a 
professional’s competence to practice is an exercise where the professionals concerned need to be part 
of the process. 
4.2 Assessment of competency 
The objective of this study was to develop a competency assessment tool that would assist registering 
bodies with their assessment of pharmacists’ competency as part of the re-registering process. The initial 
work was undertaken in an environment where registering bodies were in the initial stages of 
considering how competency should be measured. An important consideration in measuring 
competency is the increased diversity of practice in recent years (73), ranging from support in the form 
of medicines supply, drug information to both consumers and health professionals, medication 
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management in chronic disease as well as comprehensive reviews of medication in the clinical setting of 
hospitals, aged care facilities and general practice in the community.  This changing landscape will 
continue to challenge the process of assessing a pharmacist’s competency. Compared to the initial stages 
of this work, there is now increasing support for the concept of competency assessment. Many diverse 
viewpoints in pharmacy express concern about where the pharmacy profession is going. The gloomy 
view is that pharmacists are not paid for their knowledge but for the products they dispense (74). This 
has fuelled a drive by others to ensure that pharmacists develop professionally with an increased 
professional approach; one where assessment of performance is paramount to ensuring that the 
community is well served. Interestingly, the CPD survey participants in this study did not support the 
idea that dispensing was their core role. This may be an emerging trend as more professional services are 
developed in pharmacy practice.  
  
In the initial stages of this work members of the Pharmacy Board of Tasmania had concerns about how 
competency assessment would be viewed by pharmacists. Where pharmacists did not achieve an 
accepted competency standard, would this have an impact on their registration and ultimately their 
business if they owned a pharmacy? During the consultation process with the Board in the early stages 
of this research, many of its members practised as owner community pharmacists. This is likely to be 
behind the Board’s view that the first assessment for this research was ‘too clinical’. 
At present in Australia, competency in pharmacy practice relies heavily on self-reporting of continuing 
education activities such as education events provided by the drug industry who have an interest in 
promoting their own products (75) and professional orgainsations, along with journal reading with 
multiple-choice questions and audits for quality assurance and adherence to best practice guidelines for 
medication management. Self-assessment as an integral part of monitoring competency seems in theory 
to be a good approach to implement elements of the continuing professional development (CPD) cycle 
of reflection, planning, action, and evaluation.   
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There are two types of self-assessment involved in CPD. The first is where self-assessment is used in 
providing evidence of CPD activities in context with reported adherence to the standards of 
competency (11, 18). The other is a self-assessment tool that enables pharmacists to visualise the desired 
level of performance and give them feedback on their actual performance. This is in contrast to a 
competency based assessment that measures performance in practice against desired standards (76). 
Other professional bodies such as the medical profession place a greater emphasis on practical 
communication skills in the clinical setting (77). 
4.3 Pharmacists’ acceptance of competency 
The opinions of pharmacists in 2000 showed that the traditional approach to continuing education was 
well established. As illustrated in Figure 3.4, in 2006 most pharmacists (65%) overwhelmingly 
considered that CE attendance was of excellent benefit or good benefit. In 2000, only 45% of 
pharmacists considered self-directed learning to be of excellent or good benefit.  
In 2000, pharmacists did not consider a journal club, student supervision, self-directed learning, 
pharmacy setting review, self-assessment tool or a portfolio to be an activity that they would nominate 
to do on a regular basis (Figure 3.5) to maintain their competency. However, Tasmanian pharmacists 
expressed these opinions before the introduction of the Pharmacy Board of Tasmania’s Personal Audit 
of Basic Competency for Tasmanian registered pharmacists.  
The pharmacists who participated in the Phase 2 self-assessments and surveys of this research were 
generally younger pharmacists working in community pharmacy practice. Six years ago, when this work 
was started, pharmacists were not very familiar with competency but accepted that it was an important 
concept to support for the long-term benefit of the profession. The surveys undertaken for the last part 
of this work indicate that the awareness of competency has altered.  In the surveys that accompanied the 
Asthma, Diabetes and Pain self-assessments, pharmacists strongly agreed with the statement ‘Self-
assessment is my preferred approach to revise my competency in this area’ - (57%, 54% and 49% 
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respectively) where self-assessment is considered as self-directed learning. This illustrates that the 
introduction and promotion of national competency standards (11) and implementation of competency 
based re-registration in a number of states  has increased pharmacists’ awareness of CPD and their own 
need to reflect on their standard of practice.  
4.4 Self-assessments as a tool for learning and competency 
A number of studies have looked at self-assessment to support or assess the competency of medical and 
pharmacy practitioners in the form of educational support (46, 48-50, 53, 55, 66-68, 77-80), with mixed 
results. The series of self-assessment tools tested in this study were well received by the participants who 
did them. The majority of pharmacists indicated that the assessments assisted them with their 
knowledge of the topic, assisted them to help patients with medication and counsel them on aspects of 
chronic disease management e.g. use of inhalers and lifestyle issues that were relevant to their care. 
(Table 3.7, Table 3.13, Table 3.19). As this was a self-assessment exercise, it would be hard to estimate 
how this translated into the improvement of patient care in their day-to-day practice. This lack of 
validation of self-assessments has been expressed in the literature by Hanford and Hattie (81) and in 
recent years by Fjortoft (82).  
Parker, Alford and Passmore (67) looked at assessment performance in a study of family medical 
residents who having taken their In-Training Examination were surveyed to predict their scores. This 
study found that the residents’ predicted performance did not correlate strongly with their actual 
performance. A similar study with general practitioners by Tracey et al (79) looking at their knowledge in 
specific areas compared the relationship between the GPs’ self-assessment of knowledge and their 
scores on a written test.  The results showed that GPs’ insight into their educational needs was low and 
correlations between self-assessment scores and test scores were low. Tracey et al’s study was very 
similar to this research testing three areas of knowledge – thyroid, diabetes and sexually transmitted 
disease. All three tests showed a low correlation to the GP’s self-assessment. In this series of self-
assessment surveys, an analysis of variance between the survey question and completed pharmacists’ 
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responses for the statement ‘I completed all the questions successfully’ for Asthma, Diabetes and Pain 
surveys did not show any significance (p = 0.13, 0.63 and 0.72 respectively). Regarding this statement, 
77% of Asthma survey participants disagreed or strongly disagreed, 51.5% of Diabetes survey 
participants disagreed or strongly disagreed and 42% of Pain survey participants disagreed or strongly 
disagreed. The overall results indicate that 44.9% of Asthma, 72.7% of Diabetes and 73.6% of Pain 
module participants passed the self-assessments having obtained a score in excess of 60%. Interestingly 
the self-assessment with the lowest percentage of people passing had the greatest awareness of not being 
successful.  However, the responses in this study were more indirect compared to Tracey et al’s (79) 
work and may have needed more specific questions to explore this in greater depth. Several survey 
questions asked about pharmacist’s progress with this knowledge area - whether the standard was too 
clinical, too high for community pharmacists. The results show that participants were happy with the 
standard of self-assessment, even if this did not show a significant association with their score.  
The applicability of self-assessment to different types of tests was explored by Fitzgerald (66). This 
paper looked at longitudinal self-assessment accuracy with medical students’ ability to self-assess their 
performance after each test over a three-year period. In the first and second year, testing consisted of 
multiple choice, laboratory and written examinations. Their ability to self-assess their performance for 
the first two years was accurate. However, this did not follow through to their third year where they 
were assessed by an OSCE (multiple objective structured clinical exam). Fitzgerald suggested that the 
unfamiliarity of the OSCE exam contributed to the reduced self-assessment accuracy of this group, 
suggesting that familiarity with the task was important and that assessment like OSCEs may require a 
different dimension of knowledge and information to that of self-assessment performance. This would 
suggest that in order for self-assessment to reliably predict a result, the participants would need to know 
what was expected of them and perhaps have prior knowledge of the self-assessment process. The study 
of Malcolmson (48) measured both peer and self-assessment in a final year pharmaceutics assignment 
and found that the adjustment of marks between the two was small, suggesting that a familiar task is the 
type of task that is best to compare with self-assessments.  Feedback comments from this study’s 
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surveys such this ―  ‘Once I had completed one module things were easier to follow at first I wasn't 
sure exactly what was going on’ support this.  
4.5 Place in CPD of assessments 
According to Luck and Peabody the ideal method of assessing competency is by direct observation (71). 
McKinley (72) also recommends this for the medical profession. However, the costs are generally 
considered prohibitive. CPD as a concept is used to attempt to indirectly test what occurs in clinical 
practice. This may account for the increased support for CPD as a reflective self-directed activity and 
using online CPD components appears to be an attractive alternative from a cost point of view. As a 
result of the New Zealand experience where formal requirements for CPD were introduced for re-
registration, Harries (83) supports CPD because it empowers pharmacists to be professionally 
responsible for their practice. 
CPD is described by Vlasses (15) as ‘an ongoing, self-directed, structured, outcomes-focussed cycle of 
learning and personal improvement’. The objectives of CPD generally include improved health 
outcomes for delivered health services. However, a systematic review by Brown (39) points out that 
evidence for CPD benefit for health outcomes is rare.  
Reflection on performance to a set of previously described competency standards is also described as a 
self-assessment tool and is regarded as an essential part of the learning process (84, 85). The annual 
Pharmacy Board of Tasmania’s audit of competency could be considered a self-assessment of current 
practice standards. However, there is no verification of these. The Board relies on a statutory declaration 
to ensure that the self-assessments of pharmacists are accurate. Pharmacists in this study were generally 
supportive of a process of assessing competency. This may also be because participants for this study 
included pharmacists registered in Tasmania. In the introduction phase of the Royal Pharmaceutical 
Society of Great Britain’s mandatory CPD program, a questionnaire was sent out to pharmacists to 
determine community pharmacists’ perception of their clinical and professional competence. The result 
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published by Mills et al. (50) found that young female non-owner pharmacists assessed themselves to be 
more competent than male owners. Interestingly, a survey of Portuguese community pharmacists found 
that female pharmacy owners had the highest job and career satisfaction score (86). These examples 
suggest that the pharmacy practice skill set is well suited to the way female pharmacists respond to their 
work.  
In the self-assessments in this study, statistical analyses between self-assessment scores for the Asthma, 
Diabetes and Pain modules were explored with CPD rating. How long pharmacists had graduated and 
whether they were accredited to do medication reviews revealed no significant association. This would 
suggest that the pharmacists who volunteered to participate in this study were keen to explore and test 
themselves in a process that they were unfamiliar with no matter what area they practiced in. 
Interestingly, pharmacists accredited to do medication reviews were strongly represented in this group 
of volunteer pharmacists ― 30%, compared to approximately 14% in the national figures of pharmacists 
(63). This would suggest that where self-assessment tools measure knowledge as opposed to standards 
of practice, they will need to be validated before wider implementation. Pharmacists may need to be 
trained in the process to ensure that self-assessment is reliable in the area being tested.  
4.6 How could self-assessments be used 
This self-assessment tool was designed to have a reflective process, where pharmacists could reflect on 
the questions in the context of the case study presented and feedback accompanying answers to 
ascertain how their knowledge fitted with the information presented. From the reported time taken to 
do the self-assessments by participating pharmacists (Asthma Mean time = 1.4 hours, Diabetes Mean 
time = 1.2 hours, Pain Mean time = 1.15 hours) it is clear that these self-assessments were used as a test 
of knowledge and few used it as an opportunity to read around the subject. As they were self-directed, 
personal drive and time would be needed to fully exploit these modules. In busy lives, an incentive may 
be needed to stimulate this type of process.  
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A systematic review by Davis (68) examined the literature for studies, mainly for physicians, that looked 
at self-assessment compared to external observations. This highlighted the lack of consistent data in this 
area and the need for more research (87). The concern is that many registering bodies rely on self-
assessment in some form or other as part of their approach to lifelong learning. Davis’ analysis pointed 
to a number of studies which found that the lowest accuracy in self-assessment was among physicians 
who were the least skilled and most confident. Most registering bodies accept the choices of education 
that health professionals select for themselves to satisfy their learning needs. In this study, comparing 
the score to pharmacist demographics and feedback in each of the modules did not provide any 
significant association. The number of responses in each of the surveys was not large enough to do any 
in-depth analysis. However, in Davis’ review, most of the studies reported small numbers as well, 
pointing to a likelihood that this study may be reflecting a similar pattern for pharmacists.  
Validation tools developed by Azzopardi (52) along with colleagues (88) have demonstrated how an 
outcomes based approach can reliably be used so that community pharmacy practice meets community 
expectations. If there is doubt that professional competency assessments may not predict good 
standards of practice, the validation tools developed by Azzopardi could be used to monitor 
competency standards. 
 
The PROMISe research (89) undertaken at the Tasmanian School of Pharmacy’s Unit for Medication 
Outcomes Research and Education (UMORE) to develop an electronic recording system that enables 
the collection of data on pharmacy interventions could provide a way forward for measuring patient 
outcomes. This could be used to measure the level of interventions undertaken in pharmacy practice 
that could feed into a system of audit and professional educational activities, promoting direct 
competency assessment of a pharmacist in practice. 
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Perhaps the research of Azzopardi and UMORE could inform the competency process that would 
provide impetus to drive a lifelong learning process, guiding competency both in the delivery of 
medication services as well as adherence to professional practice guidelines.  Self-assessments could be 
explored as one of the tools that could be used in this process. However, research to validate these at 
different levels of practice would need to be undertaken. 
The CPD survey provided an insight into the attitude of pharmacists towards their profession. The 
pharmacists who completed this appeared to have a very professional outlook. It was surprising to note 
that these participating pharmacists did not see dispensing as one of their core practicing activities. This 
may be because thirty one percent were accredited pharmacists. Increasingly there is a recognition that 
more professional services are required to use a pharmacist’s skill and training in the clinical setting. In 
Australia this is being progressed by agreements of future services between pharmacy employers and 
government (90).   
4.7  Acceptability of self-assessments to pharmacists 
The evolution of the competency concept in pharmacy practice is evident from the time this study 
started in 2000 to the completion of the final stages of research in 2006. In the first series of pharmacist 
interviews undertaken, there was an acceptance by pharmacists who were interviewed at the time, that 
competency assessment was necessary in order for the pharmacy profession to be credible and valued 
by the community it served. However, at the time the menu of continuing education was generally 
confined to reading journals and lectures. As illustrated in Figure 3.4, these were regarded as having 
excellent benefit and good benefit by sixty three per cent and sixty five per cent respectively, compared 
to forty five per cent for self-directed learning. In the self-assessment modules in 2006, support was 
expressed by responses to the statements asking about their preferred approach to competency. Support 
for the self-assessment tool approach was agreed to or strongly agreed to by fifty seven per cent of 
Asthma module participants, sixty five per cent of Diabetes module participants and sixty five per cent 
of Pain module participants. The delivery of these self-assessments as a web based assessment tool may 
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be part of the reason why pharmacists support the idea of self-assessments. When e-learning is 
presented on the web, they can be accessed at a time of the pharmacists’ choosing and can provide a 
degree of anonymity so it tends to be well supported (53). They are increasingly being used as part of 
training to give increased confidence to specialist practitioners and undergraduate students (78) and 
when designed well can produce improved knowledge and a change in behavior that is comparable to 
conventional activities which have the same objective (55).  
4.8 Self-assessments and the application on knowledge to practice  
Participant’s comments and feedback on the self-assessment models gave mixed reactions to the correct 
answers provided to the multiple-choice questions. This may reflect how important it is to tailor the 
design of an assessment to the knowledge and practice application being assessed. A number of 
participants said that they did not agree with the answers provided. This brings into question whether 
the practice perspective determines what response that user will give. Over the years, the most common 
way of testing information effectively is by choosing the multiple-choice format. This is supported as a 
viable way of testing knowledge in pharmacy education (80) and is recognised as having a high degree of 
reliability (45). The self-assessments in this study used multiple-choice questions for all answers and the 
Asthma and Diabetes self-assessment modules had a high degree of inter-reliability. Both asthma and 
diabetes are well-defined defined areas of therapeutics and many aspects of their management are very 
practical in many respects. The Pain self-assessment on the other hand examined very complex area of 
management and many aspects of pain management are multi-disciplinary and have many dimensions 
beyond drug therapy. Cronbach’s Alpha for the Pain self-assessment was poor, despite separating out 
groups of like questions to determine their impact. One possible reason could be because of the 
combination of disease topics questions and drug therapy questions. However, when the questions for 
drug management and disease management were separated the inter-reliability of the questions did not 
improve. Perhaps more abstract questions where drug management is complex and assessments difficult 
are areas where self-assessment tools like this one may not be appropriate. 
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The lack of agreement by some participants about what the correct answer was in some instances points 
to how clinical practice and evolving evidence can influence knowledge. If an area where evidence is 
changing is not updated regularly, the multiple choice responses by a participant may not factor in 
current-evidence based practice. From the time taken reported in the results of each module, it would 
appear that participants did not use the opportunity to explore the evidence-based literature that was 
provided in the feedback.  
Wass (45) examined the assessment of clinical competency using Miller’s pyramid of competency. This 
pyramid focuses on aspects of competency - ‘Knows’, ‘Knows how’, ‘Shows how’ and ‘Does’. Wass 
made the point that these are not able to demonstrate how competencies tested in this way will translate 
into clinical practice. Perhaps this points to the limitation of self-assessments provided in a multiple 
choice question format. Interpretation of evidence-based knowledge needs to dovetail into an individual 
patient situation that is being considered at the time. This may mean that multiple choice questions can 
be misinterpreted, if they are not framed properly and if participants are not looking at the multiple 
choice questions in the proper context. 
4.9 Competency assessment research– lessons learned                      
When this research commenced, it was undertaken as a project for the Pharmacy Board of Tasmania.  
The first and second assessments were developed to meet their needs. The purpose was to develop a 
competency assessment for pharmacists in Tasmania and opinions were sought from all areas of 
practice. The Board however, had a strong driver of ensuring that any new process introduced would 
not unduly alarm the pharmacist community. This requirement was so overarching it drove the tool to a 
standard low enough to avoid rejection by pharmacists, rather than to a standard appropriate for a 
competency assessment.  
If this study were to be repeated, it should be undertaken independently, involving collaboration with all 
sectors of the pharmacy profession. However, no individual sector should hold sway on the research 
outcomes.  
The pharmacists who participated in this study approached the self-assessments as tests rather than 
using them as part of a reflective process. To ensure such self-assessments have a better impact on 
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learning, pharmacists involved would need to be educated to regard self-assessments as an ongoing 
process of continual improvement.   
4.10 Future of self-assessments in pharmacy practice  
The adoption of self-assessments in the future should be closely examined by registering bodies. Clearly, 
although fragmented and inconsistent, the current literature points to a need to revisit the role of self-
assessment in lifelong learning.  Davis (68) has proposed the following for physicians ― a holistic CPD 
approach using portfolios, documenting practice-based learning and improvement activities with greater 
detail outlined in learning objectives. Tamblyn et al highlighted the need for physician training on 
benchmarking (91). This would assist with multidimensional feedback. Objective measures that include 
externally facilitated self-assessment would facilitate the provision of evidence-based information to 
practitioners. 
The degree to which participants demonstrating their competency will support the CPD process is likely 
to depend on the level of ownership they have over the process (69). It should be multisourced (92), be 
as interactive as possible (93) and the context of practice needs to be taken into account (70). However, 
the process of competency assessment should be regular (94) but not be a burden or it may emphasize 
training rather than education (95). 
Self-assessment tools will need to be carefully designed to ensure that concerns about their 
interpretation are addressed (82). In the medical profession, workplace data and clinical audits underpin 
the revalidation process (47).  Clinical audits require a review of each patient encounter to document 
how that encounter relates to currently accepted management of a particular disease area e.g. 
hypertension. Responses from each physician are collated and a summary is sent to each participant, 
providing a comparison to their own practice.  These could support and underpin the feedback that self-
assessments provide, giving practitioners a better sense of how their perception of performance matches 
up to accepted professional benchmarks. However, a systematic review by Jamtvedt et al (96) recently 
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explored the effects of audit and feedback and found that although improvement in practice can be 
seen, the absolute effect of change in practice is low. 
From a pharmacy perspective, the application of educational principles published for the medical 
profession could be applied with modification using the Competency Standards for Pharmacists in 
Australia (11). Clearly, the literature supports the use of a multi-pronged approach, with emphasis on 
measuring outcomes in practice. Even with intensive programs like OSCEs, pharmacists can be 
supportive of them if they are made relevant to their practice (97). They can also identify poor clinical 
performance in students (98) and may be useful for newly registered graduates who have limited clinical 
skills (99).  
One of the drawbacks for pharmacy, especially in community practice, is that practitioners work in 
isolation, so competency assessment and professional support is not readily available. In these 
circumstances it is important that external activities are encouraged where peer collaboration is available, 
but this also needs to be tailored to the area of practice and be evidence based (100, 101). Clinical audits 
for pharmacists are now being made available as a service from the National Prescribing Service (102) in 
Australia. Audits combine the benchmarking of standards of clinical practice with current practice as a 
self-directed learning exercise, a learning experience that has been part of the CPD (103) cycle for GPs 
for many years. 
One of the big drivers in Australian pharmacy practice in recent years is the training of pharmacists 
accredited to perform medication management reviews. This has refocused attention on the need to 
provide higher standards of medication review than is normally the case in the community pharmacy 
setting. A key question for this and other areas of pharmacy practice is whether the system of 
accreditation will deliver the standards of practice necessary. Certainly, this study did not show any 
differences between the scores of pharmacists who were accredited and those who were not. It would 
be expected that this group should outperform other pharmacists in the clinical case aspects that were 
presented in self-assessments in this study if the accreditation process was rigorous.  
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A review in medical practice did find that professional certification is associated with quality care in 
observation studies (104). If medical practice is able to find an association between quality care and 
certification, perhaps questions should be asked regarding whether the accreditation standard for 
medication review pharmacists is adequate and how it could be remedied. This is an area that has not 
been fully explored in Australia. However, the role of self-assessment in a case history context would be 
beneficial if combined with other learning opportunities. Initial training for accredited pharmacists used 
peer mentors to assist with training. This helped alleviate the problem pharmacists have of undertaking 
the accreditation process in isolation. However, there are few instruments designed to assist with this 
process (105).  
Assessing practice by individual practitioners or by peers would need comprehensive instruments to test 
all aspects of professional competence and as illustrated in this discussion, many have not been validated 
effectively for the task they are expected to achieve. The assessment of competency is complex, is 
ongoing (84), needs to tailored to individuals’ practice and needs to be reliable (45). If self-assessments 
are used, they need to be validated for the area of practice and used in combination with other 
assessment tools that can provide an accepted level of confidence in the competency process.    
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C h a p t e r  5  
5 Conclusion  
 
Self-assessment tools have been explored as a vehicle to compare how an individual practitioner 
compares to accepted professional standards as well as exploring how practitioner knowledge is applied, 
compared to their peers. The literature suggests that such tools have not been reliably validated in areas 
of practice where their use has been reported. Analysis of variance in this study for self-assessment 
scores did not find any association with the participating pharmacists’ assessment of their own 
performance. However, the nature of a CPD cycle with an emphasis on reflection does require 
pharmacists to determine what their needs are ― an interesting proposition if some of the literature is 
reporting that they may not be good judges of what areas they should update on to improve their own 
practice. The question is, do pharmacists decide on their CPD needs purely on the basis of a perceived 
deficit of knowledge rather than improving their ability to apply knowledge and clinical interpretation 
along with a quality use of medicines perspective. How do they know what they don’t know? A more 
pragmatic conclusion would be that pharmacists consider cost, time and ease of access to education as 
well as what is on offer by educational providers such as PSA and SHPA to be the drivers in their 
decision-making for their professional education.  
Self-assessment tools need to be used in association with other CPD activities e.g. case history 
discussion, self-audit, peer collaboration and discussion as well as the traditional lectures and multiple-
choice assessments. In this context, pharmacists need to be aware of what a self-assessment will provide 
for them in CPD and what their limitations are. The self-assessment tools in this study were not used to 
the full extent that they were designed for. The amount of time taken by participants to complete these 
self-assessments was low, suggesting that the feedback provided for each question was not used by 
many of the participants. This suggests that instruments like self-assessments that are going to be used 
for competency assessment will need to be introduced in training sessions to pharmacists so they can 
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understand how they can be used, provided they are validated first.  Pharmacists need to understand 
that self-assessments are a dimension of self-reflection but not an endpoint of competency to practise. 
Registering bodies need to recognise that there may be a difference between a pharmacists’ choice of 
CPD and that it may not always be the area that needs to be addressed to improve their competency in 
all areas.  
Over the timeframe of this work pharmacists have accepted that the approach to pharmacy practice 
assessment needs to change, as evidenced by the feedback from the participating pharmacists in this 
study. Self-assessment and reflection on practice is only a recent activity that has gained a wider 
acceptance with the introduction of the CPD approach, competency audits by the Pharmacy Board of 
Tasmania and the introduction and implementation of the CPD and PI Program by the PSA. Efforts to 
develop a competency assessment tool and a self-assessment tool have demonstrated that the intent of 
the instruments and their validity is a more complex process than using a small sample of pharmacists to 
trial a sample assessment. The second competency assessment model with knowledge and practice 
approach questions is one that could be explored further. However, the content of this type of model 
needs better scoping to provide a greater depth of material.  
The final self-assessment model was well received by participating pharmacists, but needs greater clarity 
of purpose for wider implementation. Based on published literature, models of self-assessment need to 
be part of a wider set of evaluation instruments to give pharmacists feedback for practice validation.  
Ideally, self-assessment tools could be used in the intermediate steps of a learning process in a CPD 
activity. When complete, the self-assessment tool could be directly compared to the work undertaken in 
the discussion/workshop. This would use a self-assessment tool as a repeatable activity along the course 
of the CPD activity, informing progress.  
The assessment of competency needs to be further defined and its elements de-constructed to explore 
how it can be measured. Self-assessment tools are likely to be most effectively used as part of a 
composite of assessments in a way that can track progress along an educational and practice continuum.  
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Based on the experience gained in this research I would make the following recommendations: 
1. A cycle of competency should be nominated for each pharmacist over a five-year period that 
covers every aspect of their practice in both therapeutic and practice topics using a competency 
matrix to guide their CPD selection. 
2. The delivery of education to pharmacists needs to be de-constructed. Clearly the literature 
indicates that using one mode of educational CPD will not be sufficient for competency based 
learning to be successful. There should be clear guidance for pharmacists that all formats of 
CPD delivery should be undertaken. Methods of assessment like OSCEs and the delivery of 
CPD in the format of Patient Oriented Evidence that Matters (POEMS) should be blended into 
CPD delivery where possible.  
3. A greater emphasis on learning using personal practice should be promoted with more emphasis 
on the analysis of outcomes of personal practice. This could be explored using electronic 
recording systems such as the one developed in the Pharmacy Recording of Medication and 
Incidents and Services (PROMISe) research (106).  
4. The validation instruments developed by Azzopardi (52) should be explored and developed for 
the Australian setting to support the process of competency.   
5. Pharmacists need to be trained to understand that using surrogate instruments to measure their 
competencies need to be balanced against measurable outcomes of their practice.  
6. The re-registration process for pharmacists should consider two categories of pharmacists’ 
registration – clinical and non-clinical registration as illustrated in the Ontario model in Canada. 
This may allay concerns amongst pharmacists who fear that their business and livelihood will be 
taken from them if their competency is under question 
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Appendix 1: Survey of pharmacists examining the issue of  
competency 
Name (optional):………………………………..Contact/Phone/Email:……………………… 
 
 
 
 
 
 
Survey of pharmacists examining the issue of competency 
This study is to find out pharmacists’ opinions on maintaining competency. 
 
The following terms are referred to in this questionnaire: 
 
CE attendance - attendance at continuing education lectures, talks etc., 
Using a mentor - having a pharmacist provide support and advice on practice issues where 
direction is sought 
Self-directed learning – e.g. undertaking a training course, postgraduate study. 
CE presentation – giving talks, training to others. 
Self-assessment tool – provided by the Pharmacy Board for pharmacists to assess their own 
competency 
Multiple choice questions - includes multiple-choice questions in Pharmacy Board papers and 
articles. 
Peer Review – includes formal or informal review by e.g. working with another pharmacist 
Audit - includes Quality Care Program, nursing home audits. 
Student supervision – where a pharmacist supervises pharmacy students, learning new 
pharmacy knowledge in the process 
Review in the pharmacy setting – having a formal process of reviewing patient management. 
Portfolio – plan and record of continuing professional development 
OSCE – Objective Structured Clinical Examination – consists of a series of role-plays where 
a scenario is presented that will assess a particular competency. 
 
1. Age?  ____  Gender    Male    Female       Year first registered as a pharmacist?  19__________ 
 
Which of the following best describes your practise? 
 
 Community (owner)  Community 
(locum) 
 Hospital pharmacy 
 Community (manager)  University  Other 
____________________ 
 Community (pharmacist)  Industry   
PLEASE FAX OR POST THIS QUESTIONNAIRE TO: 
 
TO:  Mary Collins,  
c/- The Pharmacy Board of Tasmania, PO Box 6, South Hobart 7004 
 
FAX NO:      6224 9700 
Pharmacists are welcome to identify themselves to allow follow up, otherwise responses will
be confidential. Thank you for your feedback       
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2. What activities listed below do you use currently to maintain your competency to practise 
pharmacy. 
 
CE attendance   Multiple choice questions   
Reading Journals  Peer Review   
Regular Journal Club  Audit   
Using a mentor   Student Supervision   
Self-directed learning   Review in the Pharmacy setting   
CE presentation   Other:…………………….  
Self-assessment tool     
    
 
 
3. Please place a tick in the box which best indicates your attitude to doing the following 
activities to maintain your competency: 
 
Activity – Maintaining Competency No opinion No 
benef
it 
Some 
benefit 
Definite 
benefit 
Good 
benefit 
Excellent 
benefit 
CE attendance  ο      
Multiple choice questions  ο      
Reading journals  ο      
Peer Review ο      
Journal club  ο      
Student supervision  ο      
Self-directed learning ο      
Pharmacy setting review ο      
CE presentation  ο      
Other activity:   ο      
 
4. Please tick a box that indicates how often do you believe each of these activities should be 
undertaken in order to maintain competency? 
 
Maintain Competency 1 per 
year 
1-5 per 
year 
6-10 per 
year 
11-12 per 
year 
Every 
2 years 
Never 
CE Presentations       
Multiple Choice questions       
Reading Journals       
Peer Review       
Regular journal club       
Self-directed learning       
Pharmacy setting review       
Self-assessment tool       
Portfolio       
Other …………………. 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5. Please rate each these activities listed below as to their importance in maintaining competency. 
Each activity should be rated on a scale of 1 (most important) to 5 (least important) 
 
Maintain Competency Rating: 1(most important) – 5 
(least important). 
 
CE Presentations  
Multiple Choice questions  
Reading Journals  
Peer Review  
Regular journal club  
Self-directed learning  
Pharmacy setting review  
Self-assessment tool  
Portfolio  
Other ………………….  
 
 
6. Any other comments? Please use additional paper if required. 
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Appendix 2: First Competency assessment tool for Pharmacy  
Board of Tasmania 
 
 
Competency Self-Assessment Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mary Collins 
Developed for the Pharmacy Board of Tasmania on 
behalf of APRA 
March 2001  
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Competency Assessment Model 
 
Definition: 
Competency can be the application of pharmacist knowledge, judgement, skills and attitudes 
accepted by the pharmacy profession that are needed to deliver optimum consumer 
outcomes in pharmacy practice. 
Pharmacist Competencies are to: 
Dispense medicines 
Prepare pharmaceutical products 
Provide primary health care 
Provide drug information 
Practise pharmacy in a professional and ethical manner 
Apply organisational skills to the practice of pharmacy 
 
 
Summary of Competencies: 
 
The following is a summary of competencies that are required for initial registration as a 
pharmacist. These competencies describe an approach to pharmacy practice that includes: 
Providing the best outcome possible for consumers from a pharmacy point 
of view. 
 
Approaching tasks in a way that lives up to professional standards of other 
registered pharmacists in Tasmania. 
 
Have the appropriate knowledge base to carry out the professional task at 
hand. 
 
 118
Being aware of the scope of their professional expertise and responsibility. 
 
Being up-to-date with regard to all professional knowledge and practice 
standards that apply to pharmacists in the course of their work. 
 
Being able to recognise, implement or effect change in individuals or groups 
that can benefit from professional pharmacy input. 
 
Counsel people for whom they are professionally responsible for medication 
management or who had sought their assistance. 
 
Ensure that their place of pharmacy practice is well managed to achieve the 
pharmacy practice outcome required. 
 
Have a professional rapport with other heath professionals that fosters best 
practice health management for people to whom they are responsible.   
 
Professional decision-making is underpinned by professional research to give 
the best decision available.  
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Scenario 1 
 
A new patient presents to your pharmacy with a prescription for Imdur tablets 60mg. He tells 
you he had a recent angina attack but has since seen a specialist and was given this 
prescription by his GP today.  
While you are dispensing, his Imdur tablets, he hands a box of Solprin to your assistant. 
When you are finished dispensing his Imdur, he also asks you for some Anginine, a nurse at 
the hospital said he could buy them without a prescription 
 
 
 
 
 
 
Circle what you would do in normal practice 
circumstances below 
Dispensing always undertaken by the pharmacist or directly 
under their supervision 
Always Sometimes Never 
Patient’s history is taken when not familiar with the patient Always Sometimes Never 
 
When your assistant is approached for Solprin what action is likely?  
 
 
 
Circle what you would do in normal practice 
circumstances below 
Explains to the patient that it is important to discuss this 
with the pharmacist 
Always Sometimes Never 
The assistant will complete the purchase as it is a pharmacy 
only item and set it aside until the prescription is finalised 
Always Sometimes Never 
 
 
When the patient asks you for Anginine tablets do you  
 
 Circle what you would do in normal practice 
circumstances below 
Supply them without asking when they will be used knowing 
that he has seen a specialist 
Always Sometimes Never 
Highlight the potential for side effects with this drug Always Sometimes Never 
Discuss how best to take this drug Always Sometimes Never 
 
Your Practice approach: 
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1. The following statements are appropriate counselling tips for Anginine 
except: 
 
a. The medication should be kept handy with the patient at all times. 
b. Sublingual nitroglycerin can no longer be reliably tested for patient by looking for a 
burning or tingling sensation when dissolved under the tongue. 
c. If the patient continues to have chest pains after a total of three tablets over a 15-20 
minute period, contact your GP or ambulance immediately. 
d. Sublingual nitroglycerin tablets should be chewed, crushed or swallowed. 
 
2. Which of the following statements best describes the kinetics of aspirin: 
a. Aspirin is an analgesic, anti-pyretic, anti-inflammatory and anti-platelet drug, 
which has a half-life of 0.25 hours, is metabolised in the liver to salicylate 
with up to 90% being plasma protein bound. 
b. Aspirin is an analgesic, anti-pyretic, anti-inflammatory and anti-platelet drug 
that has a half-life of 0.25 hours, is metabolised in the plasma to salicylate and 
up to 90% of it is plasma protein bound. 
c. Aspirin is an analgesic, anti-pyretic, anti-inflammatory and anti-platelet drug 
that has a half-life of two hours, is metabolised in the liver to salicylate and 
up to 90% can be protein bound. 
 
3. Tick which statement about Isosorbide mononitrate is true: 
a. There is an increase risk of developing nitrate tolerance at doses exceeding 
120mg per day 
b. Slow release isosorbide mononitrate can be given twice daily without 
developing nitrate tolerance 
c. Isosorbide mononitrate is recommended for twice daily administration 
d. Isosorbide mononitrate is not recommended for twice daily administration 
Applying your knowledge: 
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Scenario 2 
 
 
A seventeen-year-old girl M.L. presents a prescription for doxycycline100mg daily. She 
appears anxious, indicating that she would like to have a talk with the pharmacist and says 
that she will call back for her medicine the following day. 
Some hours later M.L’s mother calls into the pharmacy and asks your assistant if her 
daughter has had a prescription dispensed. 
 
 
 
 
Circle what you would do in normal practice 
circumstances below 
Does your pharmacy assistant will tell parents if their 
teenage children have left a prescription for themselves to be 
dispensed 
 
Always Sometimes Never 
Your pharmacy staff provide no details to parents of teenage 
children 
 
Always Sometimes Never 
Indicate the need to ask their teenage children about the 
matter 
 
Always Sometimes Never 
Refer parents of teenage children’s request to the pharmacist Always Sometimes Never 
 
 
What is the pharmacist’s approach? 
 
 
Circle what you would do in normal practice 
circumstances below 
Provide parents of teenage children with heir son/daughter’s 
prescription and advise on how it should be taken 
Always Sometimes Never 
Provide parents of teenage children with the prescription but 
ask that their son/daughter should come back for 
information 
Always Sometimes Never 
Counsel about the need to respect their son/daughter’s 
privacy 
 
Always Sometimes Never 
Enquire if teenage son/daughter is living in the family home 
 
Always Sometimes Never 
Refuse to provide any information about teenage children’s 
prescription citing confidentiality 
Always Sometimes Never 
 
Your Practice approach: 
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The following day ML returns for her medication and asks about acne treatment and 
wants to know if tea tree oil can be used on her acne as well as using the doxycycline. 
1. Which of the following best summarises the advice that should be given to ML regarding 
the use of tea tree oil: 
 
a. Tea tree oil should never be used as a topical treatment because of the possibility of 
developing contact dermatitis and allergic eczema 
b. Tea tree oil should not be applied to the broken skin undiluted. It is best to avoid 
regular use of tea tree to avoid developing dermatitis 
c. Tea tree is an alternative treatment that should not be used as the same time as 
doxycycline 
 
2. Which of the following statements are true of doxycycline 
 
a. Doxycycline is the only tetracycline that needs to be given on an 
empty stomach 
 
 T  F 
b. Tetracyclines are contraindicated in pregnancy, lactation and 
children under 8 years 
 
 T  F 
c. Photosensitivity reactions and candidal overgrowth can occur with 
any tetracycline 
 
 T  F 
 
 
 
 
 
 
 
 
 
 
Applying your knowledge: 
Please tick the 
correct answer 
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3. In general, counselling on antibiotics should include which of the 
following statements 
 
   
a. Antibiotics should be taken until at least 24 hours after symptoms 
have gone. 
 
T F 
b. Antibiotics should be taken with plenty of fluid, preferably in the 
morning to avoid irritation and ulceration 
 
T F 
c. Can be taken with other medication including antacids 
 
T F 
d. Doxycycline doses should not be taken concurrently with other 
medication T F 
 
 
 
 
 
 
Please tick the 
correct answer 
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Scenario 3: 
 
A 15-year-old asthmatic Miss Gaze presents at your pharmacy and asks if she could get 2 
Ventolin inhalers because she is going on holidays for two weeks. She said she wanted a 
spare inhaler in case she looses one. In conversation she tells you that she has been very 
wheezy in the last few days. 
 
 
 
 
 
 
 
 
Circle what you would do in normal practice 
circumstances below 
Refer consumer to GP 
 
Always Sometimes Never 
Discuss and counsel regarding the consumer’s problems and 
dispense inhalers 
Always Sometimes Never 
Check inhaling technique for Ventolin 
 
Always Sometimes Never 
Recommend a spacer if consumer’s technique is not perfect Always Sometimes Never 
 
 
 
If her prescription record reveals that she had Ventolin from your pharmacy a week 
ago, what is your approach? 
 
 Circle what you would do in normal practice 
circumstances below 
Refuse supply Always Sometimes Never 
Counsel consumer on appropriate use Always Sometimes Never 
Refuse supply and contact their GP  Always Sometimes Never 
Supply one inhaler and counsel on correct use Always Sometimes Never 
Supply one inhaler, counsel on correct use and discuss 
asthma management with the consumer 
Always Sometimes Never 
 
Your Practice approach: 
 125
 
 
 
 
 
1. What are the circumstances that permit a pharmacist to prescribe and supply 
Ventolin?  
 
a. The consumer must have a pre-existing asthmatic condition, which has been 
diagnosed and managed by a medical practitioner. 
b. The consumer must produce an empty inhaler to indicate that it has been 
prescribed before. 
c. A Ventolin inhaler must have been prescribed and dispensed from a prescription 
written by a medical practitioner. 
d. There must be a standing order from the medical practitioner at the pharmacy to 
dispense another without reference to the prescriber. 
 
2. Which of the following activities are essential parts of an asthma management 
plan? 
a. Assessing the severity of asthma 
b. Achieving best lung function 
c. Maintaining best lung function with optimal medication 
d. Action plan must include a written plan for the management of deterioration, 
with written instructions to increase doses when and how to gain rapid access to 
medical care 
e. Educate and review regularly 
f. All of the above.   
 
 
 
 
 
 
 
Applying your knowledge: 
 126
3. β-agonists: 
 
a. when used on a ‘prn’ basis result in better asthma control; 
b. should always be used regularly qid; 
c. should be given via a nebuliser wherever possible 
d. can cause a delay in definitive treatment for worsening asthma. 
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Scenario 4: 
 
Mrs H is a nursing home patient in her early seventies with a history of diabetes, 
hypertension, depression and anxiety. An endocrinologist recently reviewed her during a 
hospital admission.. Her current medications are buspirone, glibenclamide, enalapril and 
paroxetine 
The RN telephones you requesting a prescription for erythromycin that had just been 
prescribed for a URTI. Mrs H administers her own medication and uses a dose 
administration aid.  The RN would like you to prepare an updated one as a matter of 
urgency. 
 
 
 Circle what you would do in normal practice 
circumstances below 
Dosett preparation is a dedicated task undertaken by 
pharmacy staff under the pharmacist’s supervision 
Always Sometimes Never 
Dosett preparation is always prepared by the dispensing 
pharmacist 
Always Sometimes Never 
Experienced pharmacy staff undertake Dosett dispensing 
under pharmacist’s supervision 
Always Sometimes Never 
Experienced trained staff undertake Dosett dispensing under 
the pharmacist’s supervision 
Always Sometimes Never 
 
In your pharmacy: 
 Circle what you would do in normal practice 
circumstances below 
A formal agreement which outlines pharmacy services to 
nursing homes provides clear guidance on services 
Always Sometimes Never 
Pharmacy staff have access and refer to written protocols on 
the pharmacy services your pharmacy provides to the 
nursing home. 
Always Sometimes Never 
Pharmacy services to the nursing homes are audited on a 
regular basis 
Always Sometimes Never 
 
What is your approach to the prescriber, where there possible concerns when you 
dispense?: 
 Circle what you would do in normal practice 
circumstances below 
Contact the prescriber where there is a significant interaction Always Sometimes Never 
Your Practice approach: 
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1. Are there any potential interactions between Mrs H’s medication that you may 
need to contact the prescriber about Yes/NO 
 
If yes, which drugs are involved? ___________________ and _________________ 
      
_________________ and ___________________ 
 
2. Which statement reflects best counselling and management for erythromycin 
dispensing: 
 
a. Treatment should be completed, needs to be taken on an empty stomach, check 
for interactions and space doses evenly. 
b. Treatment should be completed, taken on an empty stomach and doses spaced 
evenly. 
c. Treatment should be completed, needs to be taken on an empty stomach and 
doses spaced evenly to prevent diarrhoea. 
 
 
3. The new antidepressants – mechanisms of action, clinical applications 
 
 
a.  The action of SSRIs at 5HT2 receptors is probably responsible 
for the side effect of GI discomfort  T  F 
b. The newer antidepressants have a faster onset of action when 
compared with the tricyclics antidepressants  T  F 
c. The delay in onset of SSRIs is probably due to the need for 
neuroadaptive change to be made   T  F 
d. Being more expensive the newer antidepressants are less cost 
effective than the older drugs  T  F 
e. Patients taking antidepressant medication should be encouraged 
to cease therapy as soon as they begin to feel better  T  F 
    
Applying your knowledge: 
Please tick the 
correct answer 
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Scenario 5: 
 
Mr W has been having methadone 70mg as a daily dose for three months. He appears in 
your pharmacy for his  usual  dose, appears to stagger but talks to you in a coherent way. 
 
 
 
 Circle what you would do in normal practice 
circumstances below 
 Administer methadone as per schedule 
 
Always Sometimes Never 
 Refuse on the grounds that he is intoxicated 
 
Always Sometimes Never 
 Refer to his GP as you suspect he has bought some 
illicit supplies  
Always Sometimes Never 
 Prepare methadone in a dedicated secure area part of 
the pharmacy 
Always Sometimes Never 
 
 
If, your judgement points to Mr W being intoxicated do you: 
 Circle what you would do in normal practice 
circumstances below 
 Provide him with his normal methadone dose Always Sometimes Never 
 Ask him to come back later Always Sometimes Never 
 Contact his GP for advice Always Sometimes Never 
 
In documenting the administration of methadone to clients do you: 
 Circle what you would do in normal practice 
circumstances below 
 Record the dose, volume and hand out the dose to the 
client 
Always Sometimes Never 
 Check the dose and volume against current script always 
before administration 
Always Sometimes Never 
 Assess patient to ascertain if they are not at risk in 
getting the  dose 
Always Sometimes Never 
 Always administer a methadone dose of a known client, 
even if the script has expired 
Always Sometimes Never 
 
 
Your Practice approach: 
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Some days later Mr W presents with a script for Rifampicin telling you that one of his 
friends has bacterial meningitis. 
What is your approach: 
 Circle what you would do in normal practice 
circumstances below 
 Dispense the prescription and provide appropriate 
counselling 
Always Sometimes Never 
 Contact the prescriber about the script Always Sometimes Never 
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1. Which of the following statements is an accurate statement about methadone? 
 
a. Methadone is an opioid agonist and acts in a similar way to morphine and other 
narcotics 
b. Methadone is seen as having an important role in reducing the spread of HIV/AIDS 
c. Consumers who are on the Methadone Maintenance Program do not require an 
additional opioid or a higher dose of methadone for pain management 
d. Consumers who are on the Methadone Maintenance Program require approximately 
10-20%? more methadone for acute pain. 
 
2. Which of the following opioids have the longest half-life? 
a. Morphine 
b. Oxycodone 
c. Methadone 
d. Codeine 
 
3. Naltrexone is: 
 
a. Is now used to facilitate rapid and ultra-rapid withdrawal techniques 
b. It is long acting with few side effects 
c. Patients need to be opioid-free before they use it or it will induce withdrawal 
symptoms 
d. It can be used to treat benzodiazepine overdose. 
Applying your knowledge: 
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Scenario 6 
 
Mrs Long has been a regular customer in you pharmacy for various minor ailments in the 
past. She has mentioned that she dislikes taking medication and once confided in you that 
she regularly visits a herbalist. Mrs Long was dispensed sertraline a few  days ago in your 
pharmacy by a  locum and said she was fine for the first few days but now has returned 
saying that she has the shivers, sweats  a bit  and feels agitated. She thinks that she has caught 
flu and asks you what you would recommend. 
 
 
 
 Circle what you would do in normal practice 
circumstances below 
In order to select treatment for consumers, do you always 
check what they are taking 
Always Sometimes Never 
Do you ask what action the consumer has taken before you 
provide advice and assistance 
 
Always Sometimes Never 
If a consumer asked for a specific product would you supply 
it if you knew they  had taken it before without problems  
Always Sometimes Never 
 
 
When asked about medications, Mrs L tells you that she was given a liquid 
containing Hypericum tincture by her herbalist to improve her mood. What actions 
or opinion would you have in these circumstances? 
 Circle what you would do in normal practice 
circumstances below 
Herbalist preparations are unlikely to interact with 
conventional medications  
Always Sometimes Never 
There is always a need to check interactions with herbal 
medications 
Always Sometimes Never 
It is professionally responsible to contact both the GP and 
the herbalist when interactions are encountered 
Always Sometimes Never 
The best approach is to advise the patient not to consult the 
herbalist again 
Always Sometimes Never 
 
 
Your Practice approach: 
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1. Which of the following would be an appropriate drug selection for antidepressant 
patients? 
 
 
a. Fluoxamine or paroxetine for patients who suffer from depression and panic  T  F 
b. Venlafaxine for patients with high blood pressure  T  F 
c. Nefazidone for patients concerned about adverse effects  T  F 
d. Adding moclobemide to therapy for a patient taking sertraline 100mg twice a day  T  F 
 
 
2. St Johns Wort – a quack medicine or novel antidepressant? 
 
a. Studies to date suggest that St John’s wort has no role to play in the treatment of depression 
 T  F 
b. . A problem with evaluation the benefits of St John’s wort is that varying dosage regimes have been used in the studies  T  F 
c. Side effects from St John’s wort appear to be less than the side effects using conventional antidepressant medications  T  F 
d. 
Concomitant use of St John’s wort and SSRIs has been 
reported to cause serotonin syndrome 
 
 T  F 
 
 
3. Which of the following interactions with St John’s wort is incorrect? 
 
a. St John’s wort may reduce the efficacy of warfarin  T  F 
b.  St John’s wort induces the metabolism of phenytoin  T  F 
c.  St John’s wort may reduce the efficacy of digoxin  T  F 
d.  St John’s wort in combination with NSAIDs can increase the risk of bleeding  T  F 
 
. 
Applying your knowledge: 
Please tick the 
correct answer
Please tick the 
correct answer 
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Scenario 7 
 
Mrs Long is a 50 yr old with a history of chronic back pain and has been prescribed 
Panadeine Forte by her doctor. She has been requesting preparations for constipation from 
you for some time. She has seen an article in a women’s magazine on bowel cancer and is 
very concerned that she is at risk and has asked your assistant if there is a herbal remedy that 
can be used to prevent any problems developing. 
 
 
 
 Circle what you would do in normal practice 
circumstances below 
Assist consumers to select a herbal product from your 
herbal range 
Always Sometimes Never 
If a consumer mentions diet, provide them with general 
information from pharmacy resources 
Always Sometimes Never 
Inquire about other symptoms, medications and other 
medical conditions 
Always Sometimes Never 
Consumers are referred to the pharmacists to discuss their 
concerns 
Always Sometimes Never 
 
In discussing issues like bowel cancer does your pharmacy: 
 Circle what you would do in normal practice 
circumstances below 
Refer patient to their GP Always Sometimes Never 
Refer patient to GP and also discuss issues with patient Always Sometimes Never 
Contact GP and inform them of patient concerns if they are 
serious 
Always Sometimes Never 
 
 
 
 
 
2. Which of the following statements about dietary advice would your pharmacy would 
provide to consumers: 
 
a. Diet high in fibre, vegetables and fruit has a protective effect in bowel cancer 
b. Diet high in animal fat, saturated fat and beer does not increase the risk of 
colorectal cancer 
 
Your Practice approach: 
Applying your knowledge: 
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3. What are the possible signs and symptoms of bowel cancer? 
a. Bleeding from the rectum 
b. Persistent change in bowel habit 
c. Constant feeling that bowel has not been emptied  
d. All of the above 
 
3. Which is the most sensitive screening tests for bowel cancer? 
 
a. Digital rectal exam 
b. Flexible sigmoidoscopy 
c. Colonoscopy 
d. Barium enema 
 
 
4. Which of the following statements are true of Aspirin and NSAIDs are: 
a. Contraindicated in individuals at risk of colon cancer because of the risk of rectal 
bleeding 
b. Studies indicate that NSAIDs may have a protective effect against colon cancer 
c. NSAIDs may reduce the risk of polyp formation in the colon. 
d. NSAIDs should be avoided in renal failure. 
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Scenario 8 
 
34-year mother of two, who regularly has prescriptions filled for Ventolin and Becotide, and 
is occasionally prescribed prednisolone for exacerbations of her asthma. She has not had any 
scripts filled for prednisolone in the past six months.  
She requests a small box of aspirin and asks for a fungal cream for the itchiness between her 
toes. 
 
 
 Circle what you would do in normal practice 
circumstances below 
Allow assistants to complete the sale because both 
preparations are S2’s that your assistants have been trained 
in handling this type of case 
Always Sometimes Never 
Your assistant will ask about the rash and how long the 
consumer has had it 
Always Sometimes Never 
If is the consumer indicates that they are not taking current 
medication, your assistant will complete the sale giving 
advice on how to use the cream 
Always Sometimes Never 
 
In your pharmacy do you: 
 Circle what you would do in normal practice 
circumstances below 
Brief your assistants on new products 
 
Always Sometimes Never 
Monitor your staff’s handling of patient queries 
 
Always Sometimes Never 
Ensure that your staff have regular training Always Sometimes Never 
 
 
What approach would you normally take when asked by someone to recommend 
‘something for an itch between the toes’? 
 Circle what you would do in normal practice 
circumstances below 
Provide a preparation like clotrimazole cream to treat the 
problem 
Always Sometimes Never 
Ascertain a medical history and cause Always Sometimes Never 
Ask to see the affected area before making a 
recommendation 
Always Sometimes Never 
 
Your Practice approach: 
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1.  Please indicate if the following statements are true or false:  
 
a. NSAIDs, when used conjunction with paracetamol often gives better 
pain management than the sum of the analgesics above their 
individual agents  
 T  F 
b. Aspirin should be ceased 2 days before surgery to restore platelet 
function inhibited by Aspirin and other NSAIDS  T  F 
c. Prednisolone and other corticosteroids may enhance the elimination 
of salicylates markedly, resulting in sub therapeutic salicylate 
concentrations 
 T  F 
d. Aspirin is excreted in breast milk and should be avoided in nursing 
mothers 
 T  F 
e. Reyes Syndrome is known to occur during acute influenza in children 
and adolescents under 12.  T  F 
f. Aspirin is not recommended in children and adolescents under 12 
because of the possible risk of Reyes Syndrome  T  F 
g. Symptoms of onset of Reyes Syndrome include nausea, vomiting and 
a sudden change in mental status. 
 T  F 
h Celebrex has a similar adverse effects profile on gastrointestinal 
effects compared to  non-selective agents. 
 T  F 
 
 
 
 
 
2. The following are symptoms which identify non-organic causes of pain in children 
include: 
 
a. Eating normally and no demonstrated weight loss 
  T  F 
b. Pain occurring during the night that disturbs the child’s sleep 
  T  F 
c. The pain is unifocal and persistent in nature 
  T  F 
d. The child can be distracted from their pain during an examination  T  F 
 
 
 
Applying your knowledge: 
Please tick the 
correct answer 
Please tick the 
correct answer 
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3. Celecoxib (Celebrex®) – approved indication: arthritis. 
 
a. Has the advantage over older NSAIDs in that it does not have any 
adverse effects on the gastrointestinal tract  T  F 
b.  Is more selective for the COX-2 isoform that the COX-1 isoform of 
the enzyme cycloxygenase  T  F 
c. Needs to be used with care with other cytochrome P450 CYP2C- 
metabolised drugs  T  F 
d.  Prolongs bleeding time because enzyme activity in the platelets is 
mostly COX-1 based  T  F 
 
Please tick the 
correct answer 
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Scenario 9 
 
Nursing home patient Mrs Jolly is an 88 yr old with a history of heart failure. She is being 
prescribed enalapril and Indapamide by her GP and has taken Voltaren occasionally for a 
sore shoulder. You are aware that her symptoms include breathlessness and swelling ankles. 
When you last did a medication review a week ago her electrolytes were  Na 130 mmol/L, K 
5.3mmol/L and Creatinine 120 mmol/L 
The RN on duty has contacted your pharmacy requesting spironolactone 25mg daily for Mrs 
Jolly. 
 
 Circle what you would do in normal practice 
circumstances below 
A written protocol available for staff to consult on how to 
handle phone calls from nursing homes 
Always Sometimes Never 
Staff are trained and are aware of the pharmacy service 
contract 
Always Sometimes Never 
An area in your pharmacy is dedicated to nursing home 
activities 
Always Sometimes Never 
 
When delivering medicines to a nursing home do your staff : 
 
 Circle what you would do in normal practice 
circumstances below 
Ensure the security of the medicines Always Sometimes Never 
Ensure that the correct staff at the nursing homes take 
delivery of medicines 
Always Sometimes Never 
Staff report back on problems they have encountered Always Sometimes Never 
 
In reviewing the patient medication in the nursing home: 
 Circle what you would do in normal practice 
circumstances below 
Maintain a current history of medication reviews in the 
pharmacy for accurate dispensing 
Always Sometimes Never 
Have a formal identification of patients who have had a 
medication review undertaken 
Always Sometimes Never 
Documentation is made of significant communications with 
the nursing homes and medical practitioner responsible for 
the patient’s care 
Always Sometimes Never 
 
 
Your Practice approach: 
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1. Indicate which of the following is true or false: 
 
a. Enalapril has an active metabolite which is principally 
metabolised by the kidney 
 T  F 
b. Enalapril has a similar duration of action to captopril  T  F 
c. Patients who experience a cough with enalapril must 
cease taking the drug immediately 
 T  F 
d.  Potassium levels need monitoring in patients taking 
enalapril 
 T  F 
 
 
2. Which of the following physiological values for males are correct? 
 
a. Serum Creatinine   50 – 120micromoles/L 
b. Haemoglobin   115 – 165g/L 
c. INR 0.9 – 1.3 
 
3. Which of the following are correct blood values? 
 
a. Potassium   3.5 – 5.0 mmol/L 
b. Sodium   130 – 139 mmol/L 
c. Glucose   2.7 – 4.3 mmol/L 
d. Albumen   34 – 48g/L 
Applying your knowledge: Please tick the 
correct answer 
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Scenario 10 
 
Mrs Scott has had her prescriptions dispensed at your pharmacy for the last five years. She 
has had a fall recently but has generally been in good health as far as you are aware. She had 
her prescriptions filled yesterday, at the time she appeared to be very energetic. She has been 
stable on irbesartan and a hydrochlorothiazide for 6 months 
Her daughter Ms Scott arrives in to your pharmacy two weeks later and presents her 
prescription for the pill. She says that she is concerned about her mother and tells you  that 
her mother is now very dizzy and seems a bit off. She said that her mother pulled a muscle in 
her shoulder a week ago, but that pain was under control after she gave her some of her own 
pain killers for it. 
 
 
 Circle what you would do in normal practice 
circumstances below 
Convey your best wishes to the consumer in question, then 
focus on filling the prescription of her family carer. 
Always Sometimes Never 
Put a note in the consumer’s file to check it out with her 
when she comes in  
Always Sometimes Never 
Discuss the consumer’s care with her family carer because 
you  know them well 
Always Sometimes Never 
 
 
In cases like this do you consider: 
 Circle what you would do in normal practice 
circumstances below 
Sharing medication in family situations Always Sometimes Never 
Assume that Mrs Scott would not take other medication 
without discussing it with you first 
Always Sometimes Never 
 
For elderly residents who have medication dispensed at your pharmacy do you: 
 
 Circle what you would do in normal practice 
circumstances below 
Have a system in process to monitor their ability to mange 
their own medication 
Always Sometimes Never 
Feel confident that their GP will always be aware of their 
patient’s health 
Always Sometimes Never 
Where possible do you establish communication  with other 
family members to maximise your pharmaceutical care 
responsibilities 
Always Sometimes Never 
 
Your Practice approach: 
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1. Which of the following  are true regarding falls in the elderly? 
 
a. The incidence of falls increases with age 
b. Falls frequently result in hip fracture 
c. Fear of falls leads to reduced activity 
d. Benzodiazepines put the elderly at risk of falling. 
 
2. Which benzodiazepines are more likely to result in falls in the elderly? 
a. Nitrazepam 
b. Oxazepam 
c. Diazepam 
d. Temazepam 
e. Flunitrazepam 
 
3. In this scenario, if Mrs Scott’s daughter gave her Voltaren, what do you consider 
as a possible reason for Mrs Scott’s deterioration? 
a. She has problems with balance 
b. Mrs Scott is potentially suffering form the effects of a drug interaction 
c. Mrs Scott is likely to be dehydrated 
d. Mrs Scott is suffering from a lack of activity 
 
4. Is there an interaction here that you need to consider?     Yes /No 
 
If yes what drugs are involved? 
 
_________________________________  and   _________________________________ 
 
_________________________________ and   __________________________________ 
Applying your knowledge: 
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Scenario 11 
 
A consumer present at your pharmacy in a distressed state. He shows you a very inflamed 
area on his lower arms and hands. He has a burning sensation on these areas since he started 
using a cream prescribed by his dermatologist that was prepared in you pharmacy. He says it 
has been very itchy and inflamed and he has a burning sensation on his skin. The initials on 
the cream indicate that your registration student prepared this cream a week ago. In 
extemporaneous preparations do you: 
 
 
 
 Circle what you would do in normal practice 
circumstances below 
Keep a record of details of ingredients used in 
extemporaneous dispensing 
Always Sometimes Never 
Sign off on student work before it is handed out to patients 
where dose calculations are involved 
Always Sometimes Never 
 
For extemporaneous work do you: 
 Circle what you would do in normal practice 
circumstances below 
Have an assigned area for extemporaneous dispensing Always Sometimes Never 
Have a worksheet to record all extemporaneous work Always Sometimes Never 
Monitor the temperature of your pharmacy storage areas Always Sometimes Never 
Check the quality of ingredients used in extemporaneous 
dispensing before using them in dispensing preparations 
Always Sometimes Never 
 
What approach does your pharmacy take to supervision extemporaneous dispensing? 
 
 Circle what you would do in normal practice 
circumstances below 
All student work is checked before preparations are handed 
out to consumers 
Always Sometimes Never 
Checks on student work will depend on competency of the 
individual student 
Always Sometimes Never 
Competency assessment for professional work is determined 
as a joint effort between the supervising pharmacist and 
student tutor 
Always Sometimes Never 
Competency assessment in professional tasks is determined 
by the supervising pharmacist 
Always Sometimes Never 
 
Your Practice approach: 
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1. Which of the following best reflects best practice: 
a. Pharmacist initials should be recorded on the dispensing systems record 
b. Dispensing should be from the original script and from generated repeats 
thereafter.  
c.  Pharmacists supervising students need only check the final dispensed product 
given to consumers. 
 
2. What labelling requirements are missing from the following list for preparations labelled 
by a manufacturer? 
a. Warning labels 
b. Brand name and manufacturer’ 
c. Drug name and strength 
d. Aust L number 
e. Expiry and batch number  
 
Missing from the label:  _________________________________________________ 
In this case the  consumer presents at your pharmacy a week later saying that the 
spots appear worse. At this point you discover that the salicylate strength is 10 
times the recommended strength. What is you approach? 
 
 Circle what you would do in normal practice 
circumstances below 
Tell the patient that it normally deteriorates before it gets 
better 
Always Sometimes Never 
Offer to reduce the strength of the salicylate cream Always Sometimes Never 
Admit that an error has been made and replace the cream 
with the correct strength 
Always Sometimes Never 
Tell the patient that they have had a phototoxic reaction to 
the cream and discuss with the prescriber 
Always Sometimes Never 
 
 
 
 
Applying your knowledge: 
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In your pharmacy do you: 
 
 
3. Salicylate Cream is now used in the treatment of sunspots. What is the correct strength for 
this use? 
 
a. 1 – 5% 
b. 0.5% 
c. 4 – 10% 
d. 20% 
How does your pharmacy handle drug errors? 
 Circle what you would do in normal practice 
circumstances below 
Have a protocol that addresses the issue of errors Always Sometimes Never 
Record concerns and complaints made regarding pharmacy 
services in a log book or register 
Always Sometimes Never 
Contact PDL where a complaint is registered by a consumer 
is a breach of accepted professional practice 
Always Sometimes Never 
Relay complaints of unprofessional practice that have been 
made to you concerning other pharmacists to the Pharmacy 
Board 
Always Sometimes  
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Scenario 12 
 
Mr Smith 65, has fallen in your pharmacy on his way out after having his prescription filled 
for Imdur and Dyazide. Mr Smith was able to get up unaided but received a few cuts and 
grazes on his right hand and lower arm. 
Your dispensing assistant was the only person who witnessed the accident. 
 
 
Under the circumstances do your staff: 
 Circle what you would do in normal practice 
circumstances below 
Notify you of incidents, However, minor  Always Sometimes Never 
Allow Mr Smith to leave the pharmacy without getting 
involved 
Always Sometimes Never 
Will always get involved and acknowledge the liability of the 
pharmacy 
Always Sometimes Never 
  
If you as a pharmacist had witnessed this incident would you: 
 
 Circle what you would do in normal practice 
circumstances below 
Advise Mr Smith to see his GP Always Sometimes Never 
Help Mr Smith and assist him out of the pharmacy Always Sometimes Never 
Administer 1st Aid if injuries were minor Always Sometimes Never 
Document the fall, even though Mr Smith was not seriously 
injured 
Always Sometimes Never 
Maintain an up-to-date 1st Aid Certificate Always Sometimes Never 
 
What procedures have been implemented to protect staff and consumers in your 
pharmacy: 
 Circle what you would do in normal practice 
circumstances below 
Provide adequate information, training and instruction to 
staff in the use of equipment, handling of hazardous 
substances etc. 
Always Sometimes Never 
Train and provide staff with adequate facilities and safety 
equipment 
Always Sometimes Never 
Ensure the pharmacy is maintained in a safe condition for 
staff and customers 
Always Sometimes Never 
 
 
Your Practice approach: 
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1. What is the recommended approach to a patient who is unconscious but 
breathing? 
a. Transport the patient to hospital immediately.  
b. Support the patient’s head, remove any obstructions to breathing and transport to 
hospital immediately. 
c. Roll the patient of their side, remove any obstructions to breathing and transport 
immediately to hospital. 
d. Role the patient on their side, remove any obstructions to breathing, ensure that jaw 
is in a forward position and transport immediately to hospital. 
 
2. Which is the following statements is false? 
a. Modern wound management involves maintaining moisture at the surface of the 
wound to promote cell growth and cell migration to the wound site. 
b. A simple abrasion  wound can be managed using a semipermeable adhesive film 
dressing which is permeable to both gases and water vapour. 
c. In wound management the treatment of leg ulcers should always incorporate the use 
of a compression bandage. 
d. Simple wound management involves finding the cause of the wound and treating it; 
removing non-viable tissue by debridement; treating and controlling infection; 
applying a dressing and a bandage if necessary. 
 
 
3. The management of bites can be described as: 
 
a. Snakes bites require the affected limb to be immobilised and firm 
pressure applied over the whole length of the limb. 
b. Funnel web spiders – should not be treated but referred as soon as 
possible to the nearest emergency department for the administration of 
an antidote 
c. Jack jumper bites – require no specific treatment unless the person is 
allergic to jack jumpers. 
d. Blue ringed octopus bites are a medical emergency. Basic life support 
must be undertaken immediately. 
Applying your knowledge: 
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Scenario 13 
 
A carer looking after Mr English, a 70 yr old pensioner contacts your pharmacy by phone 
one morning to check up on medication dispensed at your pharmacy a week ago. He said he 
had assumed that they were a new brand of his medication but wanted to be certain. He is 
prescribed Avapro (Irbesartan), Frusemide (Lasix) and Warfarin. 
On investigation it was found that Aropax was dispensed as a single item by a locum instead 
of Avapro.   
 
 
 
 
What is standard practice in your pharmacy when this type of situation arises? 
 
 Circle what you would do in normal practice 
circumstances below 
The consumer is asked to return the medication as a matter 
of urgency 
Always Sometimes Never 
The pharmacist records the phone call 
 
Always Sometimes Never 
The pharmacist records the phone call and contacts PDL 
 
Always Sometimes Never 
 
If Mr English has not taken any medication do you: 
 Circle what you would do in normal practice 
circumstances below 
Dispense the original medication without explanation 
 
Always Sometimes Never 
Explain to the carer that an error was made and apologise 
 
Always Sometimes Never 
Blame the prescriber’s handwriting and dispense the correct 
medication 
Always Sometimes Never 
 
 
 
 
 
 
 
 
 
Your Practice approach: 
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What quality systems are in place for handing  prescriptions in your pharmacy? 
 
 Circle what you would do in normal practice 
circumstances below 
If a prescription is a repeat prescription then the pharmacy 
assistant will hand it out to the patient without reference to 
the pharmacist 
Always Sometimes Never 
The staff have been given instructions to check with the 
pharmacist  before handing over scripts 
Always Sometimes Never 
The pharmacy has a referral system  that staff adhere to 
without question 
Always Sometimes Never 
The Pharmacy Drug Error Procedure is known to all staff 
and is adhered to. 
Always Sometimes Never 
 
 
 
 
 
 
1. In the above scenario what are the most likely outcomes of Mr English taking 
Aropax for two weeks instead of Avapro: 
a. Aropax is likely to cause electrolyte changes, so Potassium levels should be checked 
b. Aropax will be no immediate impact on Mr English’s management 
c. Aropax has the potential to promote bleeding, However, no specific action in 
needed, if the drug is ceased 
d. Aropax is likely to destabilise blood pressure control in this patient. 
 
 
2. Which of the following statements are correct for Fluoxetine: 
 
a. Serotonin syndrome can occur when fluoxetine is prescribed with lithium, warfarin, 
buspirone, dextromethorphan and St John’s Wort 
b. Serotonin syndrome can occur when fluoxetine is prescribed with lithium 
moclobemide, venlafaxine, pethidine and St John’s Wort. 
c. Serotonin syndrome can occur when fluoxetine is prescribed with Lithium, selegiline, 
buspirone, warfarin and St John’s Wort 
 
 
 
 
Applying your knowledge: 
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3. Which of the following best fits a definition for Cytochrome P450? 
a. Cytochrome P450 is the name given to a group of enzymes occurring in the liver that 
are responsible for liver metabolism 
b. Cytochrome P450 is a  group of isoenzymes in the liver that metabolise most drugs 
and a myriad of other chemicals. 
c. Cytochrome P450 is the name given to coloured bodies in the plant Hypericum (St 
Johns Wort). 
d. Cytochrome P450 is a cardiac enzyme that dissolves clots in blood vessel 
endothelium. 
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Scenario 14 
 
Mrs Jones, who is 38 weeks pregnant comes into your pharmacy with her four year old son 
James. She asks you for advice on what preparation she should use to treat James’ rash. The 
rash is behind his ears and she has been treating it with Hydrocortisone 1% that you gave her 
some time ago for a previous rash. After taking a history, you determine that her son is most 
likely to have a head lice infestation. 
 
 
 
 
 
 Circle what you would do in normal practice 
circumstances below 
Indicate that it is important to keep hair clean to prevent 
future outbreaks of head lice 
Always Sometimes Never 
Provide consumer information such as Self Care so she can 
decide how to manage the families’ infections in the future. 
Always Sometimes Never 
Outline management and recommend a suitable preparation, 
explaining the reasons for you choice 
Always Sometimes Never 
 
 
After discussing the diagnosis with you she tells you that she would prefer to treat the 
head lice infection using natural remedies. How do you respond? 
 Circle what you would do in normal practice 
circumstances below 
Refer her to a natural therapist for treatment Always Sometimes Never 
Provide a treatment overview of the evidence for treating 
head lice with alternative preparations 
Always Sometimes Never 
Explain that it is a decision to be discussed with her GP Always Sometimes Never 
Provide her with a tea-tree based preparation that is 
marketed for the treatment of head lice 
Always Sometimes Never 
 
 
 
 
 
 
1. Which is the best way to prevent head lice? 
 
a. Brushing and combing regularly; 
b. Regular use of anti-head lice products; 
c. Regular use of shampoo. 
Your Practice approach: 
Applying your knowledge: 
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2. What areas of the head should be covered in the application of head lice 
treatment? 
 
a. Base of the hair; 
b. The scalp; 
c. Around the ears and neck. 
 
3. Which product is the recommended treatment for pregnant and breast-
feeding women? 
 
a. Malathion 
b. Tea tree 
c. Pyrethriods 
d. All of the above. 
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Scenario 15 
 
Mr McGraw is a 79yr old male who has been on gemfibrozil for the past three years and on 
nefazidone for depression. His GP has been recently  started him on simvastatin. Mr 
McGraw’s GP contacts you requiring some information on the medications Mr McGraw is 
on because he has presented to him with severe muscle cramps. 
 
 
 
 Circle what you would do in normal practice 
circumstances below 
Your staff have immediately known what how to respond to 
this type of query without reference to professional 
references 
Always Sometimes Never 
In your pharmacy an interaction reference is kept handy so it 
can referred to when necessary 
Always Sometimes Never 
Your pharmacy has a quality process in place  that will pick 
up interactions 
Always Sometimes Never 
The dispensary history of consumers is automatically 
checked when they present a repeat script where adverse 
effects are common 
Always Sometimes Never 
Automatically check the dispensary history of consumers 
who request OTC products that you have dispensed 
medicines for 
Always Sometimes Never 
 
How often have the references recommended by the Pharmacy Board of Tasmania 
been referenced in the past 14 days of dispensary practice in your pharmacy? 
 
 Circle what you would do in normal practice 
circumstances below 
Australian Pharmaceutical Formulary and Handbook  Daily Occasionally Rarely 
PPG or AusDi Daily Occasionally Rarely 
Poisons Act and Regulations Daily Occasionally Rarely 
 
 
 
Your Practice approach: 
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1. Which of the following are important issues to consider with simvastatin 
treatment? 
 
a. It is metabolised by Cytochrome P450 and has the potential to 
interact with other drugs metabolised in the same way. 
b. Diet and weight control are an important adjunct to treatment with 
Simvastatin. 
c. The risk benefit of treatment with simvastatin should be carefully 
considered in alcoholics. 
d. All of the above. 
2. When counselling a consumer who is starting on an antidepressant, what are 
the key points to discuss to ensure they will be compliant 
 
a. The need for at least two to four weeks of therapy before beneficial 
effects may be noticed. 
b. The need to take medication even after feeling better. 
c. The need to consult their GP before discontinuing medication. 
d. The need to take their medication at the same time each night. 
 
 
 
Applying your knowledge: 
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3. Which statement would best describe your response to this query by the GP? 
 
a. Recommend that the patient be started on quinine sulphate for 
muscle cramps. 
b. Recommend that simvastatin be withdrawn and suggest an 
alternative such as nicotinic acid.   
c. Recommend that the dose of simvastatin be reduced to 10mg/day 
d. Recommend an alternative antidepressant such as fluoxetine, 
gradually reducing nefazodone and then having a washout period 
of at least 3 days before starting fluoxetine. 
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Appendix 3: Second competency assessment tool developed 
 for the Pharmacy Board of Tasmania  
 
PHARMACY BOARD OF TASMANIA COMPETENCY ASSESSMENT 
TOOL 
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Scenario 1 
 
Competencies assessed: 
1.1 Understand the principles of drug therapy selection 
1.2 Monitor and assess individual patient’s drug therapy 
1.3 Recommend action to optimise health outcomes 
2.3 Elicit, review and assess patient history 
2.8 Counsel patients to encourage compliance with recommended therapy regimes 
4.1 Elicit a patient history 
6.3 Comply with legal requirements for the practice of pharmacy 
7.2 Work effectively within the structure of an organisation 
 
Mr Jones, a new patient, presents to your pharmacy. He tells you he had a recent angina 
attack but has recently seen a specialist. He presents a prescription for Imdur tablets 60mg 
written by his GP today.  
While you are dispensing, his Imdur tablets, he hands a box of Solprin to your assistant. 
 
When you are finished dispensing his Imdur, he also asks you for some Anginine. He 
explains that a nurse at the hospital said he could buy them without a prescription. 
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Questions relevant to this pharmacy scenario: 
 
1. Which of the following statements best describes the minimum amount of 
information required for patient history taking in this scenario: 
a. Information on age, current medications and medical conditions. 
b. Age and current medications. 
c. Age. 
 
 
2. What course of action should a pharmacist take first when supplying this patient 
Aspirin? 
a. Contact his GP about the use of aspirin with Imdur. 
b. Check the strength of aspirin required with the patient and the reason for 
therapy. 
c. Discuss aspirin supply with the patient and the strength required. 
 
3. In the pharmacy setting, what is the role of a pharmacy assistant when asked to 
supply aspirin? 
a. Pharmacy protocols require that patients who make requests for aspirin to 
the pharmacy assistant while they are waiting for their prescriptions 
should be referred to the pharmacist. 
b. Pharmacy protocols allow the pharmacy assistant to make their own 
assessment about the situation. 
c. No protocols are required when there are experienced pharmacy staff 
employed by the pharmacy. 
 
Note: Please choose
the most appropriate
multiple-choice 
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4. Indicate which staff should handle OTCs in the pharmacy setting. 
a. Only staff who have undergone accredited pharmacy assistant training 
should deal with consumer OTC queries. 
b. All experienced staff can deal with OTC queries. 
 
5. Which of the following group contains the most important ‘Referral triggers’ for 
your pharmacy staff with requests for Aspirin from older patients. 
a. Taking other medication, cardiac & renal problems, hypersensitivity. 
b. Sport injuries, headaches, use in ankle sprains. 
c. Driving, use of machinery, use in dental work. 
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Professional Decisions for this scenario:   
 
Which action should the pharmacy assistant take in these circumstances? 
 
ο Assistant will complete the transaction while the patient’s script is 
dispensed. 
ο Assistant will refer aspirin request to the pharmacist. 
 
 
Which choice should the pharmacist take regarding Mr Jones’ request for aspirin? 
 
ο Aspirin preparation requested by Mr Jones is not challenged 
because the patient has been seen by a specialist 
ο Aspirin preparation requested will be discussed with Mr Jones 
 
 
 
 
 
 
Note: Please choose
the most appropriate
answer 
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Which professional approach should be taken in dispensing for Mr Jones? 
 
ο A comprehensive history of patient’s medication is taken and OTC 
requests are considered in light of this medication history. 
ο Suggest the use of Ginkgo for its antiplatelet effect. 
 
 
 
What course of action should be taken by the pharmacist in response to Mr Jones’ request 
for Anginine  
 
ο Knowing that Anginine was initiated in hospital, no intervention 
need be considered for this patient. 
ο Counselling is undertaken with regard to Anginine. 
ο Nitrolingual spray is recommended instead of S/L tablets. 
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Summary/feedback for the pharmacist: 
 
 
In this case it would be important to ascertain if the request for aspirin was its use as an 
analgesic or as an anti-platelet agent, an alternative preparation may be recommended. 
 
Unless the reason for the request is clear, e.g. the consumer wants aspirin for a headache and 
is not taking other medication, then the assistant should refer the request to the 
pharmacist.  
 
This scenario illustrates the quality approach to supplying OTCs and the importance of 
ensuring that requests for OTCs and dispensed medicines are linked through some 
process.  
 
Supplying Anginine and aspirin should always be discussed with the patient. 
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Scenario 2 
 
Competencies assessed: 
1.2 Understand the principles of drug therapy selection  
1.3 Recommend action to optimise health outcomes 
2.3 Elicit, review and assess patient history 
2.7 Label dispensed medicines 
2.8 Counsel patients to encourage compliance with recommended therapy regimens 
6.2 Interpret and comply with relevant codes of ethics 
 
A seventeen-year-old girl, M.L., presents with a prescription for doxycycline 100mg twice 
daily for seven days. She appears anxious, indicating that she would like to have a talk with 
the pharmacist and says that she will call back for her medicine the following day. Before she 
left she bought a bottle of Tea Tree Oil from your assistant. 
Hours later, M.L’s mother calls into the pharmacy and asks your assistant if her daughter has 
had a prescription dispensed. 
 
Questions relevant to this pharmacy scenario:     
 
1. Which of the following is the most appropriate advice for ML regarding the use of 
tea tree oil: 
 
d. Tea tree oil should never be used as a topical treatment because of the possibility of 
developing contact dermatitis and allergic eczema. 
e. Care should be taken when applying Tea Tree Oil as an increasing number of skin 
inflammation cases have been reported. 
f. Tea tree is an alternative treatment that can be used as the same time as doxycycline. 
g. Tea Tree Oil is a potent anti-viral that can be used in the treatment of warts. 
Note: Please choose the
most appropriate answer 
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2. Which of the following statements are true or false for doxycycline 
 
a.  
 
 
b. Doxycycline is the only tetracycline that needs to be 
given on an empty stomach.  T  F 
c.  
 
 
d. Tetracyclines are contraindicated in pregnancy, 
lactation and  
e. children under 8 years. 
 T  F 
f.  
 
 
g. Photosensitivity reactions and candidal overgrowth 
can occur with any tetracycline.  T  F 
 
 
3. Which of the following statements for counselling on doxycycline are true or false: 
 
a. Taken until at least 24 hours after symptoms have gone. T F 
b. Taken with plenty of fluid, preferably in the morning to avoid 
irritation and ulceration T F 
c. 
 
Can be taken with other medication including antacids 
T F 
d. 
 
Should not be taken concurrently with other medication 
T F 
 
4. Indicate which of the following conditions would Doxycycline 100 mg orally, every 
twelve hourly for five to seven days be taken:  
 
a. Severe Acne 
b. Gonococcal infections  
c. Malaria 
d. Middle ear infections 
5. Indicate which of the following statements about Tea Tree are true or false? 
 
a. Tea tree oil is an extract from Melaleuca alternifolia 
 
 T  F 
b. Tea tree oil is used to treat minor burns and skin infections 
 
 T  F 
c. Tea tree oil is promoted for a short term in minor skin 
conditions because of reports that it can cause dermatitis  T  F 
d. Tea tree oil should not be injected  T  F 
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Professional Decisions for this scenario:   
 
Which action should the pharmacy assistant take? 
 
ο Your pharmacy assistant will tell parents if their teenage children 
have left a prescription for themselves to be dispensed. 
ο Refer parents with teenage children’s request to the pharmacist. 
 
 
Which action should the pharmacist take if a parent requests information about their teenage 
son/daughter’s prescription? 
ο Provide parents of teenage children with their son/daughter’s 
prescription and advise on how it should be taken. 
ο Refuse to provide any information about teenage children’s 
prescription citing confidentiality. 
ο Establish somehow that ML’s parents have her permission to pick 
up the prescription for her. 
 
In this scenario, what other actions should the pharmacist take? 
ο Advise ML of preventative measures to prevent a recurrence of her 
infection and discuss oral contraceptive issues, if appropriate. 
ο No other action. 
ο Discuss oral contraceptive issues, if appropriate. 
 
Please tick the
most appropriate
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At what age is the pharmacist obliged to maintain the confidentiality of their patient records 
 
ο Age 18 onwards 
ο Age 16 onwards 
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Summary/feedback for the pharmacist: 
 
The reason for prescribing doxycycline is this case is likely to be for an STD. This 
will require pharmacist counselling to ensure that the patient’s partner is treated and 
the patient avoids re-infection. 
 
 
There are a number of issues to consider in this case: 
 
• Counselling on partner being treated, as well as how to avoid re-infection. 
 
• How to take doxycycline, finishing the course 
 
• Maintaining confidentiality on the reasons for prescribing this medication and the 
condition if this is known. 
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Scenario 3: 
 
Competencies assessed 
1.2 Monitor and assess individual patient’s drug therapy 
1.4 Recommend action to optimise health outcomes 
2.3 Elicit, review and assess patient history  
2.4 Optimise the efficacy and safety of dispensed medicines 
2.6 Maintain records 
2.7 Counsel patients to encourage compliance with recommended therapy regimens 
2.8 Refer patients to other health professionals when appropriate 
6.2 Interpret and comply with relevant codes of ethics 
 6.3 Comply with legal requirements for the practice of pharmacy 
A 15-year-old asthmatic Miss Gaze presents at your pharmacy and asks if she could get 2 
Ventolin inhalers because she is going overseas on holidays for two weeks. She said she 
wanted a spare inhaler in case she loses one. In conversation she tells you that she has been 
very wheezy in the last few days. 
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Questions relevant to this pharmacy scenario: 
1. What are the correct circumstances that permit a pharmacist to prescribe and 
supply Ventolin?  
 
a. The consumer must have a pre-existing asthmatic condition that has been 
diagnosed and managed by a medical practitioner. 
b. The consumer must produce an empty inhaler to indicate that it has been 
prescribed before. 
c. A Ventolin inhaler must have been prescribed and dispensed from a prescription 
written by a medical practitioner. 
d. There must be a standing order from the medical practitioner at the pharmacy to 
dispense another without reference to the prescriber. 
 
1. Which of the following activities is an essential part of an asthma management 
plan?  
a. Assessing the severity of asthma. 
b. Achieving best lung function. 
c. Maintaining best lung function with optimal medication. 
d. Action plan must include a written plan for the management of deterioration, 
with written instructions to increase doses when and how to gain rapid access to 
medical care. 
e. Educate and review regularly 
f. All of the above.   
 
2. Which of the following statements is correct about beta-agonists used for asthma 
control: 
 
a. Should only be used on a ‘prn’ basis; 
b. Should always be used regularly qid; 
c. Should be given via a nebuliser wherever possible 
d. Ideal treatment for worsening asthma. 
 
Note: Please choose the
most appropriate answer 
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3. Which of the following statements about inhaled corticosteroids in asthma is 
incorrect? 
 
a. In children, regular use of corticosteroids (higher than 400micrograms daily) can 
alter growth. 
b. If a patient has a family history of glaucoma, intraocular pressures should be 
measured within a few days of starting high doses of corticosteroids. 
c. Bone density can be reduced at doses of 1000micrograms daily or above of 
beclomethasone or equivalent. 
d. Inhaled corticosteroids can cause hyper-responsiveness in asthmatics. 
 
 
4. Which of the following approaches should be taken to manage asthma:  
 
a. Identify and avoid trigger factors. 
b. Have regular visits to GP for review. 
c. Take medicines as directed. 
d. All of the above. 
5. Which of the following are possible signs and symptoms of asthma: 
 
a. Difficulty breathing 
b. Chest tightness and wheezing 
c. Cough 
d. Increased sputum production 
e. All of the above 
 
6. Montelukast is: 
a. A leukotriene receptor antagonist used in the treatment and prophylaxis of chronic 
asthma. 
b. A gonadotrophin-releasing hormone (GnRH) agonist. 
c. An alginate dressing used in the management of chronic leg ulcers. 
d. An SSRI for the management of depression. 
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Professional Decisions for this scenario:   
Which of the following actions should be undertaken when a patient complains of a poor 
response to Ventolin inhaler therapy? 
ο Discuss and counsel the consumer on their problem and check 
inhaler technique. 
ο Advise to take a double dose. 
 
Which form of inhaler therapy would you recommend for patents that have trouble with 
their inhaler? 
ο A nebuliser. 
ο  A spacer to use with their inhaler. 
 
What would your action be if a patient requested a second salbutamol inhaler within a week? 
 
ο Refuse supply. 
ο Refer patient to GP for review. 
ο Discuss reasons with patient. 
 
 
 
 
Please tick the most
appropriate answer
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Which of the following is the recommended professional approach for supplying S3 
medicines? 
 
ο An S3 can be supplied to patients known to the pharmacist. 
ο An S3 supply must include review of use to ensure compliance and 
optimum use. 
 
What would your pharmacy assistance do when asked for a salbutamol inhaler? 
ο Supply salbutamol to the patient. 
ο Refer to the pharmacist to undertake a supervised sale. 
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Summary/feedback for the pharmacist: 
 
 
Miss Gaze has presented to the pharmacist with a history of wheeze. In requesting 
salbutamol, she needs to be assessed by the pharmacist for: 
 
• Inhaler technique 
 
• Poor compliance with salbutamol 
 
• Not using a preventer if prescribed 
 
Counselling and discussion of an asthma plan should be considered if she does not 
have one. Referral to her GP for review should be considered if her inhaler technique 
if good. 
 
Travel plans need to be discussed, ensuring that she takes with her on holidays evidence that 
her medication is prescribed for her by a medical practitioner if she is going overseas. 
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Scenario 4: 
 
Competencies assessed 
1.1 Understand the principles of drug therapy selection 
1.2 Monitor and assess individual patient’s drug therapy 
1.3 Recommend action to optimise health outcomes 
2.5 Demonstrate a disciplined dispensing procedure 
3.5 Ensure drugs, medicines and chemicals are packaged and stored to maximise stability 
and safety 
3.6 Assure the quality of the final product 
6.1 Apply accepted standards of practice and professional competence 
6.3 Comply with legal requirements for the practice of pharmacy 
6.4 Establish and maintain good professional relationships 
 
Mrs H is a nursing home patient in her early seventies with a history of diabetes, 
hypertension, depression and anxiety. An endocrinologist recently reviewed her during a 
hospital admission. Her current medications are buspirone, glibenclamide, enalapril and 
paroxetine. 
The RN telephones you requesting a prescription for erythromycin that had just been 
prescribed for an upper respiratory tract infection. Mrs H administers her own medication 
and uses a dose administration aid.  The RN would like you to prepare an updated one as a 
matter of urgency. 
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Questions relevant to this pharmacy scenario: 
 
1. Are there any potential interactions between Mrs H’s medication that you may 
need to contact the prescriber about Yes/No 
 
If yes, which drugs are involved? ___________________ and _________________ 
 
  ________________________ and    ____________________ 
        
2. Which statement reflects best counselling and management for erythromycin 
(Eyrc®) dispensing: 
 
a. Treatment should be completed, needs to be taken on an empty stomach, check 
for interactions and space doses evenly. 
b. Treatment should be completed, taken on an empty stomach and doses spaced 
evenly. 
c. Treatment should be completed, needs to be taken on an empty stomach and 
doses spaced evenly to prevent diarrhoea. 
3. The new antidepressants – mechanisms of action, clinical applications, indicate 
which of the following are True or False 
 
 
a.  The action of SSRIs at 5HT2 receptors is probably responsible 
for the side effect of GI discomfort  T  F 
b. The newer antidepressants have a faster onset of action when 
compared with the tricyclic antidepressants  T  F 
c. The delay in onset of SSRIs is probably due to the need for 
neuroadaptive change to be made   T  F 
d. Being more expensive the newer antidepressants are less cost 
effective than the older drugs  T  F 
e. Patients taking antidepressant medication should be 
encouraged to cease therapy as soon as they begin to feel 
better  T  F 
Note: These 
questions are 
multiple choices with 
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4. ACE inhibitors are the drug group of choice for diabetics with hypertension 
because: 
 
a. They can reduce proteinuria, thereby reducing the microvascular complications of 
diabetes. 
b. They reduce peripheral circulation. 
c. They stimulate pancreatic secretion of insulin. 
d. They enhance the action of insulin. 
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Professional Decisions for this scenario:   
Which of the following describes what happens in your pharmacy when dose administration 
aids e.g. a Dosett, are prepared? 
ο Dose administration aid preparation is a dedicated task undertaken by 
pharmacy staff.  
ο Dose administration aid preparation is a dedicated task undertaken by 
pharmacy staff under the pharmacist’s supervision. 
 
Which of the following is best practice for preparing dose administration aids? 
ο Pharmacy staff has access and refer to written protocols on the 
pharmacy services your pharmacy provides to the nursing home. 
ο Pharmacy Staff do not have written protocols to refer to when they 
are preparing dose administration aids. 
 
In your pharmacy, which of the following best describes your pharmacy protocol for phone 
prescriptions? 
 
ο The Pharmacist on duty will discuss emergency prescriptions with 
the prescriber or the RN on duty if the prescriber has already 
written the prescription. 
ο The pharmacy assistant in the pharmacy documents all phone 
scripts from the nursing home for the pharmacist. 
 
Please tick the
most appropriate
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Summary/feedback for the pharmacist: 
Mrs H is a nursing home patient who needs regular review because of her complex medical 
condition. If the pharmacist has not reviewed her medication since her specialist review by 
the endocrinologist, then the pharmacist needs to check what changes may have occurred. 
Elderly patients may be at increased risk of hearing loss if they also have decreased renal or 
hepatic function associated with aging and receiving high doses of erythromycin.  
Erythromycin may also increase the levels of buspirone via Cytochrome P450 inhibition of 
CYT 3A4 and reports of serotonin syndrome have been documented with Paroxetine. 
The preparation of dose administrations aids is small-scale manufacturing and therefore 
needs to be done in dedicated areas by either the pharmacist or a trained assistant under the 
pharmacist’s supervision. All dose administration containers must be labelled with all the 
information other dispensed containers have. Staff should be aware of protocols the 
pharmacy has for this process. 
The pharmacist on duty should handle emergency phone scripts.
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Scenario 5: 
 
Competencies assessed 
1.2 Monitor and assess individual patient’s drug therapy 
1.4 Participate in adverse drug reaction management and reporting programs 
2.6 Demonstrate a disciplined dispensing procedure 
6.3 Maintain records 
6.3 Comply with legal requirements for the practice of pharmacy 
6.4 Establish and maintain good professional relationships 
7.2 Work effectively within the structure of an organization 
 
Mr W has been having methadone 70mg as a daily dose for three months. He presents in 
your pharmacy for his usual dose, appears to stagger but talks to you in a coherent way. 
 
Questions relevant to this pharmacy scenario: 
1. Which of the following statements about methadone is correct? 
 
a. Methadone is an opioid antagonist and acts in a similar way to morphine and other 
narcotics. 
b. Most patients require no more than 40mg daily on the Methadone Program. 
c. Consumers who are on the Methadone Maintenance Program do not require an 
additional opioid or a higher dose of methadone for pain management. 
d. Consumers who are on the Methadone Maintenance Program require approximately 10-
20% more methadone for acute pain. 
 
Note: These 
questions are 
multiple choices with 
one correct answer
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2. Which of the following opioids have the longest half-life? 
 
a. Morphine 
b. Oxycodone 
c. Methadone 
d. Codeine 
 
3. Naltrexone is used to: 
 
a. To facilitate rapid and ultra-rapid withdrawal techniques. 
b. As a long acting opioid with few side effects. 
c. To treat patients that are on opioid  
d. To treat benzodiazepine overdose. 
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Professional Decisions for this scenario:   
 
Which happens in your pharmacy with methadone dispensing? 
 
ο The methadone dose and volume are recorded and then handed out to the client. 
ο The dose and volume are checked against current script always before 
administration. 
 
 
 
Where is methadone dispensed in your pharmacy? 
 
ο Methadone is prepared in a dedicated secure part of the pharmacy. 
ο Methadone is prepared and dispensed in an area that is an easily 
accessible part of the pharmacy. 
 
 
 
 
In this situation what course of action would you consider? 
 
ο Provide Mr W with his normal methadone dose 
ο Ask Mr W to come back later 
Please tick the most
appropriate answer
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How do you record methadone in your pharmacy? 
 
ο Record the dose, volume and hand out the dose to the client. 
ο Check the dose and volume against current script always before 
administration. 
 
 
 183
Summary/feedback for the pharmacist: 
The pharmacist’s role in administering methadone to patients in a methadone maintenance 
program is vital for the safety of the patent. In this scenario it is important to have a regular 
review of the dose and current prescriptions details particularly where there is likely to be a 
number of pharmacists dispensing methadone.   
 
Pharmacists should keep up-to-date with changes to policies, procedures and guidelines 
required for methadone administration. 
 
Patients should always be assessed prior to methadone administration to ensure that the dose 
will not adversely affect their health. 
 
Privacy for methadone administration and the identity of methadone patients must be 
respected. 
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Scenario 6 
 
Competencies assessed 
1.2 Monitor and assess individual patient’s drug therapy 
1.4 Participate in adverse drug reaction management and reporting programs 
1.7 Utilise basic research skills 
2.3 Elicit, review and assess patient history 
2.4 Optimise the efficacy and safety of dispensed medicines 
4.2 Assess patient signs, symptoms and history to distinguish conditions manageable within 
the ambit of pharmacy practice 
4.3 Refer patients to other health professionals when appropriate 
6.4 Establish and maintain good professional relationships 
Mrs Long has been a regular customer in you pharmacy for various minor ailments in the 
past. She has mentioned that she dislikes taking medication and once confided in you that 
she regularly visits a herbalist. Mrs Long was dispensed sertraline a few days ago in your 
pharmacy by a locum and said she was fine for the first few days but now has returned saying 
that she has the shivers, sweats a bit  and feels agitated. She thinks that she has caught flu and 
asks you what you would recommend. 
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Questions relevant to this pharmacy scenario: 
1. Which of the following would be an appropriate drug selection for patients taking 
antidepressants? 
 
a. Fluoxamine or paroxetine for patients who suffer from depression 
and panic  T  F 
b. Venlafaxine for patients with high blood pressure  T  F 
c. Nefazodone for patients concerned about adverse effects  T  F 
d. Adding moclobemide to therapy for a patient taking sertraline 
100mg twice a day  T  F 
 
 
 
2. St Johns Wort – a quack medicine or novel antidepressant? 
 
a. Studies to date suggest that St John’s wort has no role to play in the 
treatment of depression  T  F 
b. A problem with evaluation the benefits of St John’s wort is that 
varying dosage regimes have been used in the studies  T  F 
c. Side effects from St John’s wort appear to be less than the side 
effects using conventional antidepressant medications  T  F 
d. Concomitant use of St John’s wort and SSRIs has been reported to 
cause serotonin syndrome 
 
 T  F 
 
3. Which of the following interactions with St John’s wort is true or false? 
 
a. St John’s wort may reduce the efficacy of warfarin  T  F 
b. St John’s wort induces the metabolism of phenytoin  T  F 
c. St John’s wort may reduce the efficacy of digoxin  T  F 
d. St John’s wort in combination with NSAIDs can increase the risk 
of bleeding  T  F 
 
Please tick 
true or false 
Please tick 
true or false
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Professional Decisions for this scenario:   
 
Which happens in your pharmacy? 
 
      ο If a consumer asked for a specific product would you supply it if you 
knew they had taken it before without problems  
      ο The pharmacy protocols provided to staff recommend that all requests 
for products be considered in light of any relevant patient history. 
 
 
Which is your approach to herbal preparations? 
 
ο Herbal preparations are always considered in light of what medication 
the patient is taking 
ο Herbal medicines are not likely to cause significant problems with conventional medicines, therefore there is no patient history review with 
herbal requests. 
 
 
If you know that your patient consults a herbalist, what is your approach? 
 
ο Advise the patient not to consult the herbalist again 
ο Contact both the GP and the herbalist when interactions are 
encountered 
 
 
 
Please tick the 
correct 
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Summary/feedback for the pharmacist: 
In this scenario, Mrs Long is likely to be taking a herbal product for her depression – many 
patients take herbal medicines in addition to their conventional medicines because of the 
belief that they will hot harm them. The most likely reason that Mrs Long is taking sertraline 
is to treat depression and if she had visited a herbalist for the same reason she may be also 
taking St Johns Wort. 
 
The symptoms she is complaining of could be the result of Serotonin syndrome. The 
combination of sertraline and St Johns Wort, depending of their doses, could cause this.  
 
This illustrates the importance of supporting consumers with their decisions, so that they will 
be confident in providing the pharmacist with a complete history of their medicines. 
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Appendix 4: Second Board Competency Assessment Tool 
Evaluation 
Competency Assessment Evaluation 
 
Definition of competency: 
Competency can be the application of pharmacist knowledge, judgement, skills and 
attitudes accepted by the pharmacy profession that are needed to deliver optimum 
consumer outcomes in pharmacy practice. 
 
On the following scales, please rate the competency assessment tool questions on the 
following: 
 
Applicability  
 0           1         2          3         4          5          6          7          8          9          10  
|_____|_____|_____|_____|_____|_____|_____|_____|_____| 
           Not at all                                                                                                    applicable      
 (Please mark the scale above) 
 
Ease of use: 
0           1         2          3         4          5          6          7          8          9          10  
|_____|_____|_____|_____|_____|_____|_____|_____|_____| 
           Not at all                                                                                                                       easy to use                 
 (Please mark the scale above) 
 
Professional Feedback: 
 
0           1         2          3         4          5          6          7          8          9          10  
|_____|_____|_____|_____|_____|_____|_____|_____|_____| 
           Not at all   
 (Please mark the scale above) 
 
 
Rate the assessment tool in covering the following elements of competency: 
 
Knowledge: 
 
0           1         2          3         4          5          6          7          8          9          10  
|_____|_____|_____|_____|_____|_____|_____|_____|_____| 
           Not at all   
 (Please mark the scale above) 
 
Judgment: 
 
0           1         2          3         4          5          6          7          8          9          10  
|_____|_____|_____|_____|_____|_____|_____|_____|_____| 
           Not at all   
 (Please mark the scale above) 
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Skill: 
 
0           1         2          3         4          5          6          7          8          9          10  
|_____|_____|_____|_____|_____|_____|_____|_____|_____| 
           Not at all   
 (Please mark the scale above) 
 
Attitudes: 
 
0           1         2          3         4          5          6          7          8          9          10  
|_____|_____|_____|_____|_____|_____|_____|_____|_____| 
           Not at all   
 (Please mark the scale above) 
 
 
Estimate the time it took you to complete this questionnaire (Please circle): 
 
½ an hour      one hour               1¼  hours          1½ hours           1¾ hours            2 hours  
 
Is this a reasonable method to explore competency assessment in pharmacy practice? 
 
    Yes                No           unsure                              undecided                           no opinion 
 
Comments: 
 
 
 
 
 
 
In your opinion would this assessment tool cover competency in hospital pharmacy 
practice? 
 
  Yes                No           unsure                              undecided                           no opinion 
 
Comments:  
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Appendix 5: Self-assessment module: Asthma  
Asthma Self-assessment   
 
 
Assessment instructions 
Please make sure that you have answered all the questions before you click ‘submit your 
answer’ button at the bottom of the page. 
 
Assessment objectives 
• Rational therapy for asthma management  
• Pharmacist’s role in asthma drug therapy management  
• Understanding the differences between asthma and chronic obstructive pulmonary 
disease (COPD)  
• Drug interactions in asthma therapy  
• Using a case study, review asthma therapy and explore medication changes 
required for optimal patient benefit. 
 
Assessment rubric 
A regular pensioner patient of yours, 72 yr old Mrs Brown asks you about an asthma 
drug she has just heard about – Singulair and whether it would have any benefit for her 
asthma. She tells you that she finds her current medications are not working any more 
and she has trouble using her inhalers. Her hands are arthritic and she finds that they are 
not strong enough to actuate her inhalers. 
  
She has been a smoker for 20 years and has a history of hypertension and arthritis that 
mainly affects her hands. You know that she has had several admissions to hospital in 
the past year mainly die to asthma. Recently she was told by her doctor that she has 
emphysema. She is 168 cms tall, weighs 62kg (BMI = 22 kg/m2), and at present finds it 
almost impossible to take daily exercise. When you question her further, she tells you 
that she wakes up wheezing each morning and she gets short of breath when walking up 
the footpath to her house. 
  
Her current medications are: ramipril 5 mg once daily, paracetamol 500 mg – 1 or 2 
four times daily, prednisolone 5 mg daily, fluticasone/salmeterol (Seretide) inhaler 
250/50 micrograms - 2 puffs twice daily, ranitidine 300 mg daily, ipratropium 
bromide 42 micrograms/dose (Atrovent Forte) 2 puffs three times daily when required. 
  
 
 
1. When counselling asthmatics, which of the following definitions would you use to explain 
exercise-induced asthma?  
 
A Where airway narrowing occurs during or after vigorous physical activity  
B Where symptoms of breathlessness occur during physical activity  
C Where physical activity triggers the onset of coughing  
D Where chest tightness makes exercise difficult  
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2. What is the difference between asthma and chronic obstructive airways disease (COPD)?  
 
A Asthma and COPD are the same disease, COPD occurs in older patients.  
B Asthma patients display reversible airflow limitations, COPD is not fully reversible.  
C Asthma patients produce excessive amounts of sputum compared to COPD patients.  
D Both asthma and COPD respond well to inhaled corticosteroids.   
 
3. You have decided to research COPD to further your understanding of Mrs Brown’s condition. 
On completion of your reading, you now feel able to recommend a review of Mrs Brown’s 
medication to her GP. For a review of her asthma medicines and COPD. Which of the following 
statements are correct?  
 
A Inhaled bronchodilators provide relief and may increase exercise capacity  
B 
Long acting bronchodilators provide sustained relief of symptoms in moderate to severe 
COPD 
 
C Long term systemic corticosteroids are recommended in COPD  
D 
Inhaled corticosteroid should be considered in patients with a documented response or those 
who have severe COPD with frequent exacerbations. 
 
 
 
4. When counselling asthmatics, which of the following definitions would you use to explain 
exercise-induced asthma?  
 
A Where airway narrowing occurs during or after vigorous physical activity  
B Where symptoms of breathlessness occur during physical activity  
C Where physical activity triggers the onset of coughing  
D Where chest tightness makes exercise difficult   
 
5. Mrs Brown asks you how her asthma is measured. She thinks that the best test is using her 
peak flow meter. Which of the following do you think is the ‘gold standard’ that best measures 
her lung function?  
 
A Peak flow meter   
B Spirometry   
C Lung scan  
D None of the above   
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6. As a pharmacist, you feel that Mrs Brown needs a review of her inhaler device use. Which 
devices would you consider recommending for Mrs Brown.  
 
A Metered Dose Inhaler  
B Accuhaler  
C Aerolizer  
D Autohaler  
E Turbohaler  
F Spacer   
G Handihaler   
 
7. Which of the following statements describes the most effective inhalation technique for inhaler 
devices?  
 
A Exhale, place the delivery device mouthpiece in mouth, breathe in slowly and deeply, hold 
for 10 seconds, then breathe out slowly. 
 
B Remove cover/cap of device, shake inhaler, exhale, place delivery device mouthpiece in 
mouth, activate one puff, breathe in slowly and deeply, hold for 5 seconds, then breathe out 
slowly.  
 
C Inhale before removing cover/cap of device, place delivery device mouthpiece in mouth, 
breathe in slowly and deeply, hold for 20 seconds, then breathe out slowly.  
 
 
 
8. How many puffs would you normally recommend be used at one time in a spacer?  
 
A One   
B Two  
C Six  
D As many as required   
 
 
9. In the emergency management of asthma how many puffs are recommended in the 
management of a severe or life threatening asthma attack in a spacer?  
 
A 10 puffs every 15 – 30 minutes   
B 10 – 20 puffs every 15 – 30 minutes  
C Six puffs every 15 – 30 minutes  
D 10 puffs every 30 minutes   
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10. Assuming Mrs Brown’s symptoms of wheezing and shortness of breath are asthma 
related, and she is compliant with her medications and her inhalers, as a pharmacist, 
what recommendation would you make to her GP first to improve her asthma drug 
management? 
 
 
A Recommend regular use of another beta agonist – terbutaline (Bricanyl).  
B Use the Atrovent puffer on a regular basis.  
C Increase Seretide from 250/50 2 twice daily to a dose of 500/50 2 twice daily.  
D Recommend an increase of oral prednisolone as per her asthma plan written by her GP.   
 
11. For optimum management of medication when would you recommend a short acting beta 
agonist be used alone in asthma therapy?  
 
A When symptoms require their use no more than once daily.  
B When night-time symptoms are reduced to nil.  
C When symptoms require their use no more than 3-4 times per week.  
D When symptoms are not adequately controlled by inhaled corticosteroids.   
 
12. Tick the appropriate box for the following doses of inhaled corticosteroids to indicate which 
ones are considered high, medium or low for an adult asthmatic:   
 
 D. 
High 
dose  
E. 
Medium 
dose  
F. 
low 
dose  
A. 
400- 500 micrograms per day of fluticasone 
(Flixotide)  
   
B. 
800 - 1000 micrograms per day of 
beclomethasone CFC-free (Qvar)  
   
C. 
400 - 800 micrograms per day of budesonide 
(Pulmicort)  
   
 
 
13. Which of Mrs Brown’s non-asthma medications are most likely to exacerbate her asthma 
symptoms?  
 
A Ramipril   
B Paracetamol  
C Ranitidine   
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14. In considering Mrs Brown’s request for information about another asthma drugs which of the 
following indications are currently recognised in Australia for montelukast?  
 
A Prevention of exercise-induced bronchoconstriction  
B Treatment of aspirin-sensitive asthma patients   
C Chronic asthma prophylaxis   
D 
As adjunctive therapy when inhaled corticosteroids (ICSs) or long acting beta agonists 
(LABAs) are not tolerated.  
 
E All of the above   
 
15. Having researched montelukast for Mrs Brown, indicate which of the following statements 
are FALSE about montelukast (Singulair)?  
 
A Therapy with montelukast should cease if there is no response after two – four weeks.   
B Montelukast is metabolised in the liver by cytochrome P450 isoenzymes CYP3A4 and CYP2C9  
C Dose titration can be made using 5mg tablets for dose increases beyond 10mg.  
D The addition of leukotriene receptor antagonists to established inhaled corticosteroid (ICS) is 
not more effective that doubling the dose of the ICS 
 
 
 
16. Having researched smoking interventions to counsel Mrs Brown about smoking, which of the 
following statements is false:  
 
A People who smoke heavily are less likely to benefit from NRT  
B It is important to determine if a smoker is interested in stopping smoking before suggesting 
smoking cessation therapy.  
 
C When starting treatment with bupropion, smoking should be ceased on the start of day 7 of 
treatment. 
 
D Nicotine patches are designed to be applied for 16 to 24 hours   
 
17. After discussing the possibility of quitting smoking with Mrs Brown, you discover that she has 
been thinking about it for a while. She has accepted your offer of assistance. What approach 
would you use to try to reduce her smoking?  
 
A Encourage her to obtain advice on quitting smoking when she is ready   
B Refer her to QUIT for advice  
C Recommend starting therapy with nicotine patches  
D Recommend using a peak flow meter for lung deterioration due to smoking   
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18. When should a long-acting beta2 agonist (LABAs) be introduced in asthma therapy?  
 
A When short acting beta2 agonists are used more than four times per day.  
B When moderate doses of inhaled corticosteroids (ICSs) do not control asthma symptoms.  
C When twice daily dosing is desirable for compliance.  
D When maximal doses of ICSs do not control symptoms.   
 
19. Which of the following complementary therapies can be recommended as being effective in 
the treatment of asthma?  
 
A Fish oils   
B Vitamin C  
C Homeopathy  
D Breathing exercises  
E Acupuncture  
F Alexander technique  
G None of the above   
 
20. Which of her medicines would you recommend for immediate review by her GP?  
 
A Salmeterol/fluticasone Inhaler (Seretide)  
B Ramipril  
C Paracetamol  
D Prednisolone  
E Ranitidine (Zantac)  
F Ipratropium Inhaler (Atrovent)   
 
21. If montelukast is added to Mrs Brown’s therapy, which of the following medications could be 
considered for cessation.  
 
A Oral prednisolone   
B Salmeterol  
C Inhaled corticosteroid - fluticasone  
D Fluticasone/salmeterol (Seretide) inhaler  
E Ipratropium (Atrovent)  
F None of the above   
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Appendix 6: Self-assessment module: Diabetes 
 
Assessment instructions 
Please make sure that you have answered all the questions before you click ‘submit your answer’ 
button at the bottom of the page. 
 
Assessment objectives 
• Review rational therapy for type 2 diabetes  
• Understand the management of type 2 diabetes  
• Understand the role of cardiovascular risk in type 2 diabetes  
• Review the selection of drugs for glycaemic control in type 2 diabetes 
 
Assessment rubric 
   
A retired 70-year-old teacher Mr Smith is a regular patient of your pharmacy. His current 
medications are: aspirin 150 mg once daily, ramipril 5 mg once daily, amlodipine 10 mg 
once daily, simvastatin 20 mg once daily, celecoxib 200 mg once daily. He smokes, has a 
history of hypertension and elevated lipid levels. He is 5 feet 3 inches tall, his weight is poorly 
controlled, and at present his weight is 102kg and finds it almost impossible to take daily 
exercise because of arthritic knees. He is on metformin 500mg four times daily, and has 
been on gliclazide MR 30mg daily for the past two months. 
  
He suffers regularly from flu and is just recovering from a recent bout of illness. He has 
told you that he has been visiting his daughter in Brisbane with his wife for the last four 
weeks. During that time he was admitted to the local hospital to investigate his complaints 
of dizzy spells. This dizziness was thought to have precipitated a recent severe fall that 
fractured his arm. 
 
1. Would you recommend that Mr Smith stay on Metformin?   
 
A Yes  
B No   
 
2. What are 2 other accepted indications where there is a potential role for metformin?  
 
A Weight loss   
B Polycystic ovarian syndrome  
C Syndrome X  
D Dyslipidaemia   
E Answers a, c, and d above  
F Answers b and c above   
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3. Which of Mr Smith’s medicines are involved in a significant drug – disease interactions?  
 
A Ramipril   
B Simvastatin  
C Celecoxib   
D Amlodipine  nmlkj   
 
4. Which list of medicines are regarded as essential chronic disease therapy to reduce Mr Smith’s 
cardiovascular risk factors?  
 
A Aspirin, hydrochlorothiazide, amlodipine  
B Ramipril, aspirin, amlodipine  
C Ramipril, aspirin, simvastatin   
 
5. The mainstay of diabetes type 2 treatments is still metformin and sulphonylureas; tick four of 
the drugs listed below that can also be used in the treatment of type 2 diabetes?  
 
A Rosiglitazone  
B Mirtazapine  
C Escitalopram  
D Acarbose  
E Pioglitazone  
F Repaglinide    
 
6. What are the most important signs and symptoms in a diabetic that might indicate 
hyperglycaemia?  
 
A Polydipsia  
B Diarrhoea  
C Nausea  
D Dizziness  
E Fatigue  
F Pallor   
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7. What symptoms would indicate that Mr Smith is suffering from myopathy?  
 
A Muscle pain  
B Muscle weakness  
C Nausea  
D Lethargy   
 
8. If Mr Smith had a risk benefit for metformin therapy, what dose of metformin should be 
suggested to reduce his risk of lactic acidosis?  
 
A <1.5g/day   
B < 2.0g/day  
C >3.0g/day   
 
9. Which of the following questions would assist you with Mr Smith’s care  
 
A Can you describe how you have been using your medicines  
B Did you use any other medicines when you had flu?   
C What other medicines are you taking e.g herbal medicines or supplements?  
D Have you stopped taking any of your medicines recently?   
E Tell me what medicines were dispensed for you when you were interstate?  
F All of the above   
 
10. In an ideal world, which of the following pathology results would be most relevant for you to 
ask of Mr Smith’s GP that would help you make recommendations on Mr Smith’s hypoglycaemic 
medication?  
 
A Haemoglobin   
B While cell count  
C Serum Creatinine  
D Thyroid function   
 
11. Would your pharmacy assistant supply Mr. Smith with wart or corn remover?  
 
A Yes  
B No   
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12. Which statements give the correct lifestyle advice that you would consider giving to Mr. 
Smith  
 
A Exercise for at least 30 minutes of moderate physical activity daily  
B Ensure your blood pressure is less than 140/80   
C Reduce and cease smoking if possible   
D Regular salt intake maintains ideal blood pressure in the elderly  
E 
Eat mainly plant based foods – vegetables, fruits and legumes, moderate amounts of 
carbohydrates, lean meats, poultry fish and low fat dairy products and a small amount of 
polyunsaturated or monounsaturated fat  
 
F Limit alcohol to no more than 2 drinks per day.   
 
13. What is the Glycaemic Index (GI) of   
 
 D. 50  E. 58  F. 80  
A. Jelly beans     
B. Wholemeal bread     
C. Banana     
 
 
14. What is the gold standard for measuring compliance with therapy in type 2 diabetes?  
 
A Blood sugar level  
B HbA1c   
C Blood pressure  
D Ketones in urine  
E Proteinuria   
 
 
15. What statements are true about smoking  
 
A 
It is never too late for smokers to quit, even if they already have some form of 
cardiovascular disease  
 
B 
Passive smoking is associated with a 50% increase in the risk of coronary heart disease 
among non-smokers  
 
C Cigarette smoking increases the risk of myocardial infarction two to six times   
D Recent research has found that there is a link between smoking and diabetes   
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16. For which chronic disease is smoking identified as a risk factor?  
 
A Coronary heart disease   
B Chronic Obstructive Pulmonary Disease  
C Diabetes  
D Hypertension  
E Heart Failure   
F All of the above   
 
17. Which of the following is true about oral hypoglycaemics   
 
A When monotherapy with metformin is not controlling HbA1c, combination with another 
hypoglycaemic agent should be prescribed 
 
B A glitazone could be considered in combination with metformin and or a sulfonylurea when 
diabetic control fails 
 
C A glitazone reduces HbA1c levels by 0.5-1.5%  
D All of the above   
 
18. Which of the following tests should be monitored every three to six months in a diabetic 
patient  
 
A HbA1c   
B Eye examination  
C Foot examination  
D Lipid profile  
E Serum Creatinine   
 
19. Which of the following tests should be monitored every six months in a diabetic patient  
 
A HbA1c   
B Eye examination  
C Foot examination  
D Lipid profile  
E Serum Creatinine   
 
20. Which of the following tests should be monitored every twelve months in a diabetic patient  
 
A HbA1c   
B Eye examination  
C Foot examination  
D Lipid profile  
E Serum Creatinine   
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21. What is the ideal BMI for Mr Smith?  
 
A  < 35kg/M2  
B   ≤ 25kg/M2  
C < 20kg/M2  
D      ≥ 35kg/M2  
 
 
22. As a diabetic smoker, with a blood pressure of 140/85 mmHg and a cholesterol:HDL-
cholesterol ratio of 6, what would you estimate Mr Smith’s 5-year cardiovascular risk to be?  
 
A >30%   
B 20-25%  
C 15-20%  
D 10-15%  
E 5-10%   
 
23. When a patient's oral therapy no longer provides glycaemic control, which of the following 
can be prescribed in combination with insulin?  
 
A Acarbose  
B Metformin   
C Pioglitazone  
D Gliclazide   
 
24. What does C-peptide measure?  
 
A Ischaemic heart disease  
B Islet cell function  
C Low density lipoproteins  
D Hypoglycaemic risk    
 
25. Mr Smith's GP is considering adding a third oral hypoglycemic because Mr Smith is not 
achieving HbA1c's of less than 7%. Which of the following is true about rosiglitazone?  
 
A Rosiglitazone is given as a once to twice daily dose  
B Can be given without food  
C Can be given to heart failure patients  
D Does not cause weight gain   
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26. What are the most important signs and symptoms in a diabetic that might indicate 
hypoglycaemia?  
 
A Pallor  
B Nausea  
C Tremor  
D Diarrhoea  
E Sweating  
F Cramp   
 
27. Which of the following factors would you consider when advising Mr. Smith about his risk of 
falls?  
 
A Complaints of constipation  
B Orthostatic hypotension  
C Hydration status  
D Use of NSAIDS   
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Appendix 7: Self-assessment module: Pain 
 Pain self-assessment   
 
 
Assessment instructions 
Please make sure that you have answered all the questions before you click ‘submit your 
answer’ button at the bottom of the page. 
 
Assessment objectives 
• Review rational therapy for chronic pain  
•  Understand the pharmacist's role in chronic pain  
• Role of oxycodone in use of chronic pain  
• Understand the drug interactions involved in pain management case history.  
• Awareness of the risks of abuse and dependence in chronic pain   
• Analysis of case study in order to recommend changes needed 
 
Assessment rubric 
A 68 yr old patient, Mr Parker, who until recently had a small business but was forced to 
retire because of severe osteoarthritis. He has restricted dexterity in his hands, has 
difficulty walking any distance because his knee joints have become very painful and he 
is unable to do any physical work after he was involved in a motor vehicle accident about 
five years ago. He also has a past history of asthma since childhood. However, his 
current pain regimes do not exacerbate this. He now presents a prescription for 
Oxycontin 10mg twice daily. His GP has prescribed increasing numbers of medicines to 
manage his pain. He started coming to your pharmacy two years ago shortly after he had 
reconstruction surgery of his right knee. He was taking paracetamol and indomethacin 
and seemed to cope well with his pain. He drinks about six cans of beer daily. 
About six months ago, Mr Parker’s GP prescribed Codalgin Forte. When he had a 
laminectomy about three months ago he was discharged from hospital and prescribed 
celecoxib and ketorolac. However, these did not control his pain post surgery and 
Tramadol was initiated six weeks ago.  At the time, you spoke to his GP about his pain 
control. He told you that Mr Parker’s pain was complex, and that the specialist indicated 
that some of his pain was neuropathic in origin, as a result of his surgery. 
  
Your records tell you that he is currently taking the following prescribed medications: 
Celebrex 200mg daily, Codalgin Forte 2 four times daily, Diazepam 5mg four times 
daily when required, Endep 50mg 3 at night, Indocid suppositories 100mg twice daily 
when required, Lipitor 20mg at night, Panamax 500mg 1-2 four times daily when 
required, Rani 2 150mg twice daily, Seretide Accuhaler (100/50) one inhalation twice 
daily, Temaze 10mg 1-2 at night, Toradol (Ketorolac) 30mg amps for injection by GP, 
Tramadol 150mg SR twice daily,  
OTC medicines you know that he buys from your pharmacy regularly: 
Voltaren Emulgel apply to knee as required, Glucosamine 1000mg daily.  
  
  
Mr Parker confirms that he is taking all his listed medication. However, he feels that 
he is taking too many medicines and wants to know if he should be taking all his 
medicines at the same time. Instead of taking his new Oxycontin, he want so to know 
if he could increase the doses of other pain medicines instead. 
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1. Which of the following points underpin the management principles for the use of opioids in 
chronic or recurrent non-malignant pain.  
 
A One of the aims of treatment should be to control pain to a tolerable level.  
B Pain should be evaluated over time and should include a detailed pain. history and 
assessment of impact of pain. 
 
C Pain management should include both pharmacological and non-pharmacological modalities.  
D All of the above.   
 
2. Which of the following statements are true about the initial step-wise approach to pain 
management:  
 
A Paracetamol and/or NSAIDS are regarded as first line for analgesic control.  
B Codeine, as a weak opioid, should be considered if paracetamol and NSAIDs are ineffective.  
C 
Tramadol is more effective than a codeine/paracetamol combination in the management of 
chronic non-malignant pain. 
 
D 
Opioids such as oxycodone, can be used for short periods of time with regular review to 
reduce the risk of dependence. 
 
 
 
3. Which of the following statements are true about ketorolac (Toradol)?  
 
A Ketorolac is an opioid agonist  
B Ketorolac’s main indication is in the use of chronic pain  
C Ketorolac is only available as an IM preparation  
D Ketorolac does not cause respiratory depression   
 
4. Which of the following statements are true for Codeine  
 
A Codeine has about one-sixth the analgesic activity of morphine  
B In the Caucasian population, approximately 5 to 10% cannot convert codeine to morphine  
C Codeine should not be used in patients with acute respiratory depression  
D Codeine can be used in poisoning cases where there is severe diarrhoea.   
 
5. Which of the following are correct oral doses for equivalent opioids for maintenance therapy:  
 
A Morphine 30mg four hourly is equivalent to oxycodone 20 – 30 mg four hourly.  
B Morphine 30mg four hourly is equivalent to methadone 50 mg three times daily.  
C Morphine 30mg four hourly is equivalent to codeine 60mg four hourly.  
D Morphine 30mg four hourly is equivalent to tramadol 50 mg three times daily.   
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6. In thinking about an evidence-based approach to pain, your approach to reviewing Mr Parker’s 
analgesics is along the lines of the WHO analgesic ladder. How would tramadol be categorised on 
a scheme such as this?  
 
A An NSAID  
B A weak opioid  
C A strong opioid  
D None of the above   
 
7. Which of the following drug lists indicate a duplication of pharmacotherapy in Mr Parker’s 
therapy  
 
A Paracetamol, Indomethacin, celecoxib  
B Oxycodone, ketorolac, codeine.  
C Indomethacin, ketorolac, celecoxib  
D Paracetamol, indomethacin, codeine.   
 
8. You are concerned about Mr Parker’s use of NSAIDs, which of the following statements are 
correct about NSAIDs combinations.  
 
A Combining topical and oral NSAIDs produces a better analgesic effect.  
B The use of NSAIDs combinations does not confer an additive analgesic affect.  
C The risk of GI adverse effects using NSAID combinations is not additive.   
D None of the above.   
 
9. Which of the following NSAIDS are not recommended in patients with cardiovascular disease?  
 
A Ibuprofen  
B Celecoxib  
C Diclofenac  
D Naproxen   
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10. Mr Parker has an increased risk of gastrointestinal adverse effects. In comparison to 
ibuprofen, which one of the following NSAIDs is regarded as having the highest GI relative risk 
(RR).   
 
A Indomethacin  
B Piroxicam  
C Diclofenac  
D Naproxen   
 
11. Which of the following statements are correct about nociceptive and neuropathic pain?  
 
A Nociceptive pain commonly occurs as a result of a tissue injury.   
B Neuropathic pain occurs as a result of nerve damage   
C 
The character of nociceptive pain would be described as ‘burning, shooting, stabbing’ or ‘like 
electric shocks’ or ‘like a toothache’  
 
D Neuropathic pain does not generally respond well to opioid treatment alone    
 
12. Which type of pain is least likely to respond to opioids?  
 
A Back pain   
B Abdominal pain   
C Post operative pain  
D Nerve damage pain   
 
13. In thinking about Mr Parker’s use of analgesics, you are concerned that his pain levels are 
not controlled by the analgesics that he is taking. Under what conditions do you think that Mr 
Parker may not respond to his current therapy?  
 
A The drugs prescribed are not treating his level of pain.  
B The dose of medications he is currently being prescribed is not appropriate.  
C His current medication regime may not be the best approach to his pain management.  
D All of the above.   
 
14. Which of Mr Parker’s medications are likely to be used as adjuncts for his pain management?  
 
A Diazepam   
B Temazepam  
C Amitriptyline  
D Glucosamine   
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15. Which of the following statements are incorrect about glucosamine?  
 
A Glucosamine should not be used together with paracetamol  
B Glucosamine is a normal constituent of proteoglycans found in joint cartilage and synovial 
fluid. 
 
C The most frequently reported adverse effect was abdominal pain or nausea.   
D The onset of action of glucosamine is likely to be about a month after initiation of therapy, so 
analgesic therapy is likely to be needed during this period. 
 
 
 
16. Which of the following statements best describes the role of diazepam in pain management 
therapy?  
 
A Diazepam’s sedative effect reduces the need for high opioid doses   
B Diazepam provides relief for muscle spasm and anxiety associated with chronic pain   
C Diazepam’s effect in reducing muscle spasm reduces pain threshold   
D The inhibitory effect of diazepam reduces the pain threshold by blocking opioid receptors.   
 
17. As a pharmacist, what signs would alert you to opioid addiction problems in patients like Mr 
Parker?  
 
A Running out of medication earlier that anticipated   
B Visits several GPs and has prescriptions written from them for drugs likely to cause 
dependence 
 
C Regular reports of lost prescriptions  
D All of the above   
 
18. Regarding the benefits of topical NSAIDs, which of the following are correct?  
 
A Topical NSAIDs can be substituted for oral preparations because they have a similar effect.  
B Topical NSAIDs are better than a placebo, but are not as effective as oral NSAIDs.  
C Topical NSAIDs are effective in the treatment of all types of pain.  
D The efficacy of topical NSAIDs can vary, diclofenac in topical form has greater efficacy than 
ibuprofen.  
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19. When considering the use of Oxycodone for osteoarthritis, you reflect on the prescription Mr 
Parker has just given you. What will your approach be?  
 
A Contact his GP to recommend that only one NSAID should prescribed   
B Tell Mr Parker to take his medicines as directed by his GP  
C Tell Mr Parker to keep taking his Codalgin Forte  
D Discuss current use of NSAIDs with Mr Parker, contact his GP regarding your concerns and 
refer him for a Home Medicines Review 
 
E All of the above   
 
20. Mr Parker drinks six cans of beer daily. Which of the following statements are true about 
alcohol use  
 
A Excessive alcohol use does not cause an increase in gastrointestinal bleeding   
B 
Hepatotoxicity from therapeutic doses of paracetamol is unlikely in patients who consume 
moderate amounts of alcohol daily  
 
C 
People who consume at least 3 – 5 drinks daily and who take aspirin regularly have a high 
risk of bleeding. 
 
D 
Men should have no more than three standard drinks on average and no more than five per 
day in any one week  
 
 
 
21. Which of the following recommendations would you regard as the most urgent 
recommendation to tell Mr Parker about his new prescription?  
 
A Advise him to start his new prescription and take other analgesics as needed.  
B Advise him that his new prescription will most likely reduce his need for other pain relievers 
– Tramadol and Codalgin Forte.  
 
C Tell him to make an appointment with his GP to confirm what medicines he should be on.  
D Tell him that this prescription replaces all other analgesics.    
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Appendix 8: CPD survey: demographics 
Sions 1:Views  
 
 
 
1. I am comfortable with the technology changes taking place in pharmacy 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
 
 
 
2. I see the traditional sources of pharmacy remuneration as the only source of funds for 
the future 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
 
 
 
3. For me pharmacy is just a job 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
 
 
 
4. I believe that pharmacists currently have too much to do and there is no capacity for 
change 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
 
 
 
5. I generally enjoy my work 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
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6. A pharmacist's most important job is dispensing 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
 
 
 
7. I am comfortable selling a product that may be of questionable therapeutic value as 
long as it is not harmful 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
 
 
 
 
8. I am able to perform my expected duties without interruption 
 
Unsure  
Strongly agree  
Agree  
Neutral  
Disagree  
Strongly disagree  
 
 
Sections 2:Use of website  
Website: 
  
 
1. For this website - how easy or difficult was it to use? 
 
Very difficult  
Difficult  
Neither difficult nor easy  
Easy  
Very easy  
Not sure     Please Specify …………………………………………………………. 
 
 
 
2. For this website - How easy or difficult was it to navigate? 
 
Very difficult  
Difficult  
Neither difficult nor easy  
Easy  
Very easy  
Not sure     Please Specify  …………………………………………………………. 
 
 
 
3. The material in these modules was easy to follow 
 
Very difficult  
Difficult  
Neither difficult nor easy  
Easy  
Very easy  
Not sure     Please Specify  …………………………………………………………. 
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The first 100 registered 
users who complete all 
the modules will be 
entered in a competition 
to win two bottles of 
Tasmanian wine 
Appendix 9: Online self-assessment flier 
 
 
Pharmacists’ 
Skills Assessment
 
Test your knowledge …… 
In the management of   
diabetes, asthma and pain 
 
 
 
 
 
No time to attend CE? 
Prefer to learn at a time to suit your lifestyle? 
Not sure how up-to-date your knowledge is? 
Need to do more CE activities for your portfolio? 
 
As part of a Masters research project, a free self-assessment tool designed to help you keep in 
touch has been developed with you in mind. CPD points under the CPD&PI program for 
PSA and SHPA accreditation have been applied for. 
Try your hand with the following case-based assessment tools: 
 
Pain management 
Diabetes 
Asthma 
 
How can you access these tools? 
To get a password and web address, 
send an email or contact: 
Mary Collins 
Ph +61362310672, Fax +61362313531 
Mobile 0418329398 
email: marycollins@netspace.net.au 
Registration is free 
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Appendix 10: Instructions for modules on Fourpoint Learning 
 
Dear ………………. 
Online modules guide 
 
 
Thank you for your request to use this self-assessment series of online modules developed as 
part of my Masters research. Your responses and assessment of these modules are 
confidential and will not be disclosed to a third party. 
 
The self-assessment tools are located on the Fourpoint learning website –  
http://umore.fourpointlearning.com/  
 
Instructions to the modules are attached 
 
Log in as a learner using the following: 
User name: …………….. 
Password: ……………… 
 
List of modules - (it is important to do the self-assessment modules before you do the 
surveys for each topic) 
 
Asthma management: 
1. Asthma self-assessment  
2. Asthma survey – for completion after you finish the self-assessment 
 
Pain management: 
1. Pain self-assessment 
2. Pain survey – for completion after you finish the self-assessment 
 
Diabetes management: 
1. Diabetes self-assessment 
2. Diabetes survey – for completion after you finish the self-assessment 
 
Volunteer Pharmacists: 
 General Pharmacists Survey – please complete this to obtain your CPD points  
 
Please choose as many modules that you would like to do. The Pharmacist Survey 
questions are short and will only take five minutes.  
 
Thank you for choosing these modules as part of your CPD activities. 
 
Yours sincerely 
 
Mary  
 
 
Mary Collins 
 
